The use of Raman spectroscopy for the live aseptic monitoring of stem cell differentiation by Mitchell, Adam James
- i - 
The use of Raman Spectroscopy for the Live Aseptic Monitoring of 
Stem Cell Differentiation   
 
Adam James Mitchell  
 
Submitted in accordance with the requirements for the degree of 
Doctorate of Philosophy 
 
The University of Leeds 
Faculty of Engineering 
School of Mechanical Engineering 
 
December 2014 
  
- ii - 
The candidate confirms that the work submitted is his/her own and that appropriate 
credit has been given where reference has been made to the work of others. 
 
 
This copy has been supplied on the understanding that it is copyright material and 
that no quotation from the thesis may be published without proper 
acknowledgement. 
 
 
2014, The University of Leeds and Adam James Mitchell 
- iii - 
Acknowledgements 
This has been a fantastic experience of highs and lows from start to finish. First off I 
would like to thank my three supervisors, Jennifer Kirkham, Xuebin Yang and 
Alastair Smith for their guidance, patience and understanding, particularly when 
things didn’t always go to plan. I would like to thank all the staff in the Oral Biology 
department at the University of Leeds but especially Claire Godfrey for the 
administrative support necessary when working between two sites, El Mostafa Raif 
for support and advice in cell culture and Jackie Hudson for providing training in 
histology and scanning electron microscopy. Secondly, thanks to the people at 
Avacta Group plc for helping me to establish my own cell culture facilities in their 
labs and accommodating my every need. A particular thanks to Kurt Baldwin for 
training me how to use the Raman spectrometer and always being available 
whenever it had any problems. Finally I would like to thank Lorna Ashton and Roy 
Goodacre from the University of Manchester for the training in principal component 
analysis and the use of Matlab, possibly the singularly most complicated computer 
program I have ever used!  
- iv - 
Publications and Presentations 
Research Papers 
 Raman Spectroscopy using an Aseptic Method can Detect Changes 
Associated with Osteogenic Differentiation in Dental Pulp Stromal Cells. 
PLOS one (under revision) 
Oral Presentations 
 Raman Spectroscopy in the Non-invasive Phenotyping of Human Dental 
Pulp Stem Cells (hDPSCs) – Identification of a Suitable Substrate for Cell 
Culture. Leeds School of Dentistry postgraduate research day, July 2012 
 
 Raman spectroscopy can be used to non-invasively and aseptically 
characterise stem cell differentiation. Leeds School of Dentistry postgraduate 
research day, July 2014 (1st place – oral presentation) 
 
 Raman spectroscopy can be used to non-invasively and aseptically 
characterise stem cell differentiation. Joint Doctoral Training Centre in 
Tissue Engineering and Regenerative Medicine conference, July 2014 
 
Poster Presentations 
 Raman Spectroscopy in the Non-invasive Phenotyping of Human Dental 
Pulp Stem Cells (hDPSCs) – Identification of a Suitable Substrate for Cell 
Culture. Joint Doctoral Training Centre in Tissue Engineering and 
Regenerative Medicine conference, July 2012 
 
 Development of a method for the non-invasive and non-destructive 
characterisation of human dental pulp stem cells. Leeds School of Dentistry 
postgraduate research day, July 2013 
 
- v - 
 Development of a method for the non-invasive and non-destructive 
characterisation of human dental pulp stem cells. Joint Doctoral Training 
Centre in Tissue Engineering and Regenerative Medicine conference, July 
2013 
 
 Development of a method for the non-invasive and non-destructive 
characterisation of human dental pulp stem cells. Regener8 conference, 
Leeds, October 2013 
 
 Raman Spectroscopy Using an Aseptic Method can Characterise Osteo-
induction in Dental Pulp Stromal Cells. Termis EU, Genoa, Italy, June 2014 
 
 Raman Spectroscopy Using an Aseptic Method can Characterise Osteo-
induction in Dental Pulp Stromal Cells. International Association of Dental 
Research world congress, Cape Town, South Africa, June 2014 
 
Research papers and conference abstracts can be found in Appendix C.  
 
- vi - 
Abstract 
The characterisation of stem cell differentiation is currently performed using 
invasive/destructive methods, precluding cells from further use. There is  an unmet 
need for techniques capable of characterising cells non-invasively in order to 
enhance the translation of stem cell-based therapies. Raman spectroscopy has 
previously been used to characterise cells and is non-invasive. However, almost all 
previous studies were not performed under aseptic conditions precluding any further 
use of those cells. The aim of this thesis was to determine whether Raman spectra 
could be acquired from the same stem cell cultures undergoing differentiation over 
time without compromising the sterility of these cell cultures and to identify aspects 
of the Raman spectra that may be used to predict eventual cell fate. Custom-built 
cell culture flasks with quartz windows (appropriate for acquiring Raman spectra) 
provided a platform for the maintenance of cell sterility whilst permitting the 
acquisition of Raman spectra comparable to those in the published literature. It was 
found that the osteogenic differentiation of dental pulp stem cells was associated 
with changes in protein content early in the process and prior to the end result being 
evident by the emergence of mineralised nodules. The adipogenic differentiation of 
adipose derived stem cells was found to be characterised by changes in lipid content 
throughout differentiation with the earliest detectable change after 3 days of 
differentiation. This is earlier than can typically be detected using currently 
established methods. Stem cell differentiation was also confirmed using 
conventional techniques including qRT-PCR and histology. Raman spectroscopy 
cannot provide the intricate detail of genetic/protein changes that occur as stem cells 
differentiate. However, this thesis demonstrates that stem cell fate can be monitored 
in an entirely non-invasive manner and could be applied to the scaled up production 
of differentiated stem cells for either clinical use or in a research setting. 
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Chapter 1  
Introduction 
1.1 Overview of Tissue Engineering 
An oft cited review in 1993 by Langer and Vacanti (1) marked the emergence of 
tissue engineering as a field in its own right. In this review the authors defined tissue 
engineering as “an interdisciplinary field that applies the principles of engineering 
and the life sciences toward  the development of biological substitutes that restore, 
maintain, or improve tissue function”. Current definitions have expanded upon this 
initial premise but the guiding principle remains the same. The current paradigm 
(Figure 1) in tissue engineering utilises one or more components drawn from cells, 
materials, chemical or physical cues to achieve a therapy capable of treating a given 
disease/condition. Researchers in the field are now taking this approach to repair or 
replace almost every tissue in the human body (2). 
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Figure 1. Schematic overview of tissue engineering and the factors involved. 
 
1.1.1 Materials used in Tissue Engineering 
Each tissue presents unique challenges in its repair or replacement, the cells and 
materials required to produce the desired architecture to replace bone are clearly 
different to those required to replace a blood vessel. There is a need to marry the 
structure and function of the tissue that is damaged/impaired to the design of the 
tissue engineering approach undertaken to replace/regenerate that tissue. Table 1 
outlines some of these approaches. 
  
 
• Mechcanical
• Electrical
• Pulsatile
• Growth factors
• Hormones
• siRNAs
• Natural/synthetic 
polymers
• Decellularised 
scaffolds
• Self assembling   
peptides
• Induced 
pluripotent stem 
cells (iPS)
• Embryonic stem 
cells
• Somatic stem 
cells
Cells Materials
Physical   cuesChemical cues
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Table 1. A selection of body tissues, their structure and function and biomaterials designed for their replacement/regeneration. 
Tissue Structure Function Biomaterials 
Bone Porous biological (primarily type I 
collagen) and mineral (hydroxyapatite) 
composite imparting flexibility and 
strength respectively 
Primarily to withstand and 
evenly distribute compressive 
forces 
Glass ceramic/polymer 
composites that mimic strength 
and flexibility       (3, 4) 
Intervertebral disc Gelatinous collagen matrix with high 
proteoglycan content creating a high 
swelling pressure 
Acts as a shock absorber in the 
spine able to resist high 
compressive forces and permits 
3D rotational movement 
Hydrogels that mimic high 
swelling pressure (5) 
Skin Highly cellular and vascular tissue with 
a porous elastic proteinaceous 
membrane  
Primarily to act a barrier capable 
of rapid healing 
Porous polymer meshes that 
can encourage cellular 
migration and vascularisation     
(6, 7) 
Tendon/ligament Primarily type I collagen arranged in 
uniaxial fibres with a “crimp-like” 
structure permitting elongation and 
tensile resistance 
Stabilise joints by constraining 
their range of motion 
Aligned polymer fibres with a 
high tensile strength (8, 9) 
Vasculature Layers of circumferential and axial 
aligned collagen and elastic fibres with 
high tensile strength and resistance to 
sheer stress  
To transport blood at a wide 
range of pressures 
Ordered polymer scaffolds 
primed by mechanical strains 
(10, 11) 
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1.1.1.1 Glass/ceramics in Tissue Engineering 
Glass/ceramics represent a class of inorganic materials that are typically used in 
bone tissue engineering. Perhaps one of the oldest materials is Bioglass® which is 
composed of SiO2, Na2O, CaO and P2O5, the weights of which vary according to the 
specific formulation. Bioglass® has been shown to bind to both the soft tissue and 
bone were it is implanted promoting osteogenesis and has been in clinical use since 
1985 (12). There have since been many attempts toward attenuating glass/ceramic 
scaffolds through manipulation of their composition, in order to better match their 
mechanical properties and porous architecture to those of native bone, with mixed 
results (3). Native bone contains both an inorganic mineral phase and an organic 
polymer phase that impart both its strength and flexibility. This has led to the 
development of composite glass/ceramic/polymer scaffolds in order to produce a 
scaffold that is mechanically strong yet flexible and permits enhanced attachment 
and proliferation of cells (4). There are a small number of composite scaffolds 
commercially available such as Actifuse, a silicon substituted hydroxyapatite mixed 
with a resorbable polymer, marketed by Baxter. 
 
1.1.1.2 Synthetic Polymers in Tissue Engineering  
Synthetic polymers based on poly(α-hydroxyesters), such as poly-glycolic acid, 
poly-lactic acid, their co polymer, poly(lactic-co-glycolic) acid (PLGA) and poly-
capralactone are widely used materials in tissue engineering (13). Such materials are 
already approved for medical uses by the U.S. Food and Drug Administration 
(FDA), initially for use as biodegradable sutures (14). Their uses are now vast, from 
musculoskeletal (15, 16) to nerve (17) and vascular tissue engineering (18). 
However, one of the drawbacks of such synthetic polymers is a lack of compatibility 
with cells, particularly, a lack of cell binding sites. This has led to increasingly 
complex methods of synthesis to improve their bioactivity, such as the incorporation 
of RGD cell binding motifs (19) or the tuneable release of bioactive compounds, 
such as transforming growth factors or bone morphogenetic proteins (20). Despite 
this several products based on synthetic polymers have reached the market including 
InQu®, a PLGA bone void filler marketed by Integra LifeSciences and X-repair, a 
woven PLLA mesh, used for soft tissue reinforcement during surgery marketed by 
Synthasome (14). 
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1.1.1.3 Natural Polymers in Tissue Engineering 
Natural bio-polymers do not suffer the same issues, such as a lack of bioactivity or 
cell binding sites, as synthetic polymers and are usually based on extracellular 
matrix proteins (ECM) and other macromolecules such as collagen, fibrin or 
hyaluronic acid (21). Collagens, primarily types I and II, are perhaps the most 
widely used natural polymers in tissue engineering applications as they are structural 
proteins found in the ECM of most tissues. Collagens can be processed into many 
formats including membranes (22), sponges (23) and hydrogels (24) and have been 
used in a number of different contexts including as nerve conduits for peripheral 
nerve repair (25), bladder reconstruction (26) and as skin substitutes (27). Natural 
scaffolds tend to mechanically inferior than the native tissue they are intended to 
replace due to difficulties in synthesis and processing (28). As with synthetic 
polymers some natural polymers are already available within the marketplace, 
including Excellagen®, used to treat diabetic foot ulcers, marketed by Cardium 
Therapeutics and EndoformTM, a wound dressing marketed by Mesynthes (14). 
 
1.1.1.4 Decellularised Biological Scaffolds in Tissue Engineering 
In order to retain gross tissue architecture and the intrinsic mechanical properties of 
tissues, researchers have decellularised natural tissues leaving the native ECM as a 
“biological scaffold”. The decellularisation process involves the use of detergents, 
chemicals and enzymes and may also require mechanical forces, though the exact 
parameters are generally dependent on the size and structure of the tissue/organ 
being decellularised (29). Ultimately the goal is to remove all immunogenic material 
from the tissue to prevent rejection whilst retaining as much of the native ECM and 
glycosaminoglycan’s (GAGs) as possible. A range of tissues, skin (30), tendon (31), 
bone (32) and organs, lung (33), liver (34) and kidney (35) have been decellularised 
and assessed. Whilst much of this research is still confined to animal models, a few 
decellularised products have made it to market including CryoValve® SG for 
pulmonary heart valve replacement marketed by CyroLife and Vascu-Guard®, a 
peripheral vascular patch marketed by Synovis (14). However, such products do not 
contain a cellular component which has made their regulatory approval more 
expedient. Research into decellularised scaffolds may envision a second stage where 
the scaffold is repopulated by the patient’s own stem cells prior to implantation. 
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1.2 Stem Cells and Stem Cell Based Therapies 
“Regenerative medicine” whilst frequently synonymous/combined with tissue 
engineering often puts greater emphasis on the use of stem cells to achieve the same 
goals. Stem cells have been known to science since the early 20th century with one 
of the earliest references being to what is now known as the haematopoietic stem 
cell (HSC) (36). Now widely studied, stem cells are considered to possess many 
potential applications in regenerative medicine. Intrinsic to this perception are the 
characteristics that define stem cells, namely their capacity for self-renewal and the 
potential to differentiate into one or more specialised adult cell(s) (37). Whilst it is 
true that stem cells exhibit extensive self-renewal in vitro (38), several groups have 
shown that stem cells in vivo undergo limited self-renewal, instead they maintain a 
quiescent state for the majority of normal tissue homeostasis (39, 40). Nevertheless, 
the capacity for rapid expansion ex vivo is one of the key driving forces behind stem 
cell research in regenerative medicine. 
 
1.2.1 Stem Cell Classification 
The mechanisms underpinning stem cell self-renewal vary widely between different 
stem cell populations. Self-renewal is regulated by the complex interplay between 
signalling pathways controlling the cell cycle and through interactions with the local 
microenvironment, such as the ECM and soluble growth factors and hormones (41). 
Much of this variation is linked to the developmental potential of a given stem cell, 
described as “stem cell potency” or “stemness”. Potency is a hierarchical 
classification beginning with totipotent, through pluripotent, multipotent and 
unipotent into which the majority of stem cells can be classified (Figure 2).  
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Figure 2. Overview of stem cell hierarchy with examples of cells. HSC – 
haematopoietic stem cell, MSC mesenchymal stem cell, RBC – red blood 
cell 
 
In nature only the zygote, formed after the fusion of the gametes, can be considered 
a truly totipotent cell. Totipotency therefore refers to the fact that a cell is capable of 
generating an entire organism including all of its cells and those of the extra-
embryonic tissues. However, a study by Mitalipov et al 2002 (42) suggested that 
cells of the morula at the 2 and 4 cell stage following the division of the zygote may 
also be considered to be totipotent as they were found to be capable of establishing 
fully developed Rhesus monkeys upon isolation and in vitro fertilisation 
transplantation.  
 
Approximately one week into human embryonic development, the blastocyst forms. 
The cells of the blastocyst inner mass are considered as embryonic stem cells 
(ESCs) and were first described in mice by Evans and Kaufman in 1981 (43) and in 
humans by Thomson et al in 1998 (44). Embryonic stem cells are pluripotent as they 
cannot alone give rise to a whole organism but they are capable of differentiating 
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into any of the three primary germ layers; the ectoderm, endoderm or mesoderm and 
therefore any cell within the developed organism (45, 46). This property has resulted 
in extensive research into embryonic stem cells and their potential application in 
regenerative medicine. However, research with ESCs has been stifled to an extent 
due primarily to an ethical debate regarding their isolation, the main points of which 
have been extensively reviewed by several authors (47-49). In 2006, Takahashi and 
Yamanika (50) demonstrated an ethically sound method for the production of 
pluripotent stem cells by reprogramming somatic fibroblasts using a cocktail of 
factors including Oct3/4, Sox2, c-Myc, and Klf4. The resultant cells were termed 
“induced pluripotent stem (iPS) cells”. 
 
Of particular interest to this thesis are multipotent stem cells, of which there are 
many types residing in almost all the tissues of the adult body. These include 
mesenchymal stem cells (MSCs) found in a range of tissues including bone marrow 
(51), adipose tissue (52) and dental pulp (53); HSCs, also found in the bone marrow 
(36) and neural stem cells (54). The term multipotent indicates that a stem cell may 
become any of the specialised cell types within its parent tissue. The MSC (from the 
mesodermal germ layer) is a notable exception to this rule as transdifferentiation to 
cells of the ectodermal (neural cells) and endodermal (hepatocytes) germ layers has 
been demonstrated (55, 56). Stem cell research is extensive and cell based therapies, 
in various stages of development, have been suggested for a range 
diseases/conditions. 
 
1.2.2 Stem Cell Based Therapies 
Research into stem cell based therapies ranges from basic in vitro lab based studies 
through to preclinical in vivo animal studies and the various phases of in human 
trials. Much of the early research with stem cells focused on the production of 
differentiated cell types that may have a clinical utility such as cardiomyocytes (57), 
chondrocytes (58) and hepatocytes (59) from many of the stem cell sources 
highlighted. Methods to characterise this process and to isolate and produce 
quantities of clinically relevant stem cells also featured prominently. However, 
many initial preclinical studies reported poor results when stem cells produced in 
vitro based on these early studies were used (60). It has since been demonstrated that 
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such simple in vitro studies poorly recapitulate the intricacies of stem cell mediated 
tissue repair in vivo (61). Potential reasons for this include the heterogeneity of stem 
cell populations isolated by such simple means as adherence to tissue culture plastic 
(62), inconsistent definitions regarding the characterisation of undifferentiated stem 
cells (63) and the loss of the trophic support stem cells receive from their niche in 
vivo (64). Consequently many lab based stem cell studies now seek to address these 
issues. 
 
The stem cell surface antigen profile has been extensively studied with the aim of 
improving the isolation and enrichment of therapeutically relevant stem cell 
populations. Methods such as flow cytometry have been used to isolate MSC 
subpopulations based on the expression of markers such as STRO-1, CD146 and 
SSEA-4 without any prior cell culture and have been shown to enhance colony 
forming unit – fibroblast potential resulting in a more homogenous population (65). 
Microfluidic chip systems have also been used to measure the expression of up to 96 
genes from single cells and found that the negative selection of CD105 improved the 
osteogenic potential of adipose derived MSCs (66). However, such studies serve to 
highlight the inherent heterogeneity in stem cell populations and the need for 
methods that are not reliant on such changeable markers. Furthermore, in vivo stem 
cell phenotype is maintained through the interaction between the ECM, other cells 
and the associated paracrine/autocrine signalling and mechanical forces (67-69). In 
recognition of this there is growing interest in the co-culture of stem cells with other 
‘supportive’ cell populations (70) as opposed to stem cell enrichment strategies. 
 
Greater control over the stem cell microenvironment can include many factors such 
as oxygen tension, medium perfusion, multicellular cultures and substrate stiffness, 
topography and epitope presentation. Oxygen tension is known to have a significant 
impact on cellular biology. Tissues in the body, from cartilage to circulating blood, 
are exposed to a range of oxygen concentrations (2-13%) and this has led to attempts 
to optimise oxygen supplementation in vitro to affect stem cell proliferation and 
differentiation (71-73). Similarly medium perfusion has been shown to affect both 
stem cell proliferation and differentiation down multiple lineages including neural 
and cardiac (74-76). Cells in vivo are rarely in a homogenous environment and the 
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co-culture of two or more cells types aims to recapitulate the cross-talk found 
between cells of different types. The co-culture of stem cells with endothelial cells 
has been widely studied and shows promise in stimulating angiogenesis and 
neovascularisation (77). Finally,  the substrate on which cells are cultured possess 
many characteristics that influence cell fate including stiffness, topography and 
biochemistry and have been extensively reviewed (60, 78, 79) 
      
Regardless of the many unanswered questions, in 2011 Trounson et al (80) recorded 
that there were 123 clinical trials using MSCs listed on clinicaltrials.gov; as of July 
2014 that number stood at 411 MSC based therapies at various stages of 
development. Significant progress with stem cell based therapies has clearly been 
made in the last 20 years. However, to enhance the clinical translation of stem cell 
based therapies and facilitate their scale up, non-invasive methods that are not 
perturbed by the myriad factors governing stem cell differentiation are highly 
desirable. There are many techniques that could be applied to the non-invasive 
characterisation of stem cells, some of which are listed in Table 2; of particular 
interest to this thesis is Raman spectroscopy which is more comprehensively 
described in the following sections. 
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Table 2. List of techniques that are or could be used for the non-invasive characterisation of stem cells, their mode of action and some of 
their current uses.
Technique Mode of action Current uses 
Dielectric/impedance 
spectroscopy 
Measures the interaction of a sample with a range of 
radio-frequency alternating current fields 
Combined with fluidics can be used to separate cells in 
suspension based on their electric impedance (81, 82) 
Light scattering spectroscopy Measures elastic light scattering at visible wavelengths  Measurement of the size of intracellular organelles 
such as the nucleus which can be enlarged in 
conditions such as cancer (83) 
Optical coherence tomography Analogous to ultrasound, uses light reflected from 
within 3D samples to construct an internal image  
Mapping the movements and formation of cellular 
structures within tissue engineered constructs (84, 85) 
Photoacoustic microscopy Based on the detection sound waves, induced by the 
absorbance of near infrared pulses supplied to a 
sample 
Similar to optical coherence tomography, can be used 
to map tissue engineered constructs (85) 
Raman spectroscopy Discussed in section 1.3.2 Discussed in section 1.5 
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1.3 Principles of Spectroscopy, Particularly Raman Spectroscopy 
1.3.1 Basics of Spectroscopy 
In the most basic sense, spectroscopy can be described as the study of matter using 
electromagnetic radiation (86). The electromagnetic (EM) spectrum (Figure 3) 
describes light as a function of its wavelength from sub nanometre gamma rays to 
radio waves in the order of metres. 
 
 
Figure 3. Depiction of the electromagnetic spectrum (87). 
 
In its most basic iteration a spectroscope contains a light source which is focused on 
to a sample, the light from which is split by a prism and collected on a screen 
(Figure 4). In such a spectroscope the sample will absorb photons (or emit if heated) 
of a certain wavelength of light according to its chemical composition creating a 
unique spectrum of light on the collecting screen. Every element generates a unique 
spectrum in this manner and several elements including rubidium and caesium were 
first discovered by spectroscopy. 
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Figure 4. A simplified schematic of the first spectroscope created by created by 
Bunsen and Kirchhoff in 1860, adapted from (86). 
 
Modern spectroscopes are far more complicated than this simplistic model but have 
been developed to utilise a light source drawn from almost every part of the 
electromagnetic spectrum with each describing different properties of the sample 
analysed. Some of the most common forms of spectroscopy with potential 
applications in biomedical research are listed in Table 3, many of which can be used 
in a non-invasive and non-destructive manner. 
 
 
  
 
 
Prism 
Light source 
Sample 
Screen 
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Table 3. Brief summary of spectroscopic techniques with biomedical applications  
EM Region Spectroscopic Technique Process Involved Biological Applications 
Radiowave Nuclear magnetic resonance (NMR) Changing nuclear spin orientation In vivo imaging and quantification of 
metabolites in the brain and tumour 
identification (88, 89) 
Microwave Electron spin resonance (ESR) Changing electron spin orientation In vivo measurement of tissue pO2 and 
redox status (90, 91) 
Infrared Fourier transform (FTIR), Raman Changing molecular vibrational state Molecular characterisation of cells, tissues 
and tumours (92-94) 
Visible/Ultraviolet 
(UV) 
Steady state reflectance/fluorescence 
spectroscopy 
Changing atomic or molecular 
electronic state 
In vivo cancer biomarker detection, 
reviewed in (95) 
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1.3.2 Raman Spectroscopy and its Derivatives 
Raman as with other forms of spectroscopy, measures the interaction between 
certain wavelengths of electromagnetic radiation with matter. However, it is unique 
amongst other forms of spectroscopy in that it measures a difference in the energy of 
incident and emitted photons as opposed to the energy of the photons themselves 
(96). This is due to a process known as the Raman Effect, or the inelastic scattering 
of light.  Briefly, during inelastic scattering, incident light interacts with the nuclei 
of a molecule, which results in their displacement with respect to their electron 
clouds. Such displacements represent distinct energy levels different to the non-
excited/ground state and are referred to as vibrational energy states. Hence a shift 
occurs in the energy level of emitted photons with respect to the incident photons 
due to their differing energy levels, known as a Raman shift, essentially inelastic 
light scattering, (Figure 5). Detection of Raman shifts yields information as to the 
vibrational state of the molecule under investigation and by extension its molecular 
bonds and composition as many molecular bonds possess a unique Raman shift. For 
a thorough review of biological Raman peak assignments please refer to (97). A plot 
of all the Raman shifts observed in a sample produces a spectrum where shifts are 
characterised in wavenumbers (inverse of wavelength in cm-1) from the incident 
frequency.  
 
 
Figure 5. Schematic energy level diagram of Raman spectroscopy, where νp is 
the frequency of the incident/absorbed photon and νs is the frequency of 
the emitted photon, the difference between the two equalling the 
vibrational energy state of the molecular species being characterised, (98). 
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There are several key parts to a basic Raman apparatus, an EM source, typically a 
monochromatic laser, a focusing lens, dichroic mirror, a spectrometer, and a 
detector, typically a cooled silicon charge coupled device (CCD), (Figure 6). Raman 
spectra may also be mapped to an image if a microscope is incorporated (98). The 
most common lasers currently used in the acquisition of spectra from live cells 
operate in the near infra-red region of the EM spectrum at wavelengths of 633 nm 
(HeNe laser) and 785 nm (AlGaAs diode) (99-104). The wavelengths selected are in 
part predetermined by limitations in the silicon CCDs that detect the Raman shift 
(they rapidly lose response at wavelengths >1000 nm) (92) but the selection of 
wavelength can also be seen as a compromise. Shorter wavelengths improve 
inelastic scattering efficiency and the spatial resolution of images that are captured, 
whilst longer wavelengths reduce the amount of background signal due to their 
greater power (105); though there is evidence that higher powered lasers can induce 
photodamage, a light induced reduction in cell viability (106). A lens is used to 
focus the incident light on to the sample. Emitted light is then directed to a dichroic 
mirror which separates light of an identical wavelength to the incident light, i.e. 
elastically scattered light, from the Raman shifted light which is directed to a 
spectrometer. The spectrometer splits the Raman shifted light into a spectrum which 
is recorded by a cooled silicon CCD (98). When a microscope is incorporated the 
image emitted by the sample through the microscope is channelled in the same way 
to the CCD but the spectral data is mapped to the image localising the intensity of 
the Raman shifts to the image (107). 
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Laser 
Lens 
Dichroic mirror Sample 
Spectrometer 
Silicon CCD  
Figure 6. Schematic representation of the components in a basic Raman 
experiment, additional or more specialised components can be included 
according to the application. 
 
Raman scattering is a highly inefficient process. It is estimated that between 1x106-
1x108 (108) or 1x1010 (109) photons will shift in wavelength upon interaction with a 
sample. Due to this, several derivatives of the basic Raman technique have been 
developed, including resonance Raman spectroscopy (RRS), surface and tip 
enhanced Raman spectroscopy (SERS and TERS), and coherent anti-stokes Raman 
spectroscopy (CARS). RRS uses lasers that excite the sample in the UV range (<270 
nm). It is termed resonance Raman spectroscopy as the excitation wavelength of the 
laser is matched to the absorption maximum of the molecule of interest. The key 
advantage to RRS is that by using UV lasers the Raman shifts occur in an area of the 
spectrum far from the background noise, vastly improving the resolution of the 
spectral data of interest (110). However, the technique is unsuitable for live cell 
imaging due to the potential for photo-induced mutagenicity through the use of UV 
lasers (111). SERS and TERS operate through the same principle, using metal ions - 
most often gold - to improve the resolution of images acquired by microscopes 
attached to a Raman spectrometer. In SERS, gold nanoparticles, generally coated in 
surfactant to prevent aggregation, are added to the sample. This has dual effects, first 
amplifying the power of the incident light thereby reducing the background noise 
with respect to the Raman signal, and second enhancing the Raman shifted signal 
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itself by several orders of magnitude (98). TERS works by the same principles as 
SERS, however gold is coated on the tip of an atomic force microscope in order to 
produce similar effects (112). However, neither approach is suitable for the non-
invasive imaging of live cells due to the introduction of exogenous metal ions. In 
CARS two lasers are shone on the sample, the difference in excitation wavelength 
between which corresponds to the vibrational frequency of a molecule of interest. 
As with SERS and TERS, CARS improves the resolution of Raman spectral images 
by approximately a factor of 5, producing highly detailed maps in much shorter 
timescales than with normal Raman. However, excitation of a sample at only one 
vibrational frequency greatly reduces the amount of spectral information generated 
and whilst it is possible to perform excitation at sequential frequencies, the 
propensity for live cells and their organelles to move could greatly reduce the 
accuracy of results (92, 98).  
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1.4 Analysis and Interpretation of Raman Spectra 
1.4.1 Pre-processing of Spectra 
Aside from containing chemically relevant data from a sample, Raman spectra also 
contain several extraneous components that should be removed prior to any further 
meaningful analysis. This can include fluorescence background, CCD noise, 
Gaussian noise and cosmic noise. The Raman signal from materials in the vicinity of 
the sample must also be removed (113). The method by which this is carried out is 
termed “pre-processing” and there are many approaches available to execute this. 
The aim of pre-processing is to improve the robustness and interpretability of the 
data whilst removing outliers and irrelevant data (114). Some of these techniques 
including smoothing, baseline correction, normalisation and the differentiation of 
spectra are extensively reviewed elsewhere (114, 115).  
 
Smoothing of spectra can be reasonably simple and generally involves some 
averaging of data points (116). Baseline corrections can be achieved most simply by 
an offset correction, that is, reducing the lowest point on the spectrum to zero and 
reducing all other points by the appropriate amount. A more accurate baseline 
correction involves fitting a polynomial line to the spectrum and this is particularly 
useful in removing the fluorescence background from Raman spectra (117). 
Derivative methods such as the first or second derivative are also particularly useful 
at removing the fluorescence background from Raman spectra (118). One 
commonly used smoothing filter which is also a derivative method and can be used 
to correct a baseline is the Savitzky-Golay filter (119). Here a polynomial line is 
drawn beneath the spectrum to remove the baseline and a number of points are 
selected for the averaging and smoothing of the remaining spectrum. Figure 7 
illustrates a baseline correction by fitting a polynomial line with smoothing.  
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Figure 7. An illustration of a baseline correction to a Raman spectrum by 
fitting and subtracting a polynomial line (drawn in red).  
 
The selection of which pre-processing technique is to be used on a given data set is 
very much dependant on the individual data and the severity of the extraneous 
influences within it. Further, poor pre-processing can influence the quality of any 
subsequent analysis and even produce false positives. In order to prevent this most 
researchers conduct a “grid search”, in essence conducting all possible combinations 
of pre-processing in order to find the appropriate combination. This can be a highly 
time consuming process but a study by Bocklitz et al 2011 (113) demonstrated that 
the process could be performed and optimised using a genetic algorithm to find the 
best possible combination of available techniques using several different data sets. 
 
1.4.2 Multivariate Analysis of Spectra 
Raman spectra typically have many data points most of which represent 
biochemically important data, all of which have the potential to be associated with 
one another. As such there is a need for techniques capable of uncovering and 
describing this inherent complexity. Multivariate analysis techniques achieve this by 
simplifying a data set and so aiding its visualisation and may also permit 
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classification or prediction of outcome (120). There are many techniques and some 
of the most commonly used to visualise spectral data include principal component 
analysis (PCA), partial least squares (PLS), multiple linear regression (MLR), 
artificial neural networks (ANN) and genetic algorithms (GA).  
 
PCA, perhaps the most commonly used method, takes a data matrix (tabulated 
spectral data) and reduces it into principal components (PCs). PCs describe the 
variance of the data set where PC1 contains the most variation, PC2 the second most 
variation and so on. In the case of spectral data, this means that the wavenumbers 
(peaks that relate to particular molecular species) that vary most are grouped in PC1 
and so on. In order to visualise the data, each spectrum in the data matrix is assigned 
a score and each wavenumber a loading for each PC. Scores and loadings can both 
be plotted and provide complementary results. The scores for two principal 
components can be plotted against one another in a scatter plot and this reveals how 
the spectra in the original data matrix cluster according to the variables contained 
within the two selected PCs. As such the scores plot can be used to classify the 
original spectra according to selected variables. The variables within a PC can be 
visualised with a loadings plot. The loadings for a single PC can be presented as a 
line graph revealing which wavenumbers vary most within that PC. The loadings for 
two PCs can also be presented as a scatter plot and when taken with scores plot from 
the same two PCs can be used to visualise upon which clusters of spectra the 
wavenumbers which constitute those loadings vary the most. All of this means that 
PCA can be used to identify trends, clusters and outliers within a data set and then 
relate this back to the biochemical nature of the sample investigated (120-123).  
 
Figure 8 contains an example of this description of PCA from a tutorial review of 
PCA by Bro and Smilde 2014 (121). In this example 44 different wines produced in 
4 regions (Argentina, Australia, Chile and South Africa) were compared on the basis 
of 14 different variables (ethanol, total acid, volatileA, malic acid, pH, lactic acid, 
sugar, citric acid, CO2, density, folinC, glycerol, methanol and tartaricA). The first 
aim of this analysis was to ascertain if wines produced in the same region were 
similar to one another. Figure 8A is the PCA scores plot for the data using PC1 and 
PC2; it shows that wines from each region tended to cluster together according to 
the variables measured/their composition. In order to determine which variables 
- 22 - 
were most important in the wines from each region, the loadings for PC1 and PC2 
were plotted against one another (Figure 8B). Chilean wines were found in the lower 
left quadrant of the scores plot and citric acid and CO2 were found in the same 
quadrant of the loadings plot, indicating that Chilean wine is best described by its 
citric acid and CO2 content. Similarly, Australian wines were found in the upper 
right quadrant of the scores plot and ethanol, methanol and glycerol are found in the 
same quadrant of the loadings plot, indicating that Australian wine is best described 
by its ethanol, methanol and glycerol content. Due to the absence of any wines in the 
lower right quadrant of the scores plot, malic acid found in the same quadrant of the 
loadings plot is a poor variable for describing any of the wines, at least as far as PCs 
1 and 2 are concerned. Figure 8C shows bar charts of the loadings for each 
individual PC. In this case, bar charts are the best representation as these variables 
are discrete data. In the case of spectra, which are continuous data, these loadings 
would be best drawn as line graphs.  
 
Figure 8. An illustrated example of how PCA data can be represented. The 
analysis was performed on 44 different wines produced in 4 different 
regions using 14 different variables to characterise them. A) PCA scores 
plot for PCs 1 and 2, B) Loadings for PC1 vs PC2, C) individual loadings 
for PC1 and PC2. Figures reproduced from (121). 
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PLS like PCA is a method to reduce the dimensionality of a data set producing 
scores and loadings plots that can be used to derive similar visualisation of the data. 
Where they differ is in the method for the calculation of scores and loadings (120). 
 
ANNs and GAs are techniques that are also used to solve prediction and 
classification problems and are beginning to be more widely used to analyse spectral 
data. ANNs are a computational algorithm that attempts to simulate the 
interconnectedness of biological neural networks. They contain inputs, (in the case 
of spectra wavenumbers) one or more hidden layers of neurons also termed 
processing elements, and outputs, (Figure 9). Using an iterative process of changing 
the weightings of the inputs, the network is able to ‘learn’ which features best 
describe the inputs. If a network is first trained with a data set with a known 
classification, it can then be subsequently used to predict the classification of any 
further data (124, 125). GA algorithms attempt to simulate the processes of meiosis 
and reproduction, which, in the biological sense, after many generations might be 
termed “evolution”, in that only the most fit recombination’s of genetic information 
survive. For GAs the input, in this case spectral, goes through an iterative process of 
division and recombination in an effort to identify those features which best 
approximate the input where the best approximations are retained whilst the poorest 
are discarded. As with ANNs this process can be used to classify and predict new 
data (126). Both ANNs and GAs have found a wide variety of applications from 
accounting and finance, health and medical, engineering, manufacturing and 
marketing (125). 
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Figure 9. Basic architecture of an ANN. Circled are the nodes or processing 
elements (PE). Each PE is connected to all PEs in the layer beneath. In the 
case of spectra the input layer contains the intensity of each wavenumber 
of the spectra. The nodes in the hidden layer contain a function that 
transforms the data and the output layer is the result. Through an 
iterative process of communication between the layers, the ANN ‘learns’ 
which of those inputs best describe the data as a whole. Figure adapted 
from (127).  
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1.5 Raman Spectroscopy and Stem Cells 
There are several examples where Raman spectroscopy has been/is being used as an 
adjunct to stem cell research. For example, Raman spectroscopy has been used to 
determine cell viability (99, 128, 129), to discriminate between various different cell 
types (102, 130), to identify general markers of stem cell differentiation (104, 128, 
131), to track stem cell differentiation to an osteoblastic phenotype (132), and to 
elucidate changes in ECM crystallinity with osteoblastic differentiation (101, 133, 
134).  
 
1.5.1 Raman Spectroscopy to Determine Cellular Viability 
Bai et al 2011 (99) took Raman spectra of undifferentiated umbilical cord-derived 
MSCs whose viability was either high (>90%) or low ((<20%), induced by 
starvation in PBS), predetermined by a Trypan blue assay. After statistical analysis 
they found that there was significant variation (p<0.001) in the intensity of three 
peaks at 744 cm-1 (C=O bending in tryptophan), 877 cm-1 (C-C symmetrical 
stretching in lipids) and 1342 cm-1 (CH deformation in proteins), the two former 
being 2x greater in intensity in low viability MSCs and the latter 30% lower in low 
viability MSCs. The change in intensity of the three bands was attributed to the 
generation of reactive oxygen species (ROS) caused by the reduction in viability. 
ROS are known to attack nucleic acid bases and lipids, hence the increased intensity 
of bands at 744 cm-1 and 877 cm-1. However, no further data were presented to 
support an increase in ROS, the quantification of which can be detected by several 
commercially available assays. The band at 1342 cm-1 was said to have been 
indicative of α-helical protein. ROS are known to attack di-sulphide and hydrogen 
bonds important in maintaining α-helical conformation hence a reduction in this 
band at low viability. Again however, no further data was presented to support this 
conclusion. 
 
Pully et al 2010 (128) investigated the effect on cell viability of culturing bone 
marrow derived MSCs in medium perfused microbioreactors. They identified and 
assigned peaks in their spectra at 788 cm-1 (DNA), 1004 cm-1 (phenylalanine),   
1032 cm-1 (phenylalanine), 1094 cm-1 (nucleotide backbone), 1126 cm-1 (protein), 
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1304 cm-1 (adenine), 1339cm-1 (adenine) and 1660 cm-1 (amide I) and found no 
significant variation over the course of 21 days. Whilst their spectra were not 
compared with MSCs grown in static culture (therefore not precluding the 
possibility that the presence of these bands may have been an effect of perfusion), 
their band assignments are consistent with the results of others where 
undifferentiated MSCs have been grown in static culture (99, 132, 134), indicating 
that they may be potential markers of healthy undifferentiated MSCs. They also 
noted the absence of bands at 1578 cm-1 and  1607 cm-1 which are considered to be 
indicative of necrotic cells (135). Finally, an earlier paper by Pully et al 2009 (129) 
investigated the presence of a peak at 1602 cm-1 in MSCs as well as other cell types. 
Through imaging and cluster analysis of the spectra, the band was found to be at its 
greatest intensity in the membrane of mitochondria. Though no band assignment 
was given, further evidence for a mitochondrial role/origin through the manipulation 
of Ca2+ levels (mitochondria play a key role in intracellular calcium storage and 
signalling) in the culture medium and concomitantly manipulation of the band at 
1602 cm-1 was presented. This peak, the authors argue, could therefore be 
considered a marker of healthy, metabolically active cells. 
 
1.5.2 Discriminating Between Different Cell Types Using Raman Spectroscopy 
One of the earliest studies involving cells and Raman spectroscopy utilised it to 
distinguish between differing cell types. The study by Notingher et al 2004 (102) 
looked at three different types of bone cell, primary osteoblast, SV40 large T antigen 
immortalised alveolar bone cells and the osteosarcoma cell line MG63 with the aim 
of ascertaining if Raman spectroscopy could be used to detect differences in 
phenotypically similar cell types. Using PCA and linear discriminant analysis they 
found that the two non-cancerous cell types (primary osteoblasts and SV40 alveolar 
bone cells) were clearly grouped apart for the cancerous MG63 cells with a high 
degree of prediction (96.66%). This was found to be due to differing protein and 
nuclei acid content between the two groups. A more recent study by Ilan and Kraft 
(130) sought to demonstrate that different cells, even when co-cultured, could be 
distinguished using Raman spectroscopy. In their study they took individual spectra 
from four different cell types: MDCK (Madin-Darby canine kidney cells), CHO 
(Chinese hamster ovary cells), NIH 3T3 (mouse fibroblasts), and Clone 15 
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(transfected NIH 3T3 mouse fibroblasts), using these as reference spectra to predict 
cell type with a high degree of accuracy when co-cultured. The capacity to 
accurately predict cell phenotype within a multi-cellular environment has many 
potential applications perhaps most notably in identifying cancers, another widely 
studied application for Raman spectroscopy (136-138). 
 
1.5.3 Characterising General Indicators of Stem Cell Differentiation Using 
Raman Spectroscopy 
Schulze et al 2010 (104) investigated whether Raman spectroscopy could uncover 
any general changes in cellular composition through differentiation though without 
using MSCs. They highlighted 6 bands whose intensity changed as the cells (human 
embryonic stem cell line CA1) differentiated to neural, gut, fibroblast and adipocyte 
like cells: 782 cm-1 (cysteine, uracil, thymine ring), 788 cm-1 (O-P-O stretching in 
DNA), 811 cm-1 (O-P-O stretching in RNA), nucleic acid bands, 757 cm-1 
(tryptophan ring), 937 cm-1 (C-C stretching), and 1003 cm-1 (phenylalanine ring), 
protein bands. They found a correlation in that in undifferentiated cells the nucleic 
acid band intensities were high and protein band intensities were low and that 
throughout differentiation nucleic acid band intensity decreased whilst protein band 
intensity increased. The authors’ interpretation was that undifferentiated cells are 
actively proliferating, therefore regularly doubling their DNA for mitosis, whilst 
differentiated cells are performing their function, which likely involves the 
production and secretion of proteins for numerous applications. Their conclusions 
were further confirmed through biochemical assays of cell lysates from 
differentiated and undifferentiated cells, demonstrating similar DNA/protein ratios 
to those seen using spectroscopy. A recent study by Ichimura et al 2014 (131) also 
investigated differentiation markers in embryonic stem cells using Raman 
Spectroscopy. Working at the individual cell level and using PCA to analyse the 
data, they found a clear separation between the spectra acquired from the nuclei of 
differentiated and undifferentiated ESCs. The authors did not put much emphasis on 
the band assignments of their spectra or the underlying biological meaning of the 
data, stressing that this was unnecessary if one’s aim is to remove undifferentiated 
cells from ESC cultures, cells which could ultimately be cancerous if implanted. 
However, they did speculate that epigenetic events occurring during differentiation 
may have been the cause. 
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1.5.4 Specific Indicators of Osteogenic Differentiation Determined Using Raman 
Spectroscopy 
Chiang et al 2009 (132) investigated if Raman spectroscopy could be used to 
specifically assess the differentiation of bone marrow derived MSCs to osteoblasts. 
They identified 3 bands in their MSCs following differentiation, the most prominent 
in intensity being at 960 cm-1 (PO4
3- symmetric stretch in hydroxyapatite), with 
lesser bands at 1030 cm-1 (PO4
3- asymmetrical stretching) and 1072 cm-1 (C-O 
vibration in plane stretching of CO3
2-). However, further analysis and interpretation 
of these results was lacking. In addition, there were several other issues with this 
paper. Osteogenic induction of MSCs is generally considered to take up to 28 days 
with the onset of matrix mineralisation taking place after approximately 14 days 
(139). The MSCs in this paper were only induced for 14 days. The authors state that 
prior to Raman analysis, cell were trypsinised from tissue culture plastic and 
resuspended on quartz but this could have been highly detrimental to their analysis 
as the trypsinisation process will likely remove much of the ECM produced by the 
cells which is an integral part of their phenotype. Compared with other papers, a 
relatively low number of spectra (five) were taken at each time point during 
differentiation (days 7, 11, 14 18 and 21), undermining the potential accuracy of the 
results. Finally, the authors state that they had subtracted out the contribution to their 
spectra from the biological matrix, though how and why they did this was not 
explained. Given the importance of the biological matrix in bone providing a 
nucleation site for the inorganic phase, this appears somewhat illogical. Perhaps the 
first paper to use Raman spectroscopy to demonstrate MSC differentiation to 
osteoblasts and the only paper where dental pulp-derived MSCs have been 
investigated was published by Liu et al 2005 (133). However, this was not the key 
aim of the paper, which was to characterise the expression of matrix extracellular 
phosphoglycoprotein (MEPE) with MSC differentiation. Raman spectroscopy in this 
instance was used as a tool in the end point analysis of differentiation. Peaks at    
960 cm-1 (PO4
3- stretching) and 1070 cm-1 (CO3
2-) were prominent with lesser peaks 
at 1300 cm-1, 1450 cm-1 and 2800 cm-1 said to be protein remnants. No further 
analysis was performed as the data were presented as complementary with their 
Alizarin red staining and confirmation of an inorganic matrix. 
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Two studies, one by Gentleman et al 2009 (101) and one by McManus et al 2011 
(134) have most thoroughly investigated MSC differentiation to an osteoblast 
phenotype and particularly the changes in ECM crystallinity that occur. Gentleman 
et al investigated three cell types in all, ESCs, MSCs and osteoblasts, all murine, 
each of which underwent osteo-induction and were assessed by a range of 
techniques including Raman spectroscopy, qRT-PCR, energy dispersive X-ray 
spectroscopy, SEM and TEM, immunohistochemistry, Alizarin red staining and 
alkaline phosphatase activity. The key finding of the paper was that ESCs produce 
an inorganic matrix inferior to that of MSCs and native osetoblasts. Raman 
spectroscopy was used to assess putative mineralised nodules prior to mineralisation 
at day 14 and mature mineralised nodules post mineralisation at day 28. Pre-
mineralisation Raman measurements demonstrated peaks at 815 cm-1 (C-C 
backbone stretching), 936 cm-1 (C-C skeletal vibrations), 1246, 1269 cm-1 amide I 
(protein bands), and   853 cm-1 (tyrosine), 872 cm-1 (hydroxyproline), and 921 cm-1 
(proline).  Further, peaks at 1003 cm-1 and 1665 cm-1 were demonstrated to have a 
0.96 correlation co-efficient with a type II collagen standard, indicating its 
abundance pre-mineralisation. The presence of type II collagen was confirmed with 
immunohistochemistry and qRT-PCR demonstrated the expression of the 
transcription factors SOX9, a regulator of type II collagen expression in 
chondrogenesis. This led the authors to hypothesise that MSC osteogenesis is 
mediated by endochondral ossification, an embryonic bone formation process where 
osteoblast like cells first create a cartilaginous type II collagen ECM and undergo 
hypertrophy before the onset of matrix mineralisation and maturation to type I 
collagen. Post mineralisation Raman measurements demonstrated a distinctly 
different spectroscopic profile with high intensity peaks at 960 cm-1 (PO4
3- 
symmetric stretching) and 1070 cm-1 (C-O vibration in plane stretching of CO3
2-) 
and lower intensity peaks at 1020-1100 cm-1 (PO4
3- asymmetric stretching), 1595-
1720 cm-1 (amide I), and 1243-1269 cm-1 (amide III). This was calculated as having 
a correlation co-efficient of >0.99 compared with data derived from native bone. 
The bands attributed to type II collagen pre-mineralisation were no longer present 
whilst amide I and III bands indicative of type I collagen were now detected, the 
presence of which was confirmed with immunohistochemistry, lending further 
credence to their hypothesis. Finally, multivariate principal component and factor 
analysis was performed on MSC bone nodules. This demonstrated that the band at 
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960 cm-1 was an amalgam of three distinct inorganic species, all found in native 
bone, amorphous phosphate species at 945-950 cm-1, B-type carbonate substituted 
apatite at 955-959 cm-1, and crystalline non-substituted hydroxyapatite at            
962-964 cm-1, leading the authors to conclude that MSCs had produced mature 
mineralised nodules of similar composition to native bone. 
 
The study by McManus et al (134) was largely in agreement with Gentleman et al, 
however, human MSCs were used and they also explored changes in matrix 
crystallinity with differentiation. Univariate analysis of the peaks at 960 cm-1 (PO4
3- 
symmetric stretch) and 1070 cm-1 (CO3
2- in plane vibration) revealed increasing 
carbonate to phosphate ratio between days 14 and 21 followed by decreasing matrix 
crystallinity between days 21 and 28 and an increase in the mineral to matrix ratio 
throughout when comparing the peaks at 960 cm-1 (PO4
3- symmetric stretch) and   
850 cm-1 (hydroxyproline). Factor analysis of the peak at 960 cm-1 at days 14, 21 
and 28 revealed the same three inorganic species as Gentleman et al, however, they 
varied over time. At day 14 only crystalline non-substituted hydroxyapatite at     
962-964 cm-1 was evident. At days 21 and 28 only amorphous phosphate at         
945-950 cm-1 and B-type carbonate substituted apatite at 955-959 cm-1 were 
detected. This is in contrast with Gentleman et al but in support of the univariate 
analysis demonstrating increasing carbonate to phosphate ratios and decreasing 
matrix crystallinity. However, the two are not directly comparable as species 
differences may be responsible for the differing results. 
 
The studies discussed in this section clearly demonstrate the utility of Raman 
spectroscopy for the non-invasive characterisation of stem cells. In order to further 
advance the utility of this technique, experiments need to be performed repeatedly in 
real time under aseptic conditions leaving cell cultures intact and suitable for further 
use.  
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1.6 Aims and Objectives 
The aim of this thesis was to determine whether Raman spectra could be acquired 
from the same stem cell cultures undergoing differentiation over time without 
compromising the sterility of these cell cultures. The following objectives were 
identified in order to achieve this goal: 
1. To identify cell culture substrates that are suitable for Raman spectroscopy 
but do not affect the differentiation potential of DPSCs. 
2. To develop a method for the reproducible, aseptic acquisition of Raman 
spectra from DPSCs across their differentiation pathway. 
3. To validate the newly developed aseptic methodology by characterising 
DPSC osteogenic differentiation using Raman spectroscopy and comparing 
this with conventional phenotyping methods and the results of previously 
published material. 
4. To use the new methodology to characterise differentiation down a 
previously sparsely published cell lineage; adipogenic differentiation using 
adipose-derived stem cells (ADSCs).  
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Chapter 2  
General Materials and Methods 
2.1 Dental Pulp Stromal Cell (DPSC) Isolation 
Human molars were obtained from the University of Leeds School of Dentistry 
Research Tissue Bank (DREC 07/H1306/93+5) with full ethical consent. Teeth from 
one male and two female donors, aged 9-35, mean age 22 years were used. No later 
than 24 hours after extraction, dental pulp stromal cells (DPSC) were isolated as 
follows. Teeth were immersed in 70% ethanol for several minutes after which a 
sterilised scalpel was used to remove any extraneous tissue. The teeth were then 
cracked open in a vice to expose the dental pulp. The pulp was removed from the 
tooth ensuring no fragments of dentine and enamel remained and placed in Alpha 
Modified Essential Medium (α-MEM) (Invitrogen, Paisley, UK), where it was finely 
diced with a sterile scalpel. A cell suspension was obtained by enzymatic digestion 
of the diced pulp, using 4 mg/mL dispase II (Roche, Welwyn Garden City, UK) and 
3 mg/mL collagenase I (Invitrogen, Paisley, UK), dissolved in α-MEM. Digests 
were incubated at 37°C, 5% CO2, and agitated by pipetting every 15 minutes until 
no pulp fragments remained. Cell suspensions were incubated in 25cm2 cell culture 
flasks at 37°C in basal medium, α-MEM containing 10% foetal calf serum (FCS) 
(Biosera, Ringmer, UK), 1% penicillin (10000 units), streptomycin (10 mg/mL) 
solution (Sigma-Aldrich, Gillingham, UK) and 1% 200 mM L-glutamine (Sigma-
Aldrich, Gillingham, UK). 
 
2.2 Expansion and Storage of DPSCs 
Adherent DPSCs were cultured and passaged as follows. The culture medium was 
replaced twice weekly until cultures were ~80% confluent, at which point they were 
passaged. DPSCs were washed twice with 1x phosphate buffered saline (PBS) 
(Sigma-Aldrich, Gillingham, UK) then incubated with trypsin (0.5 g/L), EDTA (0.2 
g/L) solution (Sigma-Aldrich, Gillingham, UK) at 37°C for several minutes. 
Complete cell detachment was encouraged by gentle agitation of the cell culture 
flask and confirmed under a microscope. Trypsin activity was neutralised with an 
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equal volume of  medium containing 10% FCS and the cell suspensions centrifuged 
at 1500 rpm for 5 minutes. The cell pellet was resuspended in culture medium and 
split into three 175 cm2 cell culture flasks. At the end of the second passage this 
process was repeated, however, the DPSCs were counted on a haemocytometer 
using trypan blue (Sigma-Aldrich, Gillingham, UK) to discriminate dead cells. 
DPSCs were then cryopreserved in liquid nitrogen in vials of approximately 1 x 107 
cells suspended in α-MEM containing 40% FCS and 10% dimethylsulphoxide 
(Sigma-Aldrich, Gillingham, UK) for use in all future experiments. 
 
2.3 RNA Isolation and Reverse Transcription 
Prior to qRT-PCR, RNA must be isolated from cell culture lysates and reverse 
transcribed in to cDNA. Cell lysis was performed by incubation with Trizol® 
(Invitrogen, Paisley, UK) for 20 minutes at room temperature. RNA was extracted 
from cell lysates using an RNeasy mini kit with additional DNase digestion (Qiagen, 
Crawley, UK) following the manufacturers recommendations. RNA concentrations 
were quantified using a NanoDrop spectrophotometer (Thermo Scientific, 
Wilmington, USA). A High Capacity RNA-to-cDNA Kit (Applied Biosystems, 
Carlsbad, USA) was used to prepare 200 ng of cDNA in 20 µL reaction volumes as 
per the manufacturer’s instructions. Reactions were run on a MJ Research PTC-100 
Thermo Cycler, at 37°C for 1 hour and 95°C for 5 minutes. 
 
2.4 Quartz Customised Flask Preparation 
Cell culture flasks with quartz windows suitable for Raman spectroscopy were 
prepared as follows. Holes, 1cm in diameter, were drilled in 25 cm2 cell culture 
flasks. Flasks were washed several times with sterile pure water to remove debris 
and finally sterilised with 70% ethanol. Heat sterilised quartz discs (Global Optics, 
Bournemouth, UK), 14 mm diameter x 0.15 mm thickness, were glued to the outside 
of the flasks using a UV cured methacrylate glue (Loctite, Hempstead, UK) and 
cured for 5 minutes under UV light. To ensure complete sterilisation, flasks were 
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placed under a UV lamp for 90 minutes and periodically rotated to ensure 
penetration to all surfaces. 
 
2.5 Optimised Raman Spectroscopy and Sample Preparation 
2.5.1 Raman Spectrometer 
Raman spectra were acquired using a Renishaw RM series 1000 with attached Leica 
LMDM microscope (Leica Microsystems, Milton Keynes, UK). Excitation to the 
sample was provided by a 785 nm diode laser with an output power of 250 mW 
delivering 66 mW to the sample. Holographic notch filters were used to discard 
Rayleigh scattered light. Raman scattering was detected by a thermoelectrically 
cooled CCD camera. The microscope was equipped with a motorised XYZ stage 
and a camera to visualise samples under transmitted and reflected light. The system 
was controlled using Renishaw WiRE software and processed in Grams/32 (Thermo 
Scientific, Waltham, USA). 
 
2.5.2 Raman Spectrometer Calibration 
Each day prior to collection of Raman spectra from the cells, the system was 
calibrated as follows. The absorbance of a neon light was measured for peaks at 
10930.5, 13255.5 and 13802.8 all within ±1 any deviations from which were 
corrected. Secondly, the Raman shift of the laser was measured at 0 cm-1±1 and 
corrected if necessary. Finally, a spectrum of a silicon wafer was taken which has a 
known wavenumber shift at 520 cm-1 again within a ±1 tolerance and with a 
minimum intensity value of 60000 arbitrary units.  
 
2.5.3 Sample Preparation and Spectrum Acquisition  
Once optimised, as described in Chapter 4, DPSC sample preparation and Raman 
spectrum acquisition were performed as follows. DPSCs were isolated and expanded 
as described in sections 2.1 and 2.2 . Quartz customised flasks were prepared as 
described in section 2.4. Prior to the seeding of DPSCs on the flasks, poly-L-lysine 
was used to coat the quartz surface to enhance cell adhesion. Flasks were washed 
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twice with de-ionised water then 100 µL aliquots of poly-L-lysine solution (0.1 
mg/mL, molecular weight, 70000-150000) (Sigma-Aldrich, Gillingham, UK) were 
incubated on the quartz surface for 10 minutes at room temperature. The solution 
was then aspirated and the flask placed in an incubator at 37°C overnight to dry. It 
has been shown previously that poly-L-lysine coatings have little/no effect on 
Raman spectra (140). DPSCs, 1 x 105 cells/cm2, were pipetted directly on to the 
quartz surface and the flasks were incubated overnight at 37°C to permit cell 
adherence. The following day, flasks were topped up with fresh osteogenic or 
adipogenic medium as described in the appropriate sections (5.2.1.1 and 6.2.1.1 
respectively). Prior to Raman analysis, the cell culture medium was aspirated and 
the flasks filled with Hanks balanced salt solution (HBSS) with 0.45% added 
glucose. Flasks were placed on the microscope stage inverted toward the objective. 
A 40x/0.8NA water immersion objective was immersed in a small drop of HBSS 
placed on the quartz surface. Spectra were then acquired for the region 600-1800 
cm-1 wavenumbers, the number of samples, time points, number of spectra acquired 
and exposure time are given in the appropriate sections (5.2.1.2 and 6.2.1.2). Cell 
free areas were used to acquire background spectra. Following analysis the HBSS 
was aspirated and replaced with osteogenic or adipogenic medium and placed back 
in the incubator. 
 
2.6 Processing of Raman Spectra 
Raman spectra were pre-processed in Grams/32 and further processed and analysed 
in Matlab version R2013b. A complete description of the process can be found in 
Appendix A. 
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Chapter 3 
Osteogenic Differentiation of DPSCs Cultured on Various 
Substrates Appropriate for Raman Spectroscopy 
This chapter addresses the first of the project’s objectives, the determination of a cell 
culture substrate that is suitable for Raman spectroscopy but is also compatible with 
DPSC osteogenic differentiation. 
 
3.1  Introduction 
The differentiation of stem cells into specialised cell types is a common theme in 
regenerative medicine. In vivo stem cell fate is tightly controlled through a 
combination of soluble chemical factors, cell-cell interactions, cell-extracellular 
matrix interactions and physical/mechanical forces in regions termed the “stem cell 
niche” (Figure 10) (67-69). In vitro differentiation of stem cells can be achieved by 
mimicking one or more of these parameters, most simply through chemical 
induction of cell monolayers (52, 55, 141). However, there is growing interest in 
more closely mimicking the stem cell niche through the guided differentiation of 
stem cells using rationally designed, highly specific scaffolds (142). Such scaffolds 
guide differentiation by the presentation of particular chemical motifs and/or by 
their reaction to mechanical stimuli, their gross architecture, nano-scale topography 
and charge. Some examples are presented in Table 4. Such studies demonstrate the 
complex nature of stem cell differentiation and the myriad factors that can enhance 
or diminish their potential to differentiate into a given lineage. 
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Figure 10. Representation of a generalised stem cell niche depicting the many 
factors that determine stem cell fate. 
 
One of the most enduring and common methods for culturing and differentiating 
stem cells involves their growth on treated plastic surfaces as 2D monolayers and 
traditional methods for phenotyping have stained cells in situ or researchers have 
detached the cells for their further characterisation. Raman spectroscopic analysis of 
the cultures offers the potential for repeated measurements of the same cell 
population to characterise cells in 2D culture but the technique  brings with it 
inherent problems. Raman spectroscopy can provide a ‘fingerprint’ of a sample 
based on the frequency with which the molecular bonds contained within occur. 
However, as plastic is created from organic substances it shares many of the 
molecular bonds in common with a sample of cells and at much higher frequencies, 
effectively obscuring and confounding the resulting spectra that might be obtained 
for cells cultured in monolayers on tissue culture plastic. An ideal substrate to use in 
Raman spectroscopy would therefore be inorganic, possessing minimal Raman shift 
in the region of interest for the cells, 600-1800 cm-1, termed the “biological 
fingerprint region” (135). Several studies have used Raman spectroscopy to 
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interrogate stem cells and have used a range of inorganic materials as substrates to 
culture their cells on, including, MgF2 (101, 102), CaF2 (128), quartz/fused silica 
(100, 132, 134) and glass (143, 144). 
 
The differentiation of stem cells can be influenced by the properties of a material 
used as a growth substrate as outlined in Table 4. Osteogenic differentiation of 
MSCs, from a wide variety of sources, cultured as a monolayer on tissue culture 
plastic is well characterised (52, 53, 145-148). This process takes up to 28 days and 
requires supplementation of the cell culture medium with dexamethasone,               
β-glycerophosphate and ascorbic acid. However, the growth and differentiation of 
stem cells on Raman appropriate materials such as MgF2 and quartz is much less 
well characterised. The surface chemistry of such materials is clearly different to 
that of tissue culture plastic. In order to encourage cell adhesion to Raman 
appropriate substrates, such materials are usually coated in various solutions such as 
poly-L-lysine (128, 135), fibronectin (144) and matrigel (103, 144). Whilst 
osteogenic differentiation has been demonstrated and assessed by Raman 
spectroscopy (101, 134) it is unclear whether the results are comparable to more 
common methods of cell culture or whether the unusual substrates are in any way 
modifying or influencing cell behaviour. 
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Table 4. Examples of biomaterials, their properties, and their effects on stem 
cell differentiation. 
 
The aim of this study was to assess DPSC osteogenesis on two commonly used 
Raman appropriate substrates, MgF2 and quartz, and to compare this to DPSC 
osteogenesis when cultured on tissue culture plastic.  
Material property Description 
Surface chemistry Silane modified surfaces with -SH or –NH2 functional 
groups promoted osteogenesis in bone marrow derived 
MSCs whilst –OH and –COOH groups promoted 
chondrogenesis (149) 
Fibronectin coated on a –NH2 modified surface promoted 
osteogenesis and adipogenesis in bone marrow derived 
MSCs whilst fibronectin coated on a –OH modified surface 
promoted osteogenesis alone (150) 
Macro/micro 
architecture 
Polycaprolactone scaffolds with an average pore size of 
370-400 μm promoted chondrogenesis in adipose derived 
MSCs whilst 90-105 μm pores inhibited chondrogenesis 
(151) 
Silk fibroin scaffolds with a pore size of 100-300 μm 
promoted osteogenesis in bone marrow derived MSCs 
(152) 
Nano topography Polymethylmethacrylate patterned with randomly 
positioned nanoscale circles promoted osteogenesis in bone 
marrow derived MSCs whilst an ordered pattern did not 
(153) 
Titanium with 15 nm pillars enhanced osteogenesis in bone 
marrow derived MSCs over flat titanium surfaces (154) 
Mechanical properties Polyacrylamide gels of increasing stiffness promoted 
neurogenesis, myogenesis and osteogenesis in bone marrow 
derived MSCs (155) 
Poly(ethylene glycol)-diacrylate with an ‘intermediate 
stiffness’ (55 kPa) combined with 10 µg ml-1 fibronectin 
increased adipose derived MSC osteogenesis (156) 
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3.2 Materials and Methods 
3.2.1 DPSC Adherence and Proliferation on MgF2 and Quartz 
Prior to the osteo-induction of DPSCs, their adherence to and proliferation on MgF2 
and quartz was assessed and compared with their behaviour on tissue culture plastic. 
Isolation and expansion of DPSCs was performed as previously described in the 
general methods (section 2.1). Cryopreserved DPSCs were resurrected in complete 
cell culture medium and expanded in vitro to ~80% confluence. Following this 
DPSCs were trypsinised and counted as previously described in the general methods 
(section 2.2). DPSCs were used at passage 3 for this experiment. Discs of 
magnesium fluoride (MgF2) and quartz (Qz) (Global Optics, Bournemouth, UK), 14 
mm diameter x 0.15 mm thickness, were sterilised in 70% ethanol and 
preconditioned in basal medium overnight. The preconditioned discs were then 
placed into a 24 well cell culture plate and seeded with DPSCs (5 x 103 cells/cm2). 
DPSCs were seeded into tissue culture well plates at the same density to provide a 
control. Cell cultures were maintained for 1, 3, 5 and 7 days and the medium 
replaced once after 3 days. Cell proliferation was quantified at each time point by 
cell counting as previously described in the general methods (section 2.2). 
Adherence of the DPSCs on the different substrates was assessed by scanning 
electron microscopy (SEM). Samples were washed twice in PBS then fixed in 10% 
neutral buffered formalin (NBF) (Sigma-Aldrich, Gillingham, UK) for two hours at 
room temperature. Following this, samples were dehydrated in graded alcohols for 
30 minutes each at room temperature and allowed to air dry overnight. MgF2 and Qz 
discs were placed directly on to aluminium SEM stubs. Tissue culture plastic wells 
were freed using a hot scalpel and then placed on to SEM stubs. A 4 nm gold 
coating was applied to samples using an Agar Auto Sputter Coater and the samples 
imaged using a Hitachi S-3400N SEM. 
 
3.2.2 The Effect of Culturing on MgF2 and Quartz on DPSC Osteogenesis 
Preconditioned MgF2 and quartz discs were placed into a 24 well cell culture plate, 
seeded with DPSCs (5 x 104 cells/cm2) and cultured in basal medium for three days 
to permit adhesion to their substrates. DPSCs were seeded into tissue culture plates 
at the same density to provide a control. Then, osteogenic differentiation was 
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induced by supplementing basal medium with 0.25 mM ascorbic acid, 10 mM         
β-glycerophosphate and 100 nM dexamethasone (all Sigma-Aldrich, Gillingham, 
UK) in half of the wells (n=3), the other half remained in basal medium as controls 
(n=3). Cultures were maintained for 7 and 28 days and the culture medium was 
replaced twice weekly. At each time point osteogenic differentiation was assessed 
by Alizarin red staining and quantitative real-time polymerase chain reaction (qRT-
PCR) for osteogenic marker genes, type 1 collagen (COL1A1), runt related 
transcription factor 2 (RUNX2), alkaline phosphatase (ALP), and osteocalcin (OC). 
 
3.2.3 Osteogenic Marker Gene Expression of DPSCs Cultured on MgF2 and 
Quartz Determined by qRT-PCR 
RNA isolation and reverse transcription was performed as previously described in 
the general methods (section 2.3). qRT-PCR was performed using TaqMan gene 
expression assays (Applied Biosystems, Carlsbad, USA) for COL1A1, RUNX2, ALP 
and OC: assay numbers Hs00164004-m1, Hs00231692-m1, Hs01029144-m1 and 
Hs00609452-g1 respectively. Reactions were carried out in 96 well plates as per the 
manufacturer’s instructions on a Roche LightCycler® 480  system. Optimal cDNA 
concentration was determined as 5 ng/reaction by plotting standard curves with 
known cDNA concentrations. Data was normalised to GAPDH or YWHAZ (assay 
numbers Hs99999905-m1 and Hs00237047_m1), and analysed using the 
comparative cycle threshold method (ΔCT). GAPDH is increasingly thought to be 
an unreliable housekeeping gene. A study by Ragni et al 2013 (157) demonstrated 
this and suggested YWHAZ as an alternative. To investigate this for the present study 
two patient samples were analysed both in biological triplicate and each with 3 
technical repeats for a total n=18 for each time point/substrate. Graphs of the mean ± 
SE were plotted in Microsoft Excel and statistical significance was determined by a 
Mann-Whitney test using GraphPad Instat 3 software. 
 
3.2.4 Extracellular Matrix Calcification of DPSCs Cultured on MgF2 and Quartz 
Determined by Alizarin Red Staining 
For DPSCs following 28 days in culture the cell culture medium was removed and 
cultures washed twice with PBS. DPSCs were fixed in NBF for 1 hour at room 
temperature and washed twice in de-ionised water. A 1% Alizarin red solution 
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(Sigma-Aldrich, Gillingham, UK) was prepared, adjusted to pH 4.2, and incubated 
on DPSCs for 20 minutes at room temperature. The Alizarin red solution was then 
removed and excess stain washed away with repeated washes with de-ionised water. 
DPSCs were then imaged using an Olympus BX50 microscope with accompanying 
Nikon DS-Fi1 camera. 
 
3.2.5 Determination of F- in Cell Culture Medium using Energy Dispersive X-ray 
Spectroscopy (EDX) 
Samples of cell culture medium from day 7 and 28 cell cultures were analysed using 
EDX to detect the presence of fluoride ions. Samples were loaded on to the cool 
stage (set to -15°C) of a Hitachi S-3400N scanning electron microscope. EDX 
acquisition time was set to 60 seconds and the atomic percentage of fluoride 
recorded. Known concentrations of NaF dissolved in de-ionised water were used to 
plot a standard curve. Sample fluoride concentration was derived from this and 
converted to parts per million.  
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3.3 Results 
Tissue culture plastic is an unsuitable cell culture substrate for Raman spectroscopy 
applications due to its strong Raman signal. Quartz and MgF2 are both routinely 
used in Raman spectroscopy and therefore their suitability for DPSC culture was 
compared with tissue culture plastic. 
 
3.3.1 The Effect of Substrate Choice on Adherence and Proliferation of DPSCs 
DPSCs successfully adhered to all three substrates after 1 day assuming a 
characteristic flattened morphology and had proliferated to confluence within 5 days 
(Figure 11). 
 
Figure 11. Scanning electron micrographs of DPSCs cultured on (A-B) MgF2, 
(C-D) quartz and (E-F) tissue culture plastic after 1 (A, C, E) and 5 (B, D, 
F) days. No discernible differences were observed between substrates at 
either time point. Scale bars = 200 µm. 
 
A B 
C D 
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Proliferation of DPSCs on all three substrates was similar over the course of 7 days 
and no significant differences in cell numbers were observed (Figure 12). Negligible 
dead cells were recorded on all three substrates. Population doubling times were 
41.6 hours on MgF2, 36.8 hours on quartz and 36.1 hours on tissue culture plastic. 
  
 
Figure 12. Line graph charting DPSC proliferation over 7 days for cells 
cultured on MgF2, quartz (QZ) and tissue culture plastic (TCP). The 
values represent mean ± SD. No significant differences in the numbers of 
live or dead cells were observed between cells cultured on each substrate 
at any time point. 
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3.3.3 The Effect of Substrate Choice on the Expression of Osteogenic Marker 
Genes 
Prior to the commencement of qRT-PCR, probe efficacy and optimal cDNA 
concentration were determined by plotting standard curves of known cDNA 
concentration for each probe (Figure 13). 
 
Figure 13. Standard curves using known concentrations of cDNA from naïve 
DPSCs and probes for the four osteogenic marker genes: type 1 collagen 
(COL1A), runt related transcription factor 2 (RUNX2), alkaline 
phosphatase (ALP) and osteocalcin (OC) and the housekeeping genes 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and tyrosine 3-
monooxygenase/tryptophan 5-monooxygenase (YWHAZ). 
 
Probe efficacy for all genes of interest was good as demonstrated by R2 values 
nearing 1. Optimal cDNA concentration was determined to be 5 ng/reaction yielding 
a mid-range CT value ~20-25 which would permit increases or decreases in gene 
expression to be detected throughout the experiment. 
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Housing keeping genes are used to normalise the expression of target genes in qRT-
PCR analysis. For this to be meaningful the expression of the house keeping gene 
should vary little throughout an experiment. Figure 14 shows the expression of 
GAPDH and Figure 15, YWHAZ by DPSCs cultured on all three substrates over the 
course of 28 days of osteogenic induction. 
 
Figure 14. CT value of GAPDH, derived from 3 biological replicates each with 3 
technical replicates, from DPSCs cultured on MgF2 (M), quartz (Q) and 
tissue culture plastic (T) over 28 days of osteo-induction. Results show 
mean ± SD. p<0.01 for QD28 vs D0, MD7, QD7, TD7 and QD28, p<0.001 
for TD28 vs D0, MD7, QD7, TD7 and MD28. 
 
Figure 15. CT value of YWHAZ, derived from 3 biological replicates each with 
3 technical replicates, from DPSCs cultured on MgF2 (M), quartz (Q) and 
tissue culture plastic (T) over 28 days of osteo-induction. Results show 
mean ± SD. p<0.05 for QD7 vs D0 and TD28, p<0.01 for D0 vs TD7, MD7 
vs MD28 and QD7 vs QD28, p<0.001 for MD7 vs D0, QD28 and TD28 and 
TD7 vs QD28. 
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Statistically significant variation can be observed in the expression of both 
housekeeping genes using a one-way ANOVA with Bonferroni post-test. For 
GAPDH: p<0.01 for QD28 vs D0, MD7, QD7, TD7 and QD28, p<0.001 for TD28 
vs D0, MD7, QD7, TD7 and MD28. For YWHAZ: p<0.05 for QD7 vs D0 and TD28, 
p<0.01 for D0 vs TD7, MD7 vs MD28 and QD7 vs QD28, p<0.001 for MD7 vs D0, 
QD28 and TD28 and TD7 vs QD28. However, whilst expressed at lower levels than 
GAPDH, the expression of YWHAZ was the more consistent of the two and therefore 
was used to normalise all subsequent data. 
 
qRT-PCR was used to determine the expression of osteogenic markers at early (day 
7), and late (day 28), stages of cell culture, (Figure 16). At day 7, the only 
significant difference between cells cultured on the two Raman-appropriate 
substrates and those cultured on tissue culture plastic was a higher level of RUNX2 
expression for DPSCs cultured on quartz, (p=0.0083). At day 28, there was highly 
significant lower expression for COL1A and OC in DPSCs cultured on MgF2, 
(p<0.0001). There were also significantly lower levels of COL1A, RUNX2,  ALP and 
OC expression in DPSCs cultured on quartz, (p=0.0191, p=0.0401, p=0.0011 and p= 
0.0367 respectively). 
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Figure 16. A comparison of DPSC osteogenic gene expression after 7 and 28 
days of induction after culturing on A) MgF2 (M) and tissue culture 
plastic (T) and B) quartz (Q) and tissue culture plastic (T). Statistical 
significance only displayed for direct comparisons, i.e. expression levels at 
the same time points on different substrates, *, p<0.05, **, p<0.01, ****, 
p<0.0001. Results show mean ± SE, n=18. The expression of early 
osteogenic markers at day 7 is broadly similar between substrates but the 
expression of late markers at day 28 is much lower on MgF2. 
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3.3.4 DPSC Extracellular Matrix Calcification as Determined by Alizarin Red 
Staining  
Alizarin red staining was used to indicate extracellular matrix calcification after 28 
days of osteogenic induction (Figure 17). Uniform positive staining was observed 
for DPSCs cultured on quartz and tissue culture plastic but not for those cultured on 
MgF2. 
 
Figure 17. Alizarin red staining of DPSCs cultured on (A) MgF2, (B) quartz and 
(C) tissue culture plastic after 28 days of osteogenic induction. Below (E-
G) respective controls with no osteo-induction. Scale bars = 100 µm. 
Alizarin red staining whilst positive for DPSCs cultured on MgF2 was 
weaker than those cultured on quartz and tissue culture plastic. 
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3.3.5 Fluoride Ion Levels in Cell Culture Medium Detected by Energy Dispersive 
X-ray Spectroscopy 
EDX was used to determine the presence of F- in the cell culture medium of DPSCs 
cultured on MgF2 as a possible cause for the observed lack of late stage osteogenic 
differentiation in these cultures (Figure 18). The presence of Mg++ was not 
investigated as cells will naturally absorb Mg++ from culture medium. There was no 
significant difference found in F- levels in cultures ± MgF2 discs at both 7 and 28 
days. F- concentrations were consistent at approximately 1 ppm.  
  
Figure 18. Fluoride concentration  in cell culture medium samples with and 
without magnesium fluoride discs at (A) day 7 and (B) day 28 as 
determined by EDX. Results show mean ± SD, n=6. No significant 
differences were observed. 
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3.4 Discussion 
Prior to the commencement of studies attempting to utilise Raman spectroscopy to 
predict/characterise stem cell differentiation, it was essential to determine whether 
potential Raman appropriate cell culture substrates had any effect on the osteogenic 
differentiation of DPSCs. MgF2 and quartz were chosen as the Raman appropriate 
substrates, being two of the more commonly used substrates for such applications 
(100-102, 132, 134). Osteogenic differentiation of DPSCs on the two substrates was 
assessed by the expression of  four markers genes, COL1A, RUNX2, ALP, and OC, 
at early and late stages of differentiation and by Alizarin red staining. The data was 
then compared with DPSCs cultured on tissue culture plastic under the same 
conditions. 
 
Differentiation of DPSCs on all three substrates was confirmed by a significant 
increase in the expression of the early marker genes RUNX2 and ALP after 7 days of 
induction relative to undifferentiated DPSCs, followed by a decrease in their 
expression after 28 days of induction. Further, DPSCs cultured on all three 
substrates exhibited a significant increase in the expression of the late marker OC 
after 28 days of induction. This is a gene expression profile that is typical for the 
osteogenic differentiation of DPSCs, and MSCs more generally, and is consistent 
with the findings of many authors reported previously (141, 158-162). Alizarin red 
staining demonstrates the presence of calcium and as such can be used as a marker 
of extracellular matrix calcification (163). Positive Alizarin red staining after 28 
days of osteogenic induction was observed for DPSCs cultured on all three 
substrates. When combined with the gene expression analysis this indicates the 
differentiation of DPSCs towards a mature osteoblast-like phenotype over the course 
of the experiment. However, the aim of this study was not to demonstrate the 
osteogenic differentiation of DPSCs on MgF2 and quartz but to ascertain if 
differentiation on these substrates was comparable with the more common format on 
tissue culture plastic. 
 
Lower expression levels of osteogenic marker genes by DPSCs on both MgF2 and 
quartz  suggested weaker/delayed  osteogenic differentiation compared with DPSCs  
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cultured on tissue culture plastic. However, of the two substrates MgF2 was 
associated with the most significant reduction in gene expression. DPSCs cultured 
on MgF2 demonstrated significantly lower expression levels of the late 
differentiation marker OC, indicating weaker progression of osteogenic 
differentiation. This was further confirmed by weaker Alizarin red staining 
indicating lower degrees of extracellular matrix calcification. Fluoride is known to 
be toxic to cells at millimolar concentrations (164) impairing mitochondrial function 
leading to ATP depletion (165). Magnesium ion, Mg2+, is known to compete with 
Ca2+ for protein binding sites potentially impairing cellular functions (166) and may 
also inhibit osteogenic differentiation (167). EDX was therefore used to determine if 
higher F- concentrations were present in the cell culture medium of DPSCs cultured 
on MgF2 as a potential explanation for the weaker osteogenic differentiation. Mg
2+ 
levels were not checked as cells naturally deplete Mg2+ from culture medium. 
However, there was no significant increase in F- detected at either early or late time 
points of the culture period. This is consistent with the findings of Notinger et al 
2004 (102) who also concluded, indirectly through a MTT metabolic assay, that 
there was negligible F- release from MgF2 discs. Therefore a different factor such as 
surface chemistry or nano-topography must be the cause of the weaker osteogenic 
differentiation on both MgF2 and quartz. 
 
There is little published data regarding the surface chemistry and nano-topography 
of MgF2, however, more data is available regarding quartz. A study by Weder et al 
2010 (168) demonstrated that fibroblasts adhered most strongly to flat quartz 
surfaces compared with quartz with nanopillars. However, when quartz nanopillars 
were functionalised with streptavidin they increased cell spreading and proliferation 
(169). In this study, flat, polished quartz surfaces were used and no differences in 
the adhesion or proliferation of DPSCs was found when compared with DPSCs 
cultured on tissue culture plastic, however, without further experimentation nano-
topography cannot be ruled out as influencing DPSC differentiation. Koehler et al 
2013 (170) demonstrated that various proteins adsorbed to quartz to varying degrees 
dependent upon the pH of their solution. The authors attributed this to differences in 
the electrostatic potential of pure SiO2 (quartz) and of their proteins under various 
pH values. Fears et al 2013 (171) have shown that certain proteins undergo 
conformational changes when adsorbed to quartz. Again this was attributed to the 
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interplay of electrostatic charge between substrate and protein. As previously 
discussed, stem cell differentiation is known to be guided by the presence of 
particular proteins presented in the correct conformation, such as might be found in 
their extracellular matrix. These studies suggest that the potential for such proteins 
to be absent or changed by their interaction with quartz or possibly MgF2 may result 
in the weaker osteogenic differentiation of DPSCs cultured on these surfaces. 
However, further work would be required to test this hypothesis. Although DPSCs 
exhibited weaker osteogenic differentiation on both MgF2 and quartz, the effects 
were less dramatic with quartz and as a result quartz was chosen as the cell culture 
substrate for all future experiments. This was a conclusion also reached by Draux et 
al 2009 (172) when comparing the morphology and proliferation of cancer cells 
cultured on quartz, calcium fluoride and zinc selenide. 
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Chapter 4 
Development of a Method for the Phenotypic Characterisation of 
DPSCs by Raman Spectroscopy Under Sterile Conditions 
Previous studies investigating the use of Raman spectroscopy in the characterisation 
of cells have used either fixed cells or live cells in a non-sterile environment. The 
aim of this study was to develop a method to permit the repeated acquisition of 
Raman spectra from live cells under aseptic conditions with time. This is a            
pre-requisite if Raman spectroscopy is to be used in an entirely non-invasive and 
non-destructive manner.  
 
4.1 Introduction 
Raman spectroscopy as a technique shows promise both as a research tool and in 
clinical diagnostics as it has the capacity to be entirely non-invasive (93, 110, 173). 
It achieves this by exploiting a natural phenomenon in the interaction between light 
and matter, namely the Raman effect, and as such does not require the use of any 
exogenous labels. Upon interaction with a molecule, a small number of photons 
from a monochromatic light source (light of a single wavelength) will undergo a 
transfer of energy resulting in a small shift in their wavelength relative to the 
incident light (Figure 19). The Raman shift can be defined as the amount of energy 
transferred  that is required to bring about a change in the vibrational motion of the 
interacting molecule. This transfer of energy is different and unique for every 
molecular species/bond. Therefore a sum of all the various shifts in wavelength, 
expressed in wavenumbers, and the frequency with which they occur provides a 
biochemical fingerprint of a sample. Raman spectroscopy can be performed with a 
wide variety of wavelengths of light from ultra violet (UV) to infra-red and with a 
wide range of power. Typically high powered lasers using shorter wavelengths in 
the UV region increase the efficiency of Raman scattering and therefore the quality 
of the resulting spectra (174). However, in the interrogation of living biological 
samples a compromise must be made as UV light can damage DNA and the heat 
generated by high powered lasers could induce a heat shock response (106, 175). 
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Many previous studies have used a 785 nm (near infra-red) light source and it has 
been shown that 115 mW laser power applied to a live sample for 40 minutes does 
not cause damage to the sample (135). 
 
 
Figure 19. Diagram of light interaction with ethylene, illustrating Raman 
scattering. 
 
Perhaps the simplest and most efficient method to analyse cells using Raman 
spectroscopy is to fix them prior to analysis. The primary goal of fixation is to 
preserve a sample in as close to a physiological state as possible. In order to achieve 
this metabolism has to be arrested to prevent autolytic degradation and cellular 
organelles and molecules must be immobilised in order to stabilise the sample for 
further examination (176). There are many techniques available for cellular and 
tissue fixation including chemical, such as aldehydes or alcohols and temperature 
both heating or freezing. All have their advantages and disadvantages and the choice 
of fixation method is generally determined by the data the investigator wishes to 
obtain from a given sample. Listed in Table 5 are some of the known issues with 
various fixation methods.  
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Table 5. Various fixation methods and some of the known artefacts they can 
induce 
 
Despite the artefacts fixing a sample can introduce there have been studies 
investigating fixed cells with Raman spectroscopy. In two recent studies Ali et al 
2013 (182, 183) found Raman spectroscopy coupled with K-means cluster analysis 
was able to differentiate between the different layers in formalin fixed, paraffin 
embedded and de-waxed skin samples. However, Raman bands indicative of lipids 
were significantly perturbed compared with non-fixed samples. Meade et al 2010 
(184) investigated the effect of two chemical fixatives, formalin and Carnoy’s 
fixative, on various cell lines using Raman spectroscopy coupled with principal 
component analysis (PCA). Whilst it was reported that formalin was the better 
fixative when spectra were compared with those from live cells, neither were an 
adequate match with nucleic acid degradation, protein denaturation and lipid 
leeching all observed in the spectra. When comparing the effect of ethanol, 
formaldehyde and heat fixation on spectra acquired from Rhodobacter sphaeroides, 
Kniggendorf et al 2011 (140) reported similarly poor spectra when compared with 
non-fixed samples. Regardless of the merits and issues with sample fixation it is 
clear that a study whose aim is to repeatedly measure spectra from live cells cannot 
use any form of cell fixation.  
 
Many more studies have used Raman spectroscopy to investigate live cells. One 
approach is to suspend the cell sample prior to analysis (185-187) negating the need 
to culture the sample on substrates appropriate for Raman spectroscopy but rarely 
used in cell culture. This approach may also have  clear uses as demonstrated by 
Fixation method Known issues 
Aldehydes Crosslinking of protein amino acid residues by methylene 
bridges (177, 178) 
Molecular changes in nucleic acids, carbohydrates and 
phospholipids (178-180) 
Alcohols Antigen loss through protein coagulation (178, 181) 
Heating Protein coagulation, nucleic acid breakdown and leakage of 
low molecular weight proteins (140) 
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Pascut et al 2011 (185). If the cells are passed though the laser beam and a spectrum 
can be acquired fast enough (~5 seconds) this opens up the possibility for Raman 
cell sorting analogous to fluorescence-activated cell sorting (FACS) or it could 
permit the discrimination of differing cell types in a heterogeneous cell sample. 
However, such an approach when monitoring the course of stem cell differentiation 
would probably be detrimental as regular disruption of the sample and the associated 
extracellular matrix would likely inhibit differentiation given that the deposited 
matrix helps guide the process (67-69). Several others have used Raman 
spectroscopy to investigate adherent cell samples (101, 132, 134). However, these 
studies were investigating specific differentiation events, such as extracellular 
matrix calcification, so neither the maintenance of sterility or repeated 
measurements were required. 
 
The aim of this study was to develop a method that would permit the long term 
aseptic culture of DPSCs whilst at the same time allowing the acquisition of high 
quality reproducible Raman spectra.  
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4.2 Materials and Methods 
4.2.1 Quantifying the Metabolic Activity of DPSCs Immersed in Various Solutions 
using an Alamar Blue Assay 
Quartz disc preparation and DPSC culture was performed as previously described in 
section 3.2.1. DPSCs were seeded at a density of 5 x 104/cm2 in 24 well plates and 
allowed to proliferate to confluence. At this point DPSCs were washed twice with 
PBS and then incubated with 1 mL of either PBS, HBSS (Invitrogen, Paisley, UK) 
with 0.1% or 0.45% added glucose (described as “low” and “high” concentrations 
respectively by Invitrogen cell culture medium formulations), Hibernate® medium 
(Invitrogen, Paisley, UK) or α-MEM. Hibernate® medium is designed for the storage 
and transport of live cells in ambient conditions. Into triplicate wells containing 
DPSCs, 100 µL Alamar Blue reagent (Sigma-Aldrich, Gillingham, UK) was added. 
Wells without cells were used as controls. Assays were incubated at ambient 
temperature for four hours to simulate the conditions of Raman spectra acquisition. 
Absorbance at 570 nm and 600 nm was measured using a Thermo Scientific 
Varioskan Flash Multimode Reader every 30 minutes. The percentage of the Alamar 
Blue dye that had been reduced was calculated at each time point with the following 
equation (Figure 20): 
 
% Reduction = ((εoxλ2*Αλ1)-(εoxλ1*Αλ2)/(εredλ1*Α’λ2)-(εredλ2*Α’λ1))*100 
Figure 20. Calculation for the % reduction of Alamar Blue dye. ελ1 and ελ2 are 
constants representing the molar extinction coefficient of Alamar Blue at 
570 and 600 nm, respectively, in the oxidised (εox) and reduced (εred) 
forms. Αλ1 and Αλ2 represent the absorbance of the test wells at 570 and 
600 nm respectively, Α’λ1 and Α’λ2 represent their negative controls. 
Adapted from (188) 
 
4.2.2 Cell Culture 
4.2.2.1 Culture of DPSCs in Petri Dishes for Raman Spectroscopy 
DPSCs were cultured on quartz discs as previously described in section 3.2.1. When 
confluent the DPSCs were transferred to a sterile petri dish containing a quartz 
platform. HBSS was added until the DPSCs were covered and the lid replaced 
(Figure 21). The Raman spectrometer was calibrated as previously described in the 
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general methods (section 2.5.2). A 785 nm diode laser with an output power of 250 
mW, delivering 66 mW power to the sample, provided excitation. A 50x/0.75NA 
dry objective was used to visualise the DPSCs and collect spectra. Raman refracted 
light was collected back through the objective and passed through a 40 µm slit into 
the spectrometer. Ten spectra were acquired with a 60 second integration time over 
the wavenumber range 600-1800 cm-1. A cell-free replica was used to determine the 
background. Spectra were pre-processed as described on Appendix A and graphs 
drawn in Microsoft Excel. 
 
Figure 21. Diagrammatic representation of Raman spectroscopy using a petri 
dish. 
 
4.2.2.2 Culture of DPSCs in Quartz Cuvettes for Raman Spectroscopy 
DPSCs were cultured as previously described in the general methods (section 2.2). 
A Raman grade quartz cuvette with 1 mm thick walls and screw top (Sigma-Aldrich, 
Gillingham, UK) was sterilised in ethanol and left in cell culture medium overnight. 
The following day one side of the cuvette was seeded with 5 x 104 DPSCs/cm2 and 
cultured to confluence (Figure 22). Prior to analysis, the cell culture medium was 
aspirated and cuvettes filled with HBSS with 0.45% added glucose. The Raman 
spectrometer was calibrated and set up as previously described in the general 
methods, with one exception, a 5x microscope objective was used. This was because 
as the thickness of a material increases high numerical aperture objectives suffer 
from increasing spherical aberration and thus reduced collection efficiency of the 
Raman refracted light (189). Ten spectra were acquired with a 60 second integration 
time and one of the other quartz walls used to acquire the cell free background. 
Spectra were pre-processed as described in Appendix A and graphs drawn in 
Microsoft Excel. 
 
- 60 - 
 
Figure 22. Diagrammatic representation of Raman spectroscopy using a quartz 
cuvette. 
 
4.2.2.3 Culture of DPSCs in Quartz Customised Cell Culture Flasks for Raman 
Spectroscopy 
DPSCs were prepared and quartz customised cell culture flasks (Figure 23) 
produced as previously described in the general methods, sections 2.2 and 2.4. 
Quartz windows were coated in 0.01% poly-L-lysine (molecular weight 70,000-
150,000) solution and DPSCs seeded at 4 x 105/cm2. Prior to Raman analysis, cell 
culture medium was aspirated and flasks filled with HBSS containing 0.45% added 
glucose. The Raman spectrometer was calibrated and set up as previously described 
(section 2.5.2) and the 50x/0.75NA objective attached. Ten spectra were acquired 
with a 60 second integration time and a cell free flask used to acquire background. 
Spectra were pre-processed as described in Appendix A and graphs drawn in 
Microsoft Excel. 
 
 
Figure 23. Diagrammatic representation of Raman spectroscopy using a quartz 
window modified cell culture flask. 
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4.2.3 Optimisation of Optics for Raman Spectroscopy 
DPSC culture in quartz customised flasks and the calibration and set up of the 
Raman spectrometer were performed as previously described in the general 
methods, sections 2.4 and 2.5 (Figure 24). It has previously been shown that the 
quality of images acquired through coverslips using a laser confocal system can be 
improved by the use of water immersion lenses (190). The Raman spectrometer also 
employs a confocal system so several water immersion objectives were tested to 
investigate if the quality of the spectra acquired could be further improved. A range 
of objectives were selected, 20x/0.95NA, 40x/0.8NA, 63x/0.9NA and 63x/1.2NA. 
Lower magnifications generate a larger spot size and therefore sample a greater 
number of cells, whilst higher numerical apertures possess a greater Raman 
collection efficiency through a thin substrate. The effect of Raman acquisition time 
was also investigated within the confines of the cells being in ambient conditions for 
no more than 4 hours. Fifty spectra were acquired with a 30 second integration time 
and compared with the acquisition of 15 spectra with a 120 second integration time. 
In each instance the signal:noise was calculated as the peak intensity of 
phenylalanine at 997 cm-1 divided by the standard deviation of all the intensity 
values in the range of 1700-40 cm-1, which was designated as noise due to the 
absence of any Raman peaks produced by the sample. All spectra were processed 
and graphs plotted as described in Appendix A. 
 
 
Figure 24. Diagrammatic representation of Raman spectroscopy using a quartz 
window modified cell culture flask and a water immersion objective.  
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4.3 Results 
4.3.1 Metabolic Activity of DPSCs in Solutions Appropriate for Raman 
Spectroscopy 
An ideal solution in which to immerse cells for Raman spectroscopy would have a 
minimal number of constituents and be chemically well defined so as to possess 
little background signal. However, optimal maintenance of living cells generally 
requires complex solutions. An Alamar Blue assay was performed on DPSCs 
immersed in various solutions to ascertain the best compromise. The percentage of 
the Alamar Blue dye reduced by DPSCs was calculated over the course of 4 hours at 
regular 30 minute intervals (Figure 25). As one might expect DPSCs in the more 
chemically complex solutions reduced a greater amount of the Alamar Blue 
indicating that they were more metabolically active. However, the lower R2 value 
from the DPSCs in α-MEM indicated that their metabolism began to slow after ~3 
hours. The 3 test solutions (HBSS with 0.1% or 0.45% glucose and Hibernate®) all 
maintained cells such that a steady rate of Alamar Blue reduction was observed over 
the 4 hour period. The HBSS with 0.45% added glucose was selected for future 
experiments, as it is better chemically defined than Hibernate® medium whilst still 
being able to maintain DPSC metabolic activity in ambient conditions. 
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Figure 25. Alamar Blue reduction by DPSCs in various solutions. R2 values 
displayed indicate linearity. DPSCs reduced Alamar Blue in a linear 
fashion over four hours. DPSCs in the more complex solutions (α-MEM 
and Hibernate) reduced more Alamar Blue than those in simpler solutions 
(HBSS and PBS) 
 
4.3.2 Raman Spectroscopy of DPSCs in Different Sterile Cell Culture Conditions 
4.3.2.1 Raman Spectroscopy of DPSCs Cultured in Petri Dishes 
The first cell culture method investigated was to culture DPSCs on quartz discs, 
performing Raman spectroscopy within a closed petri dish in order to maintain 
sterility. Figure 26c shows a spectrum acquired from DPSCs minus the background. 
Several peaks were evident, including, 999 cm-1, 1027 cm-1 and 1599 cm-1. 
However, these peaks are likely to have been contributed by the polystyrene from 
the petri dish (Figure 27). This method was therefore discounted due to the potential 
for the Raman signal from the petri dish to obscure the result. 
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Figure 26. Raman spectra of DPSCs cultured on quartz in a closed petri dish. 
A) raw control spectrum, B) raw test spectrum, C) processed difference 
spectrum. 
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Figure 27. Raman spectrum of a petri dish. Inset is the previous spectrum 
acquired from DPSCs for comparison. The Raman peaks from the 
polystyrene petri dish are clearly evident in the spectrum of the DPSCs. 
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4.3.2.2 Raman Spectroscopy of DPSCs Cultured in Quartz Cuvettes 
The second method investigated was to culture DPSCs in quartz cuvettes designed 
for use in bench top spectrophotometers. Figure 28c shows a spectrum acquired 
from DPSCs minus the background. Some peaks indicative of cells were evident at 
1000 cm-1, 1032 cm-1, 1186 cm-1 and 1637 cm-1. However, there were clearly issues 
with high signal to noise ratios and the result was still far removed from a typical 
cell spectrum in the published literature (102, 135). 
 
 
Figure 28. Raman spectra of DPSCs cultured in a quartz cuvette. A) raw 
control spectrum, B) raw test spectrum, C) processed difference spectrum. 
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4.3.2.3 Raman Spectroscopy of DPSCs Cultured in Quartz Customised Cell Culture 
Flasks 
The final method tested was to culture DPSCs on quartz windows attached to 
standard cell culture flasks. Figure 29c shows a spectrum acquired from DPSCs 
following subtraction of the background. Several peaks indicative of cells were 
again evident at wavenumbers 998 cm-1, 1260 cm-1, 1332 cm-1, 1445 cm-1 and     
1648 cm-1. Whilst clearly in need of further optimisation this result was the most 
consistent with the published literature (102, 135) so quartz window modified flasks 
were taken forward as the cell culture method of choice. 
 
 
 
Figure 29. Raman spectra of DPSCs cultured in quartz customised flasks. A) 
raw control spectrum, B) raw test spectrum, C) processed difference 
spectrum. 
0
1000
2000
3000
4000
5000
6000
7000
8000
600 1100 1600
In
te
n
si
ty
 A
.U
Wavenumber cm-1
0
2000
4000
6000
8000
10000
600 1100 1600
In
te
n
si
ty
 A
.U
Wavenumber cm-1
1500
1700
1900
2100
2300
2500
2700
600 800 1000 1200 1400 1600 1800
In
te
n
si
ty
 A
.U
Wavenumber cm-1
A B 
C 
- 68 - 
4.3.3 Raman Spectroscopy of DPSCs using Various Optical Configurations 
To better match the refractive index of the light path from objective to sample 
several water immersion objectives were tested, where the objective was immersed 
in an aliquot of HBSS atop the quartz window of the modified flasks. Figure 30 
shows the processed Raman spectra of DPSCs acquired with several different 
objectives. The results were very similar to previously published data (102, 135), 
with many peaks evident, particularly those acquired with the 40x/0.8NA and 
63x/1.2NA objectives. 
   
 
Figure 30. Representative processed spectra acquired using A) 25x/0.95NA 
water immersion objective, B) 40x/0.8NA water immersion objective, C) 
63x/0.9NA water immersion objective and D) 63x/1.2NA water immersion 
objective. Sample n=50, control n=10, 30 seconds acquisition time. The 
40x/0.8NA and 63x/1.2NA (B and D) objectives appear to produce the 
least noisy spectra. 
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To quantify the results, the signal to noise ratio was calculated using the peak at    
997 cm-1 and the region 1700-40 cm-1 which was designated as noise due to the 
absence of any Raman peaks in this region given off by the cells (Table 6). This 
confirmed the superior performance of the 40x/0.8NA and 63x/1.2NA objectives 
compared with the others based on the higher signal:noise in spectra acquired using 
those objectives.  
 
Table 6. Average signal to noise ratio of Raman spectra acquired from DPSCs 
over 30 seconds using various water immersion objectives. The 40x/0.8NA 
and 63x/1.2NA objectives outperformed the other two as indicated by the 
higher signal:noise ratio of spectra acquired using them. 
 
Microscope 
objective 
Signal intensity of 
peak at 997 cm-1 
Noise at 1700-40 cm-1 Average S:N 
25x/0.95NA 157.25 24.64 6.37 
40x/0.8NA 174.58 8.19 21.32 
63x/0.9NA 174.82 15.83 11.04 
63x/1.2NA 251.37 11.99 20.97 
 
The results of the Alamar Blue assay, described in section 4.3.1, suggested that the 
metabolic activity of DPSCs may begin to slow after 3-4 hours in ambient 
conditions. Within this time constraint, the effect of acquiring multiple spectra (50) 
with a short (30 seconds) exposure time, (Figure 30), was compared with acquiring 
fewer spectra (15) with a longer (120 seconds) exposure time (Figure 31). The same 
peaks were clearly evident in all spectra from the various microscope objectives. 
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Figure 31. Representative processed spectra acquired using A) 25x/0.95NA 
water immersion objective, B) 40x/0.8NA water immersion objective, C) 
63x/0.9NA water immersion objective and D) 63x/1.2NA water immersion 
objective. Sample n=15, control n=3, 120 seconds acquisition time. All 4 
objectives appear to produce less noisy spectra when fewer are acquired 
over longer exposure times vs many over shorter exposure times (Figure 
30). 
 
The signal to noise ratios of the spectra derived using each of the objectives were 
calculated again using the same method as previously described (Table 7). This 
demonstrated an approximate doubling of signal to noise ratio when using fewer, 
longer exposures. The 40x/0.8NA and 63x/1.2NA objectives performed the best 
again in this respect. 
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Table 7. Average signal to noise ratio of Raman spectra acquired from DPSCs 
over 120 seconds using various water immersion objectives. Superior 
performance using the 40x/0.8NA and 63x/1.2NA objectives was repeated 
as indicated by the higher signal:noise ratios of spectra acquired with 
them. 
 
Microscope 
objective 
Signal intensity of 
peak at 997cm-1 
Noise at 1700-40 cm-1 Average S:N 
25x/0.95NA 858.65 37.54 22.87 
40x/0.8NA 941.64 21.49 43.81 
63x/0.9NA 810.45 51.53 15.78 
63x/1.2NA 1222.85 25.07 48.76 
 
The results of these experiments indicate that the optimal conditions for the 
acquisition of Raman spectra from living DPSCs were obtained when using a cell 
culture flask modified with a quartz window and using a 40x/0.8NA water 
immersion objective sampling 15 separate loci with a 120 second exposure.  
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4.4 Discussion 
In order to use Raman spectroscopy to non-invasively characterise the course of 
DPSC differentiation using one continuous sample taking repeated measurements 
over time, a new method was required that could permit both long term aseptic cell 
culture and the acquisition of high quality, reproducible Raman spectra.  
 
To develop such a methodology, the testing of several possibilities was required in 
order to refine an optimal method. Two initial approaches were discounted at an 
early stage: the use of enclosed petri dishes and quartz cuvettes. Acquiring spectra 
using petri dishes presented several problems not least that the petri dish itself was 
detected by the spectrometer despite the distance from the focal point. Maintaining 
sample sterility for a prolonged period would also likely have been an issue 
requiring regular transiting of the cell sample to the petri dish.  
 
Quartz cuvettes provided a much simpler cell culture modality, eliminating the need 
to transfer the cell sample from one culture environment to another for the purpose 
of acquiring spectra. However, the thick walls of these cuvettes at ~2 mm, precluded 
the acquisition of high quality spectra. This was due to the need to use low 
magnification microscope objectives with a longer working distance to the sample 
reducing the amount of Raman signal collected.  
 
Finally, conventional cell culture flasks that had been modified with quartz windows 
for sampling were tested. This method provided the first clear detection of several 
peaks, commonly seen in cell samples, such as phenylalanine at ~998 cm-1 and CH3, 
CH2 at 1445 cm
-1. However, the spectra acquired had a poor signal:noise ratio and 
were likely unusable in further analysis. Work by Hasselhoff et al 1999 (190) 
demonstrated that the resolution of images acquired using confocal laser systems 
could be improved by using a water immersion lens if the sample itself was 
immersed in a mounting solution beneath a glass coverslip. Based on this 
observation, several water immersion lenses were tested with the customised cell 
culture flask in order to improve the quality of the Raman spectra acquired. This 
approach yielded a significant improvement in the quality of the spectra. Figure 32 
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shows a representative spectrum acquired using a 40x/0.8NA from DPSCs cultured 
in a quartz customised cell culture flask. 
 
 
Figure 32. Representative Raman spectrum of DPSCs after optimisation of cell 
culture technique, Raman optical and system configuration and 
processing of spectra. Major peak assignments are marked based on (97) 
 
The three cell culture modalities used this this study underline an important 
consideration when attempting to acquire Raman spectra from DPSCs or indeed any 
cell. In the published literature non-sterile approaches are used to acquire spectra 
from cells. This permits the use of high powered microscope objectives with very 
short working distances between the cells and objective. A short working distance 
allows the capture of a greater proportion of the Raman refracted light from the cells 
thereby increasing the signal:noise ratio of the spectra acquired. The first two cell 
culture modalities assessed in this study (petri dishes and cuvettes) both required a 
long working distance between the cells and objective due to their design and so the 
spectra acquired had a poor signal:noise ratio. The final method tested (quartz 
window customised flasks) had a much smaller working distance between the cells 
and objective and so the spectra acquired had a better signal:noise ratio. This 
underlines that when attempting to acquire spectra from cells in an aseptic manner 
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there is tension between the need to maintain an enclosed sterile culture environment 
and capturing as much Raman signal from the cells as possible by reducing the 
working distance. This may reflect why previous studies have not used an aseptic 
method as the primary aims were to demonstrate that Raman spectra could be 
acquired from, and used to, characterise cells. 
 
Whilst using quartz window customised flasks meets the criteria of being able to 
maintain DPSCs in aseptic conditions over long periods and permits the acquisition 
of high quality, reproducible spectra there are still potential issues. The lack of 
control over temperature and O2/CO2 concentrations means that sampling must be 
performed in ambient conditions. Additionally the culture flasks must be filled with 
fluid to prevent desiccation when presenting the samples to the microscope objective 
which may hinder efficient gas diffusion. DPSC metabolism was shown to remain 
constant over four hours under ambient conditions. However, this does not preclude 
the induction of a heat shock or hypoxic response. This will be addressed in the 
following chapter.  
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Chapter 5 
Characterisation of DPSC Osteogenic Differentiation using Raman 
Spectroscopy 
The aim of this study was to use the aseptic methodology developed in Chapter 4 to 
characterise osteogenic differentiation of DPSCs using Raman spectroscopy and to 
validate this using traditional  phenotyping techniques. The osteogenic lineage was 
chosen for this work as there have been previous studies where Raman spectroscopy 
has been used to characterise osteogenesis (though not maintaining culture sterility), 
the data from which could be used to inform as to the validity of the method. 
 
5.1 Introduction 
Raman spectroscopy has the capacity to be both non-invasive and non-destructive 
and utilises a monochromatic light source to determine sample chemistry. Upon 
interaction with the sample a small fraction of the light, approximately 1 in 106 to 
108 photons (108), is shifted in wavelength with respect to the incident laser. Many 
chemical bonds in the sample cause unique Raman shifts such that the resultant 
spectrum can be considered to be a ‘molecular fingerprint’ that is unique to the 
sample under analysis. As described in section 1.6 there are many active areas of 
research with Raman spectroscopy and stem cells a number of which have 
specifically addressed the osteogenic differentiation process. These studies have 
identified a spectroscopic signature for the differentiation of stem cells down the 
osteogenic lineage based on the emergence and relative ratios of peaks in their 
Raman spectra as illustrated in Figure 33. Whilst these data have highlighted the 
potential usefulness of Raman spectroscopy in stem cell phenotyping, to date studies 
taking multiple longitudinal measurements of the same cell population have been 
limited due to the need to maintain sterility of the cell cultures. One recent study by 
Ghita et al 2014 (191) acquired spectra from aseptic osteo-induced MSCs over a 28 
day time period and their data agreed with the findings of previous studies. 
However, their focus was on acquiring spectra later in the differentiation process 
from putative and developed mineralised nodules at which point Raman 
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spectroscopy is not strictly required to determine differentiation status (mineralised 
nodules can be seen easily under a light microscope without the need for staining). 
The early stages of osteogenesis - and the potential to use Raman spectroscopy as a 
predictive indicator of the process - remain to be  addressed. 
 
 
Figure 33. Proposed timeline of events outlining the osteogenic differentiation 
process of stem cells using Raman spectroscopy, based on data from (101, 
104, 129, 132-134). 
 
Raman scattering efficiency is very poor and the distance between the sample and 
the microscope objective needs to be as small as possible to combat this. In order to 
maximise the potential of Raman spectroscopy as a tool for non-invasive stem cell 
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characterisation, studies need to be conducted under aseptic conditions while 
maintaining the strength of the Raman signal. This would then ultimately permit 
early/predictive identification of differentiation such that stem cells may be used in 
further downstream applications. In this study, having developed the aseptic method 
in Chapter 4, the aim was to validate this using the osteogenic differentiation of 
DPSCs as an exemplar. DPSCs are one of several cell sources that are more broadly 
classed as MSCs. They were chosen specifically for this study as they have a proven 
predisposition toward the osteogenic/dentinogenic lineage (192), presenting a 
reliable and well documented sample for evaluating the newly developed method. 
Furthermore, the findings outlined in Figure 33 provided a priori  knowledge as to 
which spectral features to expect. Therefore DPSCs were osteo-induced and Raman 
spectra acquired at regular time intervals throughout the osteogenic pathway both to 
determine technical feasibility and identify whether changes in the Raman spectra 
might be indicative/predictive of the differentiation process. The majority of spectra 
were acquired during the  earlier stages of differentiation to ascertain if there were 
any features that were predictive of eventual cell fate. Finally, qRT-PCR for the 
osteogenic markers genes ALP and OC as well as Alizarin red staining were 
performed to confirm that DPSCs had successfully undergone osteogenic 
differentiation.  
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5.2 Materials and Methods 
5.2.1 Analysis of DPSC Osteogenic Differentiation using Raman Spectroscopy 
5.2.1.1 Cell Culture 
Triplicate samples of DPSCs, taken from each of three donors, were isolated, 
expanded and prepared for Raman spectroscopy as described in the general methods 
(sections 2.1, 2.2 and 2.5.3). When samples reached confluence, after approximately 
3 days of culture in basal medium, osteogenesis was induced by supplementation of 
basal medium with 0.25 mM ascorbic acid, 10 mM β-glycerophosphate and 100 nM 
dexamethasone (all Sigma-Aldrich, Gillingham, UK). This time point was 
designated as day 0. To assess the effects of Raman spectroscopy and the sampling 
process on DPSCs, an equal number of samples were maintained in osteogenic 
conditions but did not undergo Raman analysis. The total culture period for both 
sample groups was 28 days. 
 
5.2.1.2 Raman Spectroscopy 
Raman spectroscopy was performed using a Renishaw RM series 1000 microscope 
as described in the general methods (section 2.5.3). Spectra were acquired at days 0, 
3, 7, 10, 14 and 28. At each time point, 15 spectra were acquired over the 
wavenumber range 600-1800 cm-1 with an exposure time of 120 seconds for a total 
of 135 spectra at each time point. To obtain a spectrum, the DPSC monolayer was 
first focused under transmitted white light then over-focused by 5 µm and switched 
to 785 nm light to acquire the spectrum. All spectra were acquired from the DPSC 
monolayer, even at later time points, despite the presence of mineralised nodules, for 
consistency. Cell free sections of quartz, identical to that used in the experiments, 
were used to acquire background spectra. 
 
5.2.1.3 Processing and Analysis of Spectra 
Pre-processing of spectra was performed in Grams/32 with further processing and 
validation carried out using principal component analysis (PCA) performed in 
Matlab version R2013b. A full description of this process can be found in Appendix 
A. Briefly, in Grams, the background was subtracted from each individual spectrum, 
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the x-axis normalised to the peak at ~1000 cm-1, the baseline flattened and smoothed 
using a 7 point Savitzky-Golay filter and the lowest point on the y-axis offset to 0. 
All spectra were then exported to Microsoft Excel for further processing in Matlab. 
PCA was performed on all spectra from each individual donor and used to remove 
outlying spectra from each time point. The data was then averaged using one 
spectrum from each donor per time point. Following this 2nd derivative spectra were 
calculated and further smoothing performed.  
  
5.2.2 The Effect of Raman Spectroscopy on Osteogenic and Cell Stress Marker 
Gene Expression using qRT-PCR 
RNA isolation and reverse transcription were performed as previously described in 
the general methods (section 2.3). qRT-PCR was performed using TaqMan gene 
expression assays (Applied Biosystems, Carlsbad, USA) for ALP and OC: assay 
numbers Hs01029144-m1 and Hs00609452-g1 respectively, to investigate 
osteogenic marker expression and, heat shock transcription factor 1 (HSF1), hypoxia 
inducible factor 1 (HIF1A) and lactate dehydrogenase (LDH): assay numbers 
Hs00232134-m1, Hs00153153-m1 and Hs00929956 respectively, to investigate cell 
stress marker expression. Reactions were carried out in 96 well plates as per the 
manufacturer’s instructions on a Roche LightCycler® 480  system. Optimal cDNA 
concentration was determined as 5 ng/reaction by plotting standard curves with 
known cDNA concentrations. Data was normalised to YWHAZ assay number 
Hs00237047_m1, and analysed using the comparative cycle threshold method 
(ΔCT). DPSC samples from three patients, one in duplicate (total number of samples 
= 4), were analysed ± Raman spectroscopy after 28 days of osteo-induction. Each 
sample was analysed in triplicate giving a total n=12 for each group. A sample from 
day 0 was used to provide a baseline. Graphs of the mean ± SE were plotted in 
Microsoft Excel and statistical significance was determined by one-way ANOVA 
using GraphPad Instat 3 software. 
 
5.2.3 The Effect of Raman Spectroscopy on Extracellular Matrix Calcification 
using Alizarin Red Staining  
Alizarin red staining was performed on DPSCs at day 28 ± Raman spectroscopy 
(n=2 for each) as described in section 3.3.4.  
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5.3 Results 
5.3.1 Characterisation of Osteogenic Differentiation of DPSCs by Raman 
Spectroscopy 
Raman spectroscopy has previously been used to demonstrate late stage osteogenic 
differentiation of stem cells by analysing putative mineralised nodules (101, 134). In 
this study DPSCs were analysed by Raman spectroscopy with a focus on earlier time 
points, prior to the emergence of mineralised nodules, to ascertain if the spectra 
were indicative/predictive of or associated with the osteogenic differentiation 
process. Figure 34 depicts the average spectra for each time point (day 0 to day 28) 
following subtraction of the signal from the (quartz) background. Many peaks 
typical of biological samples were clearly evident such as phenylalanine at 1003 cm-
1, CH3, CH2 found in collagen at 1453 cm
-1 and amide I at 1660 cm-1. 
 
Figure 34.Average background subtracted spectra of osteo-induced DPSCs at 
days 0, 3, 7, 10, 14 and 28, n=135 spectra per time point from three 
separate donors. A selection of peaks typical of spectra from biological 
samples are marked * 
 
Principal component analysis (PCA) was performed on spectra obtained from 
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n=135 spectra at each time point. Figure 35 is a 2D scatter plot of PC1 and PC2 
scores accounting for 54.2% and 12.4% of the variation in the data set respectively. 
 
Figure 35. Principal component analysis of the osteogenic differentiation of 
DPSCs at days 0, 3, 7, 10, 14 and 28. 2D scatter plot for principal 
components 1 and 2. Each position displayed is the average of three 
spectra, one from each donor, for every time point. There is a clear trend 
in PC1 between days 0 and 10 and a further trend in PC2 between days 0 
and 10 and days 10 and 28. 
 
The PCA scores plot demonstrated a clustering of spectra at each time point, 
illustrating that the spectral collection was reproducible. As expected, there was 
overlapping of spectra between adjacent time points as there was a phenotypic shift 
that was continuous in nature during cellular differentiation. Despite the overlapping 
of time points a clear trend was observed from day 0 to day 10 along PC1 while a 
trend from day 10 to day 28 was observed along PC2. Loadings plots can be drawn 
for each PC to illustrate those spectral features that are responsible for the variance 
in that PC. Peaks on the same side of a loading plot will be behaving similarly, 
whilst peaks on opposite sides of a loading plot will be behaving differently with 
respect to their scores within a given PC. Figure 36 illustrates the loading plots for 
PC1 and PC2. 
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Figure 36. PCA loadings plot for A) PC1 and B) PC2 from the PCA of DPSCs 
that had been osteo-induced for 0, 3, 7, 10, 14 and 28 days. Significant 
positive and negative peaks are marked. 
 
The loading plot for PC1 showed positive peaks for wavenumbers corresponding to 
amide bonds (1266 cm-1 and 1660 cm-1), CH3, CH2 from collagen (1345 cm
-1 and 
1453 cm-1), phenylalanine (1003 cm-1) and lipids (1126 cm-1) whilst wavenumbers 
corresponding to ribose (975 cm-1 and 1020 cm-1), the nucleic acids guanine and 
adenine (1420 cm-1) and DNA (1481 cm-1) had negative peaks. Similarly the loading 
plot for PC2 had positive peaks at 1003 cm-1, 1453 cm-1 and 1660 cm1 with negative 
peaks at 975 cm-1, 1020 cm-1 and 1420 cm-1. Putative peak assignments were based 
on Movasaghi et al 2007 (97). As the above individual PCs both use the same areas 
it may be hard to differentiate which are the important vibrations with respect to 
time, therefore PC1 was plotted against PC2 (Figure 37). In this instance the 
position of a given wavenumber on the plot when transposed on the original scores 
plot indicates where that wavenumber varies most greatly, as illustrated in section 
1.4. This loadings plot showed that two protein associated peaks at 1453 cm-1 and 
1660 cm-1 transpose along the trend in PC1 from days 0 to 10, whilst two 
DNA/RNA associated peaks 975 cm-1 and 1020 cm-1 transpose along the trend in 
PC2 from days 10 to 28 as did the phenylalanine peak at 1003 cm-1. 
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Figure 37. PCA loadings plot for PC1 versus PC2, the outer green circle 
indicates 95% confidence. In the key are groups of wavenumbers from 
peaks that vary significantly. 
 
Finally, to confirm osteogenic differentiation of DPSCs at day 28 several Raman 
spectra were acquired from putative mineralised nodules, (Figure 38). The well 
characterised mineral associated region, 955-964 cm-1, described in several previous 
studies (101, 133, 134), was clearly evident. 
 
Figure 38. Average background subtracted spectra of osteo-induced DPSCs at 
day 28 acquired from sites of putative mineralised nodules, n=5. The well 
characterised mineral associated region at ~955-964 cm-1 is clearly 
evident, marked *. 
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5.3.2 Confirmation of Osteogenic Differentiation of DPSCs ± Analysis by Raman 
Spectroscopy using qRT-PCR and Alizarin Red Staining 
qRT-PCR and Alizarin red staining were used to confirm osteogenic differentiation 
of DPSCs. Samples that had undergone Raman measurements and those grown in 
parallel without being subject to Raman were analysed to determine if the data 
acquisition process and the Raman spectroscopy itself had any effect on DPSC 
osteogenic differentiation. Significant increases in ALP and OC expression were 
observed between days 0 and 28 irrespective of whether or not the DPSCs had 
undergone Raman analysis (p<0.001 and p<0.05 respectively) (Figure 39). There 
was no significant difference in the expression of either gene between DPSCs which 
had/had not been analysed by Raman spectroscopy. 
 
Figure 39. A comparison of DPSC osteogenic gene expression at day 0, and day 
28 from cells that had/had not undergone Raman spectroscopy. Results 
show mean ±SE, n=3 (day 0), n=12 (day 28 + Raman), n=12 (day 28 – 
Raman). *** p<0.001, * p<0.05. Statistical significance was determined 
using a one-way ANOVA. Significant increases in the expression of both 
genes was found between days 0 and 28 and there was no difference in the 
expression between DPSCs that had and had not undergone Raman 
spectroscopy. 
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Alizarin red staining was used to demonstrate extracellular matrix calcification by 
DPSCs after 28 days of osteo-induction for samples that had been analysed by 
Raman spectroscopy and those that had not (Figure 40). Positive Alizarin red 
staining was observed in all samples, with no discernible differences between the 
Raman and non-Raman groups. 
   
 
Figure 40. Alizarin red staining of DPSCs after 28 days of osteo-induction that 
A) had undergone Raman measurements and B) had not undergone 
Raman measurements. Scale bars = 100 µm. Positive staining of 
mineralised nodules was observed regardless of whether the DPSCs had 
undergone Raman spectroscopy or not. 
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5.3.3 Comparison of Cell Stress Marker Gene Expression Between DPSCs ±  
Analysis by Raman Spectroscopy using qRT-PCR 
The data acquisition process when performing Raman spectroscopy has the potential 
to induce a cell stress response due to, for example, limited gas diffusion and 
exposure to ambient temperature and gas concentrations. In order to test for any cell 
stress response, the expression of three marker genes: heat shock transcription factor 
1 (HSF), hypoxia inducible factor 1 (HIF) and lactate dehydrogenase (LDH) was 
determined by qRT-PCR from DPSCs at day 0 and day 28 ± Raman spectroscopy 
(Figure 41). No significant differences in the expression of all three genes was 
observed between the groups. 
 
Figure 41. A comparison of DPSC cell stress marker expression at day 0 and 
day 28 from cells that had/had not undergone Raman spectroscopy. 
Results show mean ±SE, n=3 (day 0), 12 (day 28 + Raman), 12 (day 28 – 
Raman). Statistical significance was determine using a one-way ANOVA. 
No significant changes in gene expression were observed. 
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5.4 Discussion 
The aim of this study was to validate the method developed and described in 
Chapter 4 by using Raman spectroscopy to investigate the well-characterised 
osteogenic differentiation of DPSCs, prior to the outcome becoming apparent by the 
emergence of mineralised nodules in the cultures. At this end point there is no need 
for a non-invasive method to determine cellular differentiation status as such 
nodules are clearly discernible under an ordinary microscope without staining. 
Therefore there was a focus on acquiring spectra in the first 14 days of osteo-
induction with a view to identifying spectral features that may indicate/predict cell 
differentiation. 
  
PCA was performed on spectra acquired throughout the DPSC osteo-inductive 
differentiation process. PCA is already widely used in the analysis of spectroscopic 
data (103, 123, 131, 193, 194) and is well suited to reducing the complexity of large 
multivariate data sets (121). The PCA scores plot of PC1 versus PC2 demonstrated 
two phases in the process hinged at approximately day 10, a relatively early stage in 
the osteogenic lineage for these cells (139). The loadings for PC1 and PC2 indicated 
that the pattern of those spectral features indicative of proteins and lipids was similar 
while features indicative of DNA and RNA had the opposite pattern to those of 
protein and lipids but were also similar to one another. When the loadings for PC1 
and PC2 were plotted against each other, protein associated peaks were shown to 
vary the most in PC1 and therefore from days 0 to 10 while DNA/RNA associated 
peaks varied the most in PC2 and therefore from days 10 to 28. It is clear from the 
averaged spectra at each time point that the protein associated peaks at 1453 cm-1 
and 1660 cm-1 were increasing in intensity. Taken together this suggests that in the 
early stages of DPSC osteogenic differentiation, increasing protein content is the 
main spectroscopic marker. This is in agreement with the findings of many others 
(101, 104, 134) and is the first instance where this has been demonstrated using the 
same cell cultures. However, a firm conclusion is more difficult to draw in the case 
of the DNA/RNA associated peaks contributing to the trend in PC2 due to their 
relatively low signal intensity in the original spectra and the lower contribution of 
PC2 (12.4%) to the variation within the data set.  Schulze et al 2010 (104) found that 
one of the major indicators of differentiation in embryonic stem cells was the ratio 
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of spectral peaks related to proteins and DNA/RNA, concluding that the intensity of 
protein associated peaks increased in intensity whilst DNA/RNA peaks decreased in 
intensity with differentiation. Whilst it is clear from the data here that the intensity 
of protein associated peaks increases with time, the trend was less clear with regards 
to DNA/RNA. Finally, the method was clearly able to detect late stage osteogenic 
differentiation when directed toward mineralised nodules as evidenced by the 
prominent mineral associated region at 955-964 cm-1. 
 
In order for Raman spectroscopy to be truly non-invasive, Raman spectra were 
acquired repeatedly over time from the same cell cultures under aseptic conditions, 
using the method developed and described in Chapter 4. This allowed DPSCs to be 
cultured and analysed over time in the same culture vessel. However, a lack of 
optimised environmental control during the acquisition of spectra had the potential 
to induce a cell stress response. In order to investigate any cell stress the expression 
of heat shock transcription factor 1 (HSF), hypoxia inducible factor 1 (HIF1) and 
lactate dehydrogenase (LDH) was determined by qRT-PCR. HSF is a transcription 
factor regulating the expression of several important heat shock factor proteins 
including HSP70 and HSP90 (195) and whilst it is primarily induced by 
hyperthermia it has been shown to be activated in response to increasing temperature 
following hypothermia (196). HIF1 is expressed in response to hypoxia which at 
physiological levels (2-9% O2) is beneficial and a key regulatory mechanism in 
several biological processes including embryogenesis and stem cell function, 
however overexpression at pathological levels (<1% O2) is associated with several 
conditions including ischemia and cancer (197-199). LDH expression is known to be 
stimulated by HIF1 expression and is associated with cancer through increased 
anaerobic glycolysis by a process termed the Warburg effect (200, 201). No 
significant differences in the expression of all three markers genes were found in 
DPSCs associated with the Raman sampling process and relative to the start of the 
experiment. Whilst this is not an exhaustive interrogation of the effects of 
performing Raman spectroscopy on DPSCs in ambient conditions for approximately 
3 h at a time, it does indicate that any effects were negligible as far as these key 
stress markers are concerned. Previous studies have also demonstrated that Raman 
spectroscopy and in particular exposure of cells to near infra-red lasers with a power 
on the sample of up to 115 mW does not induce cell damage (102). Finally, the 
- 89 - 
method had no effect, detrimental or otherwise, on the osteogenic differentiation 
process as evidenced by no differences in the expression of osteogenic marker genes 
or in Alizarin red staining between DPSCs that had or had not undergone analysis by 
Raman spectroscopy. 
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Chapter 6 
Assessment of the Adipogenic Differentiation of ADSCs by Raman 
Spectroscopy 
In Chapter 4 an aseptic method capable of acquiring longitudinal Raman 
measurements from cells in culture during their sequential differentiation was 
developed; in Chapter 5 this method was validated through the characterisation of 
the osteogenic differentiation of DPSCs. In this final study, a less well characterised 
differentiation lineage was studied by Raman spectroscopy. Adipogenic 
differentiation was chosen to illustrate the potential of the methodology because 
there is a very clear end point to the process evidenced by, the accumulation of   
lipid-rich vacuoles within the cells. Adipose derived stem cells (ADSCs) were 
therefore selected as the cell source for the study. 
 
6.1 Introduction 
There have been several studies using Raman spectroscopy to characterise the 
osteogenic differentiation process as described previously in section 1.5.4 and 
Chapter 5. This is perhaps unsurprising given that the end point of osteogenesis is 
the formation of mineralised nodules which are easily detected by Raman 
spectroscopy and possess a chemistry very different to that of the surrounding cells. 
However, there has also been a small number of studies that have illustrated the 
possible use of Raman spectroscopy to characterise cardiac (103, 202) and neural 
cell differentiation (203). 
 
Adipogenic differentiation, one of the archetypal lineages along which MSCs 
differentiate (55), is accompanied by very clear biochemical/intracellular events. 
During the initial stages of adipogenic differentiation, stem cells undergo a period of 
growth arrest and mitotic clonal expansion which triggers the expression of two key 
pro-adipogenic transcription factors: peroxisome proliferator-activated receptor γ 
(PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) (204-206). The 
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induction of PPARγ and C/EBPα and subsequent maintenance of their expression is 
required to produce a mature adipocyte phenotype and leads to the expression of 
several genes indicative of a mature adipocyte phenotype including fatty acid 
synthase, fatty acid binding protein, leptin and adiponectin (139, 207). The action of 
these genes results in increased glucose uptake, fat accumulation and insulin 
sensitivity, producing the characteristic adipocyte phenotype of large spherical cells 
containing many lipid-rich vacuoles. This is therefore a longitudinal process with 
clear chemical changes that Raman spectroscopy should be well suited to 
characterising. 
 
Two studies have previously used Raman spectroscopy to attempt to characterise 
adipogenic differentiation. However, these studies used the derivative Raman 
methods, outlined in section 1.3.2, surface enhanced Raman spectroscopy (SERS) 
and coherent anti-stokes Raman spectroscopy (CARS). Both of these methods have 
their drawbacks. SERS is not non-invasive as the sample has to be treated with gold 
nanoparticles and CARS can only provide excitation at one vibrational frequency at 
a time, increasing the total time required for analysis. Moody et al 2010 (208) used 
the SERS approach to characterise the adipogenic differentiation of ADSCs over 22 
days. The authors also took spectra from uninduced cells to determine which 
spectral features were unique to differentiating cells. It was found that peaks in the 
regions 1200-1275 cm-1 and 1390-1610 cm-1 were the most useful for describing 
differentiation. However, due to the small laser spot size used (2 µm), many of the 
peaks in these regions varied greatly in intensity due to differences in the loci from 
which they were acquired. Further, the authors admitted that the use of gold 
nanoparticles produced spectra of higher intensity near the endosomes where the 
particles aggregated and also resulted in weaker spectra over time as the 
nanoparticles were exocytosed, making their spectra difficult to compare. Finally, no 
mathematical analysis of the spectra was undertaken to explore the relationship of 
specific spectral features with one another over time. Mouras et al 2012 (209) used 
CARS amongst other methods to characterise the adipogenic differentiation of 
ADSCs over 14 days. CARS only provides excitation at a single vibrational 
frequency at a time and the authors use of CARS in their study was restricted to 
measuring the intensity of the CH2 stretch frequency, which is associated with lipids, 
at 2845 cm-1. 
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There is very little spectroscopic data on the adipogenic differentiation of stem cells 
in the literature. However, the adipogenic differentiation process itself is rich in 
clear chemical transitions that should be well suited to Raman analysis. In this study, 
adipogenic differentiation was induced in ADSCs over 14 days taking spectra at 
regular time intervals. As with the previous chapter, the aim was to ascertain if there 
were any features in the spectra that could be used to predict differentiation, 
particularly in the early stages of process before the presence of fat droplets became 
evident by eye.    
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6.2 Materials and Methods 
6.2.1 Analysis of ADSC Adipogenic Differentiation using Raman Spectroscopy 
6.2.1.1 Cell Culture 
Adipose derived stem cells where purchased from Zen-Bio (Zen-Bio, Research 
Triangle Park, CA, USA). Each batch was comprised of cells from multiple donors 
(see Table 8 for details). ADSCs had tested positive for tri-lineage differentiation 
and the cell surface markers CD44 and CD105 and negative for the cell surface 
markers CD31 and CD45 prior to purchase. Informed ethical consent was obtained 
by Zen-Bio prior to isolation and sale. ADSCs from each batch were expanded and 
prepared separately for Raman spectroscopy as described in the general methods 
(sections 2.1, 2.2 and 2.5.3). Cells were left 48 hours to adhere then either adipo-
induced using adipogenic induction medium supplied by Zen-Bio (DMEM / Ham’s 
F-12 (1:1, v/v), HEPES pH 7.4, foetal bovine serum, biotin, pantothenate, human 
insulin, dexamethasone, isobutylmethylxanthine, PPARγ agonist, penicillin, 
streptomycin, amphotericin B (concentrations not supplied)) or cultured in basal 
medium. This time point was designated as day 0. At day 7, half the adipogenic 
induction medium was aspirated and replaced with adipogenic maintenance 
medium, also supplied by Zen-Bio (DMEM / Ham’s F-12 (1:1, v/v), HEPES pH 7.4, 
fetal bovine serum, Biotin, pantothenate, human insulin, dexamethasone, penicillin, 
streptomycin, amphotericin B (concentrations not supplied)). To assess the effects of 
Raman spectroscopy and the Raman sampling process itself on ADSCs, an equal 
number of cultures were maintained in adipogenic or basal medium but did not 
undergo Raman analysis. Each individual batch of ADSCs was analysed once. 
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Table 8. List of ADSC multi-donor batches used in the study including the 
average age of the donors across each batch sample. 
Batch Number of donors Average age 
1 6 51 
2 8 44 
3 7 44 
4 7 32 
5 9 48 
 
6.2.1.2 Raman Spectroscopy 
Raman spectroscopy was performed using a Renishaw RM series 1000 microscope 
as described in the general methods (section 2.5.3). Spectra were acquired at days 0, 
3, 7, 10 and 14 in both basal and adipogenic culture. The number of spectra acquired 
and the parameters used are described in section 5.2.1.2. 
 
6.2.1.3 Processing and Analysis of Spectra 
Descriptions of the processing and analysis of spectra can be found in section 5.2.1.3 
and Appendix A. Outlier removal  was not required in the processing of spectra 
acquired from ADSCs. 
 
6.2.2 The Effect of Raman Spectroscopy on Adipogenic and Cell Stress Marker 
Gene Expression 
RNA isolation and reverse transcription were performed as previously described in 
the general methods (section 2.3). qRT-PCR was performed using TaqMan gene 
expression assays (Applied Biosystems, Carlsbad, USA) for peroxisome 
proliferator-activated receptor gamma (PPARγ) and adiponectin (ADIPOQ): assay 
numbers Hs01115513_m1 and Hs00605917_m1 respectively, to determine 
adipogenic marker gene expression, and HSF1, HIF1 and LDH (assay numbers 
listed in section 5.2.2), to determine cell stress marker gene expression. Gene 
expression analysis was carried out on ADSC batches 1, 3, and 5 ± testing by 
Raman spectroscopy at day 0 and at day 14 of basal and adipogenic cultures.  Gene 
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expression was analysed using the same ADSC batches cultured in adipogenic or 
basal medium. Reactions and analysis were carried out as described in section 5.2.2. 
 
6.2.3 The Effect of Raman Spectroscopy on Lipid Accumulation using Oil Red O 
Staining 
To test for the presence of lipid droplet accumulation within the ADSCs following 
their differentiation, Oil red O staining was performed on adipo-induced and basal 
cultured samples ± sampling by Raman spectroscopy after 14 days. Oil red O 
staining was performed on ADSC batches 2 and 4 cultured in either adipogenic or 
basal medium. Prior to staining, a 0.5% stock solution of Oil red O was prepared in 
100% isopropanol (Sigma-Aldrich, Gillingham, UK). A working solution was 
created by diluting the stock 3:2 in de-ionised water and filtered prior to use. ADSCs 
were first washed with PBS then fixed in NBF for 1 hour at room temperature. 
ADSCs were then washed with de-ionised water, followed by 60% isopropanol and 
then stained with Oil red O solution for 15 minutes at room temperature. Excess Oil 
red O stain was washed away with 60% isopropanol. Finally, to stain cell nuclei, 
samples were stained with Haematoxylin (Sigma-Aldrich, Gillingham, UK) for 30 
seconds and the excess stain washed away with de-ionised water. ADSCs were 
imaged on a Leica DMI6000b microscope (Leica Microsystems, Milton Keynes, 
UK). 
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6.3 Results 
6.3.1 Characterisation of Adipogenic Differentiation of DPSCs by Raman 
Spectroscopy 
In Chapter 5, the osteogenic differentiation of DPSCs was characterised by Raman 
spectroscopy and compared with data from previous studies to assess the validity of 
the newly developed methodology described in Chapter 4. In this study, a less well 
described differentiation lineage (adipogenesis) was characterised using Raman 
spectroscopy. Figure 42 depicts the average spectra for each time point (days 0 , 3, 
7, 10 and 14 of culture) for ADSCs cultured under adipogenic conditions and in 
basal culture. There was a clear increase in the intensity of many peaks, including 
the characteristic CH3, CH2 group in lipids at 1302 cm
-1, CH2 in fatty acids at 1441 
cm-1 and C=C in lipids at 1654 cm-1 in spectra from adipo-induced ADSCs after 7 
days of induction compared with similar spectra obtained from cells in basal culture. 
 
Figure 42. Average background subtracted spectra from adipo-induced (a) and 
basal cultured (b) ADSCs taken at days 0, 3, 7, 10 and 14, n=75 spectra 
per time point from 5 multi-donor batches. A pronounced change in 
spectra from adipo-induced ADSCs can be seen from day 7 onwards 
whilst spectra from basal cultured ADSCs varied little.  
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PCA was performed on spectra obtained from 5 ADSC multi-donor batches which 
had been averaged, n=75 spectra at each time point. Figure 43 is a 2D scatter plot of 
PC1 and PC2 scores accounting for 99.3% and 0.3% of the variation in the data set 
respectively. There was a clustering of all the spectra from basal cultured ADSCs 
and the majority of the spectra at days 0 and 3 from the adipo-induced ADSCs 
(circled in the figure). However, spectra from adipo-induced ADSCs at days 7, 10 
and 14 clearly cluster away from this and from one another. This resulted in two 
trends firstly in PC1 from day 0 to 14, secondly in PC2 from day 0 to 7 and then day 
7 to 14. 
 
Figure 43. Principal component analysis of spectra acquired from (a) adipo-
induced and (b) basal cultured ADSCs at days 0, 3, 7, 10 and 14 of culture. 
Each point is the average of 5 spectra, one from each multi-donor batch. 
Circled are all the spectra from the basal cultured ADSCs, indicating no 
trends in the data with time. Trends can be observed in the spectra from 
adipo-induced ADSCs in both PC1 and PC2 with increasing time in 
culture. 
 
In order to ascertain which peaks were responsible for the variation within the 
principal components, the loadings for each PC were plotted (Figure 44). The 
loadings for PC1 showed positive peaks for wavenumbers corresponding to C-N 
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bonds in proteins and lipids (1082 cm-1), CH3, CH2 in lipids (1302 cm
-1), CH2 in 
fatty acids (1441 cm-1) and C=C bonds in lipids (1654 cm-1) whilst wavenumbers 
corresponding to the nucleic acids guanine and adenine (1417 cm-1) and DNA   
(1481 cm-1) had negative peaks. Similarly, the loadings plot for PC2 had positive 
peaks corresponding to C-C bonds in collagen (971.5 cm-1), and amide bonds   
(1266 cm-1 and 1660 cm-1). The assignment of the negative peaks in PC2 is less 
certain. Putative peak assignments based on Movasaghi et al 2007 (97). 
 
 
Figure 44. Loadings from the principal component analysis of ADSCs in 
adipogenic and basal culture, (A) principal component 1, (B) principal 
component 2. Significant peaks of interest are indicated. 
 
In order to identify the time point at which each peak varied most, the loadings for 
PC1 and PC2 were plotted against one another (Figure 45). As previously described 
in Chapter 5, the position of a given wavenumber on the loadings plot when 
transposed to the original scores plot indicates the samples in which a particular 
wavenumber varied the most. This demonstrated that the lipid associated peaks in 
the lower right quadrant of the loadings plot varied the most between days 3 and 7 in 
spectra from adipo-induced ADSCs found in the same quadrant of the scores plot. 
Similarly, it was also observed that the protein and nucleic acid associated peaks 
varied between days 10 and 14 in spectra from adipo-induced ADSCs. 
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Figure 45. PCA loadings plot for PC1 versus PC2, the outer green circle 
indicates 95% confidence. In the legend are groups of wavenumbers from 
peaks that vary significantly. 
 
In order to determine if any spectral features were indicative of the early 
differentiation process, PCA was performed on spectra from ADSCs cultured in 
adipogenic or basal medium at day 3 (Figure 46). Principal components 1 and 3 
were plotted accounting for 44.6% and 5.6% of the variation respectively. All of the 
spectra from the ADSCs cultured in basal medium and a majority of those from the 
adipo-induced ADSCs were clustered together. However, a small number of spectra 
were removed from the main cluster based on contributions from both PC1 and PC3 
in the adipogenic culture group. 
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Figure 46. Principal component analysis of spectra from (a) adipo-induced and 
(b) basal cultured ADSCs after 3 days. It can be seen that even at this very 
early stage of adipogenic culture, spectra from adipo-induced ADSCs  are 
beginning to cluster away from spectra obtained from cells in basal 
medium. 
 
The loadings for PC1 and PC3 (Figure 47) highlighted that there were two potential 
molecular species in the prominent 1430-1460 cm-1 region, the first in PC1 at     
1452 cm-1 and the second in PC3 at 1438 cm1. Based on the review by Movasaghi et 
al 2007 (97) these may represent CH3, CH2 in collagen and CH2 in fatty acids 
respectively. The remaining peaks in PC1 correspond to phenylalanine (1006 cm-1) 
and amide bonds (1655 cm-1). 
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Figure 47. Loadings from the principal component analysis of ADSCs in 
adipogenic culture and basal medium, (A) principal component 1, (B) 
principal component 3. Marked are significant peaks of interest. 
 
Finally, three spectra from 14 day, adipo-induced ADSCs were plotted (Figure 48). 
There was a clear shoulder on the latter portion of the peak in the 1430-1460 cm-1 
region which further indicated the presence of two separate molecular species in this 
area. 
 
 
Figure 48. Graph of three background subtracted spectra from adipo-induced 
ADSCs after 14 days of induction. Indicated are the two putative peaks in 
the 1430-1460 cm-1 region as shown by the shoulder in the latter portion of 
the region. 
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6.3.2 Adipogenic Differentiation of ADSCs ± Analysis by Raman Spectroscopy 
using qRT-PCR and Oil Red O Staining 
In order to confirm the adipogenic differentiation of ADSCs the expression of two 
adipogenic marker genes PPARγ and ADIPOQ were measured and Oil red O 
staining used to detect lipid droplet accumulation. Both were also used to determine 
if the Raman acquisition process had any effect on adipogenesis. Significant 
increases in PPARγ and ADIPOQ expression were observed during the culture 
period irrespective of the Raman acquisition process (p<0.001 for PPARγ, ADIPOQ 
was undetectable at day 0). However, there was significantly less expression of 
PPARγ and ADIPOQ in ADSCs that had been subjected to Raman analysis 
compared with those that had not been analysed by Raman (p<0.01 and p<0.001 
respectively). 
 
Figure 49. A comparison of ADSC adipogenic marker gene expression at day 0 
and day 14 from ADSCs in adipogenic culture that had/had not 
undergone Raman spectroscopy. Results show mean ± SE (n=9). *** 
p<0.001, ** p<0.01. Statistical significance was determined using a one-
way ANOVA. Significant increases in the expression of both genes was 
found between days 0 and 14, however, there was also a significant 
difference in the expression of both genes between cells that had 
undergone Raman spectroscopy compared with those that had not. 
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The expression of both marker genes was also analysed in ADSCs cultured in basal 
medium. A significant decrease in the expression of PPARγ was observed after 14 
days irrespective of the Raman acquisition process (p<0.001). However, no 
significant differences in the expression of either gene were observed between 
ADSCs that had/had not undergone Raman analysis. 
 
 
Figure 50. A comparison of ADSC adipogenic marker gene expression at day 0 
and day 14 from cells cultured in basal medium that had/had not 
undergone Raman spectroscopy. Results show mean ± SE (n=9). *** 
p<0.001. Statistical significance was determined using a one-way ANOVA. 
No significant differences in the expression of either marker gene was 
detected between cells that had undergone Raman spectroscopy compared 
with those that /had not. 
 
Oil red O staining confirmed the presence of lipid droplets in adipo-induced ADSC 
cultures after 14 days regardless of whether the cells had undergone Raman analysis 
or not (Figure 51). No lipid droplets were detected in the basal cultured ADSCs 
(Figure 52). 
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Figure 51. Oil red O staining of ADSCs after 14 days of adipo-induction for 
cells that A) had undergone Raman measurements and B) had not 
undergone Raman measurements. Scale bars = 50 µm. Positive staining of 
lipid droplets was observed regardless of whether ADSCs had undergone 
Raman spectroscopy or not. 
 
 
Figure 52. Oil red O staining of ADSCs after 14 days of culture in basal 
medium. Scale bar = 50 µm. No lipid droplet accumulation was observed. 
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6.3.3 Comparison of Cell Stress Marker Gene Expression Between ADSCs ± 
Analysis by Raman Spectroscopy using qRT-PCR 
The expression of the three cell stress markers HIF, LDH and HSF was determined 
to test if the Raman sampling process had induced any cell stress response as 
described in section 5.3.3. The expression of all three markers was significantly 
increased for ADSCs cultured under adipogenic conditions for 14 days regardless of 
Raman sampling, p<0.001, with the exception of HIF in ADSCs that had not 
undergone Raman analysis (Figure 53). However, there were conflicting differences 
in the expression of the three markers between ADSCs from the Raman and non-
Raman groups. There was a significant increase in the expression of HIF, p<0.001, 
in ADSCs that had undergone Raman, a significant decrease in the expression of 
LDH, p<0.001 and no difference was observed in the expression of HSF.  
 
Figure 53. A comparison of ADSC cell stress marker gene expression for cells 
cultured under adipogenic conditions at day 0 and day 14 ± Raman 
analysis. Results show mean ± SE (n=9). *** p<0.001. Statistical 
significance was determined using a one-way ANOVA. Significant up-
regulation of all stress marker genes was observed after 14 days in 
adipogenic culture regardless of whether the cells had undergone Raman 
spectroscopy (with the exception of HIF). Significant differences in the 
expression of HIF and LDH were also observed between the Raman and 
non-Raman groups. 
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6.4 Discussion 
The aim of this study was to characterise the adipogenic differentiation of ADSCs 
by Raman spectroscopy using the aseptic methodology developed and described in 
Chapter 4. In Chapter 5 it was shown that this methodology was capable of 
generating data in agreement with the published data using Raman spectroscopy in 
characterising osteogenic differentiation. In this study, adipogenesis was selected for 
characterisation as spectroscopic data in the literature is sparse for this 
differentiation lineage. 
 
PCA was performed on spectra acquired from ADSCs throughout the adipogenic 
differentiation process during 14 days of adipogenic culture. The PCA scores plot 
for PC1 versus PC2 demonstrated a continuous trend in PC1 from day 0 to day 14 
and a trend in PC2 from day 0 to day 7 followed by a trend from day 7 to day 14. 
PC1 encompassed the vast majority of the variation in the data set (99.3%). When 
the loadings for PC1 were plotted, it was found that several peaks indicative of 
lipids and fatty acids were behaving in a similar fashion whilst peaks indicative of 
nucleic acids were behaving in an opposing manner. PC2, whilst only accounting for 
0.3% of the variation in the data set, was found to be comprised of peaks relating to 
protein content. When the loadings for PC1 and PC2 were plotted against one 
another, it was demonstrated that lipid associated features were most variable early 
on in the differentiation process, between days 3 and 7. Features associated with 
nucleic acid and protein varied most at the end of the process, at day 14. This is 
broadly in agreement with the study by Moody et al 2010 (208) who also 
determined that peaks in the region 1390-1610 cm-1 varied most during the 
adipogenic differentiation process, many of which were also found to vary in this 
study. The spectra from ADSCs cultured in basal medium varied little over the 
course of 14 days and those spectra formed a tight cluster upon PCA analysis 
underlining the lack of variation in these cells in the absence of inductive cues. 
Finally, to ascertain if any spectral features may have been predictive of the 
differentiation process, PCA was performed on spectra from ADSCs cultured under 
adipogenic and basal conditions after 3 days of culture. The results indicated that 
spectra from the adipo-induced cells were beginning to cluster away from spectra 
obtained from cells cultured in basal medium. The loadings indicated that this was 
- 107 - 
due to a single lipid associated peak at 1438 cm-1. This analysis also indicated a 
novel finding that there is likely two closely related molecular species in the region 
1430-1460 cm-1, a region that is often taken to be a single peak indicative of 
proteins. Confirmation of MSC adipogenic differentiation using conventional 
techniques such Oil red O staining or qRT-PCR usually occurs between 7 and 21 
days (52, 55, 139), the Raman spectra in this study indicate that adipogenesis can be 
detected several days earlier and in a non-invasive manner. 
 
As previously described for osteo-differentiation in Chapter 5, qRT-PCR and 
histological staining were used to confirm that adipogenic differentiation had 
occurred over the culture period and to determine if the process had been perturbed 
by the Raman sampling method. There was a significant increase in the expression 
of both PPARγ and ADIPOQ following 14 days of adipogenic induction and Oil red 
O staining confirmed that adipo-induced ADSCs had produced lipid-rich vacuoles. 
A mature adipocyte phenotype was therefore observed in adipo-induced ADSCs 
irrespective of whether or not they had undergone Raman analysis but the 
expression levels of adipogenic marker genes was significantly reduced in ADSCs 
that had undergone Raman analysis. This was most prominent in an approximately 
10 fold reduction in the expression of ADIPOQ, however, it is difficult to ascertain 
if this reduction in gene expression was biologically significant as a mature 
adipocyte phenotype (the presence of lipid-rich vacuoles) was observed. It is widely 
accepted that there is a dysregulation of adipogenesis and the associated marker 
genes in obesity as a result of hypoxia (210). Indeed, several studies have 
demonstrated that ADIPOQ expression is reduced under both persistent or 
intermittent hypoxia (211-213) such as might be anticipated during prolonged 
Raman sampling. Furthermore, the increased expression of HIF1 as a result of 
hypoxia has been shown to directly reduce the expression of ADIPOQ by adipocytes 
(214) whilst inhibition of HIF1 has been shown to increase ADIPOQ expression 
(215). In this study HIF1  expression was significantly increased in ADSCs that had 
undergone Raman analysis compared with those that had not. Therefore the 
increased expression of HIF1 in ADSCs that had undergone Raman analysis may 
have caused the observed decrease in the expression of ADIPOQ and may also have 
been further exacerbated directly by hypoxic conditions.  
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LDH and HSF were the other two cell stress markers assessed in this study and both 
were up-regulated in ADSCs after 14 days of induction regardless of whether the 
cells had undergone Raman analysis. LDH expression is known to be stimulated by 
the expression of HIF1 (201). However, this does not explain the observed increase 
expression of LDH in ADSCs that had not undergone Raman sampling where HIF1 
expression was not up-regulated, indicating that some other factor must have been 
responsible for this observation. Glucose is required for fatty acid synthesis by 
adipocytes. However, glucose metabolism can also result in the production of lactate 
and it has been shown that in older adipocytes with high fat content that there is a 
shift toward producing more lactate from glucose as opposed to fatty acids (216, 
217). In order to metabolise any excess lactate there would need to be a concomitant 
increase in lactate dehydrogenase production and this may explain the observed 
increase in its expression and may also indicate that the ADSCs may have been 
overstimulated. Finally, given that adipocytes are a key cell type in energy 
metabolism and that LDH is also involved in energy metabolism, with hindsight, 
LDH is likely a poor choice of cell stress marker for this study. There is little data in 
the literature indicating a role for HSF in adipocytes or adipose tissue, healthy or 
otherwise, so the reason for the up-regulation of HSF observed after 14 days of 
induction is unclear. However, it can be concluded that this was not due to the 
Raman sampling process as there was no significant difference in the expression of 
HSF between ADSCs that had/had not undergone Raman analysis. 
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Chapter 7  
Discussion 
The field of tissue engineering and regenerative medicine has evolved rapidly in the 
last two decades. The core aim of the field is to enhance the body’s innate healing 
capacity using a combination of bioactive scaffolds, cells and chemical and physical 
cues to achieve improved clinical outcomes for patients. To this end there are 
numerous active clinical trials for the treatment of a plethora of conditions using 
what could be described as tissue engineering/regenerative medicine based 
approaches. Of these clinical trials 411 are listed as MSC based therapies on 
clinicaltrials.gov (as of July 2014). Despite this, there is a shortage of techniques 
that are capable of characterising cells in a non-invasive manner. Development of 
such a technique would offer the following benefits for cell based therapies: 
1. Improved safety, as the cells used would be those that were characterised. 
This would add a layer of quality control in the development of cell based 
therapies. 
2. Easier passage through EU regulatory approval as the use of a non-invasive 
cellular characterisation methodology on those cells to be implemented in a 
cell based therapy could be considered minimally manipulated. 
3. Reduced costs to implement as current techniques rely on expensive 
reagents such as antibodies conjugated with fluorophores and DNA 
primers/probes. 
4. Reduced quantity of cells (which can be a scarce resource) required due to 
the fewer number of experiments required. 
5. Reduced time required to carry out characterisation saving both time and 
money. 
There are many techniques currently being investigated that would permit the non-
invasive characterisation of cells, many of which are spectroscopic approaches (82, 
83, 218-220). Spectroscopy itself is simply the study of the interaction between 
electromagnetic radiation (light) and matter. Different forms of spectroscopy utilise 
almost every aspect of the electromagnetic spectrum. Raman spectroscopy typically 
operates in the near infra-red region of the spectrum, at least when used in cellular 
characterisation and is capable of providing a “chemical fingerprint” of a sample 
- 110 - 
based on the molecular bonds contained within (135). As such Raman spectroscopy 
is well suited to detecting differences between cell cultures or differences over time 
within the same cell culture. There have been many studies that have used Raman 
spectroscopy to characterise cell viability, differences in cell type and cell 
differentiation (99, 101, 102, 104, 128-134) as described in section 1.5. However, to 
date, there have been very few studies where the sterility of the cell cultures used 
was not compromised. Maintaining cell sterility throughout analysis using Raman 
spectroscopy is required for the technique to be considered truly non-invasive 
otherwise the cells analysed could not subsequently be used. The aim of this project 
was to develop a method that would permit the acquisition of repeated Raman 
measurements from the same cell cultures over time and to validate this method by 
using it to characterise stem cell differentiation compared with conventional 
methodologies.   
 
7.1 Development of an Aseptic Method for Longitudinal Stem Cell 
Characterisation by Raman Spectroscopy 
The objective addressed in Chapters 3 and 4 was the development of a novel method 
for the acquisition of Raman spectra that was aseptic and non-invasive. Specifically 
in Chapter 3 a material that was suitable for Raman spectroscopy and did not 
interfere with the osteogenic differentiation of DPSCs was assessed. In Chapter 4 an 
enclosed cell culture system that remained aseptic throughout Raman measurements 
was developed.  
 
Previous studies have used a range of materials as substrates for cell culture in order 
to perform Raman spectroscopy. These include quartz, MgF2 and CaF2 as discussed 
(100, 101, 128) in section 3.1. The rationale for the use of these materials is        
two-fold; firstly, they are inorganic in nature and so possess minimal Raman signal 
in the region of interest for cells and secondly they cause little background 
fluorescence as they contain few impurities. However, there is little data in the 
literature regarding the effects on stem cells associated with their culture on these 
substrates as most cell culture is routinely performed on treated polystyrene 
surfaces. In Chapter 3 the proliferation, viability and osteogenic differentiation of 
DPSCs cultured on quartz or MgF2 was compared with DPSCs cultured on tissue 
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culture plastic. It was found that proliferation and viability of DPSCs was unaffected 
by culturing on quartz or MgF2. However, gene expression analysis and Alizarin red 
staining demonstrated that the osteogenic differentiation of DPSCs was reduced on 
both quartz and MgF2, though this effect was far greater in DPSCs cultured on 
MgF2. This effect could not be attributed to the dissolution of ions into the cell 
culture medium but may have been due to differences in the surface chemistry and 
nano-topography of quartz and MgF2 compared with tissue culture plastic. 
Nevertheless, tissue culture plastic is unsuitable for Raman spectroscopy 
applications so quartz was selected as the substrate of choice for the remainder of 
the project. 
 
There are many studies in the literature where Raman spectroscopy has been used to 
characterise cells (99, 101, 102, 104, 128-134). However, almost all of these studies 
compromised the sterility of their cells in acquiring spectra. There are advantages to 
working in a non-sterile manner, such as reducing the working distance between the 
microscope objective and sample therefore increasing the amount of Raman signal 
collected. Smaller working distances also mean that a very high magnification 
microscope objective can be used, permitting the study of intracellular organelles. 
However, if cells are to be used after analysis by Raman spectroscopy they must 
remain sterile. The objective in Chapter 4 was to design a novel cell culture method 
that would permit this. Three different approaches were investigated.  
 
The first approach attempted was to culture cells on a quartz disc mounted on a 
quartz platform within a petri dish. This was unsuccessful as a Raman signal from 
the plastic petri dish could still be detected. The second approach was to culture 
cells on the inside of a quartz cuvette and this failed due to too long a working 
distance reducing the intensity of the Raman signal collected. This was likely due to 
the thickness of the quartz cuvette. Baldwin and Batchelder (189) showed that when 
acquiring spectra through an interface as the interface gets thicker, then a lower 
magnification and numerical aperture microscope objective must be used, however, 
this increases the working distance and therefore reduces the amount of Raman 
signal collected. Finally, cell culture flasks that had been modified with quartz 
windows were investigated and found to allow the collection of the greatest amount 
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of Raman signal from the cells compared with the previous two methods. This 
approach then went through several rounds of optimisation to select the microscope 
objective and exposure parameters that resulted in the best possible Raman signal 
being acquired. There is little data in the literature where high quality spectra have 
been acquired from cells under sterile conditions, most likely due to the difficulties 
in satisfying both criteria. It is unclear whether the method described here in Chapter 
4 permits the acquisition of the best possible Raman spectra from cells. However, 
the spectra acquired were comparable to those in the literature acquired from cells 
under non-sterile conditions as evidenced by the detection of many commonly 
detected biologically associated features in the spectra (Figure 54).  
 
 
Figure 54. A comparison of spectra from A) undifferentiated DPSCs cultured 
using the aseptic methodology developed and described in Chapter 4, B) 
undifferentiated bone marrow-derived MSCs reproduced from (134). 
Whilst there are differences between the two spectra there are also 
similarities including many peaks typical of spectra acquired from 
biological samples such as phenylalanine at ~1000 cm-1, CH2 in proteins at 
~1450 cm-1 and amide I at ~1660 cm-1. 
 
7.2 Validation of the Aseptic Method using Raman Spectroscopy to Characterise 
Stem Cell Differentiation 
The objective in Chapters 5 and 6 was to validate the novel cell culture method 
developed in the previous chapters by using Raman spectroscopy to characterise the 
differentiation of a well-studied lineage, osteogenic differentiation followed by its 
use to study a less well studied lineage, adipogenic differentiation. 
A B 
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The characterisation of the osteogenic differentiation process using Raman 
spectroscopy was carried out in Chapter 5. Several published studies using a non-
sterile method provided a guide as to the spectral features to expect to detect (101, 
104, 129, 132-134). However, the presence/absence of particular peaks might be 
considered to be only the most basic indicator. The data sets in this thesis contain 
~800 spectra from various time points during differentiation and each spectrum 
contains ~1200 variables (the wavenumbers which relate to particular molecular 
species). In order to derive meaningful information from such a large multivariate 
data set its dimensionality must be reduced, decreasing the number of variables 
whilst retaining as much information as possible. PCA is ideal for this task as it 
combines variables into principal components according to how much their variation 
affects the data set as a whole. PCA was used here to better describe the changes in 
the cell spectra as the differentiation process progressed. It was found that the early 
stages of osteo-differentiation were characterised by changes in two peaks 
associated with molecular species commonly found in proteins and more specifically 
in fibrillar collagen. It is known that stem cells undergoing osteogenic differentiation 
first produce a collagen rich extracellular matrix prior to mineralisation. It is 
possible that this is what was detected and that this feature could be used as an early 
indicator of osteo-differentiation before the result becomes evident by the 
emergence of mineralised nodules. In Chapter 6 the adipogenic differentiation 
process was characterised. As with the previous chapter, PCA was again used to 
describe changes in the spectra over time. It was found that spectral features that 
related to molecular bonds found in lipids and fatty acids varied throughout the 14 
days of adipo-induction. However, a single peak in the day 3 spectra associated with 
fatty acids was found to distinguish a number of the spectra acquired from adipo-
induced ADSCs from the spectra acquired from the ADSCs cultured under basal 
conditions. As such the emergence of this peak may serve as an early indicator of 
adipogenic differentiation prior to the later emergence of readily observed large 
lipid-rich vacuoles. 
 
The main objective of Chapters 5 and 6 was to demonstrate that Raman 
spectroscopy could be used to characterise the osteogenic and adipogenic 
differentiation of stem cells in an aseptic culture environment. In addition, qRT-PCR 
and histochemical staining were used to confirm that differentiation had occurred 
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and if the sampling process had had any effect on differentiation. Significant         
up-regulation in the expression of both osteogenic and adipogenic marker genes was 
observed at the end of their respective induction and Alizarin red and Oil red O 
staining were both positive regardless of whether the cells had undergone analysis 
by Raman spectroscopy. There was no difference in osteogenic marker gene 
expression between DPSCs that had/had not undergone Raman analysis indicating 
that neither Raman spectroscopy or the sampling protocol had apparently affected 
osteogenic differentiation. However, the expression of adipogenic markers genes 
was significantly reduced in ADSCs that had undergone Raman spectroscopy 
compared with those that had not. Potential reasons for this were discussed in 
section 6.4, however, the reduction in gene expression was unlikely to be  
biologically significant as evidenced by the prominent Oil red O staining observed 
in ADSCs that had undergone Raman analysis. A recent review by Vogel and 
Marcotte 2012 (221) explored the relationship between mRNA and protein 
production and reported that only 40% of the variation in protein levels can be 
attributed to mRNA levels the rest resulting from post-transcriptional regulation, 
indicating that changes in mRNA levels may not result in altered cellular phenotype. 
The expression of a panel of cell stress marker genes was also measured by qRT-
PCR in both studies. There was no significant variation in marker gene expression in 
DPSCs undergoing osteogenic differentiation and expression was not affected by 
Raman sampling. However, statistically significant variations were observed in 
ADSCs undergoing adipogenic differentiation potential reasons for which were 
discussed in section 6.4. This indicates that differences in either the source of the 
MSCs used or in the differentiation lineage/differentiated phenotype may have 
influenced a cell stress response. 
 
In this study, characterisation of osteogenic differentiation was carried out using 
DPSCs. Characterisation of adipogenic differentiation was carried out using ADSCs. 
Both cell types have a known propensity towards to their respective osteo and 
adipogenic lineages (192, 222). It is well known that MSCs derived from different 
sources such a bone marrow, adipose, or dental pulp possess slightly different 
properties (223-225). Aside from the noted differences in differentiation capacity 
toward a given lineage, MSCs from different sources can also vary in their cell 
surface antigen profile and immunosuppressive capabilities (225-227). It has 
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recently been shown that hypoxic culture conditions can improve the proliferation 
and differentiation of MSCs (228) and more recently that the response to hypoxia 
varies between MSCs derived from different sources (229). This indicates that the 
difference in MSCs used between the osteogenic and adipogenic studies in Chapters 
5 and 6 may have influenced the observed difference in cell stress response. There 
are also differences in phenotype between osteoblasts and adipocytes. Although 
closely related lineages, differentiation towards an osteoblast phenotype usually 
occurs at the expense of the adipocyte phenotype and vice versa (230). This is 
thought to be due to the up-regulation and activity of the two transcription factors 
PPARγ and RUNX2 which up-regulate adipogenesis and osteogenesis respectively 
whilst suppressing the expression of the other transcription factor (231-233). This 
highlights the divergence between the two phenotypes which is further increased 
upon terminal differentiation. 
 
7.3 Future Work 
This project was a proof of principle study, testing the hypothesis that stem cell 
differentiation could be characterised over time using Raman spectroscopy in an 
aseptic cell culture environment. Stem cells were cultured and differentiated in 
monolayer culture as this represented the simplest most predictable/reproducible cell 
culture modality. As discussed in section 1.1 tissue engineering approaches use one 
or more of cells, scaffold materials, physical and chemical cues in formulating 
potential treatment strategies. Therefore an interesting future study would be to 
characterise stem cell differentiation on a range of scaffold materials using Raman 
spectroscopy where differentiation was guided either by the scaffold itself or the cell 
culture medium. However, this would present some challenges: 
1. The cell culture system would need to be redesigned to accommodate the 
scaffold material. 
2. The Raman signal from the scaffold may obscure the Raman signal of the 
cells. 
The design of a new cell culture vessel would depend entirely on the scaffold 
material being used, something that works for a solid glass ceramic is unlikely to be 
suitable for a hydrogel. Figure 55 depicts a potential method for acquiring Raman 
spectra from cells cultured on a glass ceramic scaffold. In this instance the scaffold 
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would be placed on an O-ring within the vessel. The reasons for this are two-fold, 
first to allow perfusion of the medium to all parts of the scaffold so reducing the 
likelihood of cell death and second to position the scaffold as close as possible to the 
microscope objective. The struts of the O-ring would need to be reasonably tall and 
the vessel itself reasonably thin as the working distance to the scaffold would need 
to be as small as possible to permit the use of higher magnification microscope 
objectives. The lid of the vessel would need to be removable or the vessel itself 
modified to permit changing of the cell culture medium. Whether removable or not, 
the lid would need to be thin so that Raman spectra could be taken through it. 
Finally the vessel should be fabricated from quartz or another material the generates 
minimal Raman signal. 
Stem cells cultured on a solid 
scaffold
Thin removable quartz lid
Thin custom built culture vessel, 
preferably made of quartz
O-ring to hold the scaffold
 
Figure 55. A schematic of a potential aseptic cell culture system for acquiring 
Raman spectra from cells cultured on a solid scaffold. 
 
Clearly the system just described or the one developed and described in this thesis 
would not work for cells encapsulated in an amorphous hydrogel. In the case of 
cell/hydrogel constructs it would be possible to pass them through a quartz capillary 
(Figure 56). Again the walls of the capillary would need to be thin so that spectra 
could be acquired through them. Additionally the capillary would need to be sealed 
at the ends which means they would be single use, the constructs being transferred 
into a fresh capillary each time they are analysed. 
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Thin walled quartz capillary 
sealed at both ends
Hydrogel containing cells 
or a cell pellet
 
Figure 56. A schematic for a potential method to acquire Raman spectra from a 
cell pellet or cells encapsulated in a hydrogel. 
 
The other major issue when acquiring Raman spectra from cells cultured on 
scaffolds is accounting for the Raman signal generated by the scaffold itself and 
delineating this from the signal generated by the cells and their ECM. The first point 
to consider is whether the scaffold produces Raman peaks in regions that will most 
likely be used to characterise the cells. For example bioactive glass ceramic 
scaffolds can contain hydroxyapatite to facilitate stem cell differentiation down the 
osteogenic lineage (234). MSCs following osteo-induction will produce far less 
hydroxyapatite in the form of mineralised nodules than would be contained within 
the scaffold and it would therefore be difficult to attribute any hydroxyapatite 
associated peaks in the spectra as being the result of cellular differentiation. This 
leads to the second point, that of the processing of spectra from cell/scaffold 
constructs. Processing of Raman spectra generally requires a subtraction of the 
background signal. In the case of a cell/scaffold construct spectra of an unseeded 
scaffold within the sampling vessel would serve as the background. However, due to 
sampling geometry and localised differences in the chemical composition of the 
scaffold between sampling loci there would likely be small differences in each 
background spectrum obtained. This could in part be ameliorated by using an 
average of the background spectra, however, the sample chemistry of the scaffold 
beneath each cell from which a spectrum is acquired will still vary and contribute to 
the cell spectrum. 
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An approach that would help tackle both the problems discussed would be the 
incorporation of a completely sterile enclosure around the entire microscope. Such 
chambers are readily available from several manufacturers and permit control over 
temperature, oxygenation and humidity similar to an incubator. Control over these 
factors could help mitigate any cell stress response. However, if the chamber was 
also a glove box with an airlock (Figure 57) samples could be worked on directly 
with higher magnification microscope objectives without compromising sterility, 
removing the need for de novo culture vessels. As higher magnification/numerical 
aperture microscope objective produce a smaller focal volume contributions to 
spectra from a scaffold could be reduced. In order for this to be implemented as a 
quality control method for the production and characterisation of stem cells for 
patient use the equipment and method would have to be designed with adherence to 
good manufacturing practice (GMP) in mind. 
 
 
Figure 57. Image of a glove box that could be placed around a Raman 
microscope the direct acquisition of Raman spectra from sterile cells. 
Image from http://www.laboratory-
supply.net/gloveboxes/isolation_glovebox.html  
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7.4 Implications of Aseptic, Non-invasive Stem Cell Characterisation using 
Raman Spectroscopy 
Raman spectroscopy already has proven utility in discriminating between different 
cell types and the characterisation of cells as discussed in section 1.5. Methods such 
as immunofluorescence and qRT-PCR are currently widely used in this regard. 
Raman spectroscopy however is non-invasive and non-destructive, so cells remain 
alive and no labels are added. The capacity to do this under aseptic conditions is a 
key advance in promoting Raman spectroscopy as an alternative to conventional 
methods in cellular characterisation as this means that cells are not only analysed but 
can be retained for further use. This project has demonstrated that despite the 
limitations of working with an aseptic culture environment (reduced Raman signal 
from increasing the working distance between sample and microscope as well as 
acquiring spectra through a quartz interface) the spectra produced are still of 
comparable quality to those taken in a non-sterile environment. This may encourage 
future investigators not to forsake culture sterility in favour of maximising Raman 
signal. 
 
As part of a separate project under the supervision of Avacta Group plc, the industry 
CASE sponsor of this project, a hypothetical business plan concerning the 
application of Raman spectroscopy to cellular characterisation was developed. The 
full report can be found in Appendix B, herein lies a summary. The plan was not 
intended as a formal business plan but an aspirational outline for a Raman 
spectroscopy based product including all its potential applications, target market, 
risk factors and costings. Two target markets were identified, the research 
community and the health care sector. This was based on the product’s ability to 
monitor cellular phenotype and differentiate between cells of different phenotypes. 
Such abilities would permit the live monitoring of stem cell differentiation status, 
something that would be of great use to the research community and the detection of 
cancerous cells which differ in phenotype to the surrounding cells within a biopsy, 
which would be of use to the health care sector. In order to achieve this several 
technologies would need to be developed. This includes software that can reliably 
and reproducibly conduct pre-processing and analysis of Raman spectra, automation 
of the system such that it can acquire spectra from the desired area of the cell/sample 
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and development of an aseptic environmentally contained sampling area such as that 
described in section 7.3. It was shown that such a product could also offer 
significant savings in time and money when compared with current techniques used 
to achieve the same ends. However one of the greatest risks to the development of a 
Raman spectroscopy based product would be convincing the target market to adopt 
the technology, particularly as it is an unfamiliar technique to the end users.   
 
7.5 Conclusion 
The development of techniques capable of non-invasive and non-destructive cellular 
characterisation is a key target in tissue engineering and regenerative medicine. 
Building on previous work, this thesis has shown that Raman spectroscopy can be 
used in such a capacity whilst also maintaining the sterility of the cell cultures 
analysed. It was shown that high quality reproducible spectra could be acquired 
from cells in order to characterise their differentiation down the adipogenic and 
osteogenic lineages. The spectra acquired were of a comparable quality to those 
reported in the literature from studies where the sterility of samples was sacrificed in 
favour of reducing the working distance to the samples increasing the intensity of 
the Raman signal collected. This highlights that whilst the Raman effect may be 
weak it is still possible to work at longer distances, maintain the sterility of samples 
and still detect changes in cellular phenotype. This work could lead to greater 
acceptance of Raman spectroscopy as a viable technique for cellular characterisation 
and lead to further refinements of the method. 
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List of Abbreviations 
 ΔCT – Comparative cycle threshold  
 ± – Plus or minus 
 2D – Two dimensional 
 3D – Three dimensional  
 ADIPOQ – Adiponectin 
 ADSC – Adipose-derived stem cell 
 AlGaAs diode – Aluminium gallium arsenide diode 
 ALP – Alkaline phosphatase 
 α-MEM – Alpha modified essential medium 
 ANN – Artificial neural network 
 ANOVA – Analysis of variance 
 CARS – Coherent anti-stokes Raman spectroscopy 
 CCD – Charge coupled device 
 CD31 – Cluster of differentiation 31/Platelet endothelial cell adhesion 
molecule 
 CD44 – Cluster of differentiation 44/Homing cell adhesion molecule 
 CD45 – Cluster of differentiation 45/Protein tyrosine phosphatase, receptor 
type, C 
 CD105 – Cluster of differentiation 105/Endoglin 
 CD146 – Cluster of differentiation 146/Melanoma cell adhesion molecule 
 cDNA – Complementary deoxyribonucleic acid 
 C/EBPα – CCAAT/enhancer binding protein α 
 CHO – Chinese hamster ovary cells 
 cm – Centimetre 
 c-MYC - V-myc avian myelocytomatosis viral oncogene homolog 
 COL1A1/COL1 – Alpha-1 type 1 collagen  
 DMEM – Dulbecco’s modified Eagle’s medium 
 DNA – Deoxyribonucleic acid 
 DNase – Deoxyribonuclease 
 DPSC – Dental pulp stem/stromal cell 
 ECM – Extracellular matrix 
 EDTA – Ethylenediaminetetraacetic acid 
 EDX – Energy dispersive X-ray spectroscopy 
 ELISA – Enzyme linked immunosorbent assay 
 EM – Electromagnetic 
 ESC – Embryonic stem cell 
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 ESR – Electron spin resonance 
 EU – European Union 
 FACS – Fluorescence activated cell sorting 
 FAD – Fatty acid desaturase 
 FCS – Foetal calf serum 
 FDA – Food and drug administration 
 FTIR – Fourier transform infrared spectroscopy 
 g – Gram 
 GA – Genetic algorithm 
 GAG – Glycosaminoglycan 
 GAPDH – Glyceraldehyde 3-phosphate dehydrogenase 
 GMP – Good manufacturing practice 
 HBSS – Hanks balanced salt solution 
 HeNe laser – Helium neon laser 
 HEPES – 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
 HIF – Hypoxia inducible factor 1 
 HSC – Haematopoietic stem cell 
 HSF – Heat shock transcription factor 1 
 iPS – Induced pluripotent stem cell 
 KLF4 – Kruppel-like factor 4 
 kPa – Kilopascal 
 L – Litre 
 LDH – Lactate dehydrogenase 
 m – Metre 
 MDCK – Madin-Darby canine kidney cells 
 MEPE – Matrix extracellular phosphoglycoprotein 
 mg – Milligram 
 mL – Millilitre 
 MLR – Multiple linear regression 
 mm – Millimetre 
 mM – Millimolar 
 MRI – Magnetic resonance imaging 
 MSC – Mesenchymal stem/stromal cell 
 MTT – 3-(4,5-dimethylthiazol-2-yl)2,5-diphenyltetrazolium 
 mW – Milliwatt 
 NA – Numerical aperture 
 NADH – Nicotinamide adenine dinucleotide (reduced) 
 NBF – Neutral buffered formalin 
 ng – Nanogram 
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 NHS – National health service 
 nm – Nanometre 
 nM – Nanomolar 
 NMR – Nuclear magnetic resonance 
 OC – Osteocalcin 
 OCT3/4 – Octamer-binding transcription factor 3/4 
 PBS – Phosphate buffered saline 
 PC – Principal component 
 PCA – Principal component analysis 
 PCR – Polymerase chain reaction 
 PE – Processing element 
 PLGA – Ploy(lactic-co-glycolic acid) 
 PLLA – Poly-L-lactide 
 PLS – Partial least squares 
 pO2 – Partial pressure of oxygen 
 PPARγ – Peroxisome proliferator-activated receptor γ 
 qRT-PCR – Quantitative real-time polymerase chain reaction 
 Qz – Quartz 
 R&D – Research and development 
 RBC – Red blood cell 
 RGD – Arginylglycylaspartic acid 
 ROS – Reactive oxygen species 
 rpm – Revolution per minute 
 RRS – Resonance Raman spectroscopy 
 RUNX2 – Runt related transcription factor 2 
 S:N – Signal to noise ratio 
 SD – Standard deviation 
 SE – Standard error 
 SEM – Scanning electron microscopy 
 SERS – Surface enhanced Raman spectroscopy 
 siRNA – Small interfering ribonucleic acid 
 SOX2 – SRY (sex determining region Y)-box2 
 SOX9 – SRY (sex determining region Y)-box9 
 SSEA4 – Stage specific embryonic antigen 4 
 SV40 – Simian vacuolating virus 40 
 TEM – Transmission electron microscopy 
 TERS – Tip enhanced Raman spectroscopy 
 µg – Microgram 
 UK – United Kingdom 
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 µL – Microliter 
 µM – Micrometre 
 US – United States of America 
 UV – Ultraviolet 
 YWHAZ – Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase 
activation protein, zeta 
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Appendix A 
Step by Step Pre-processing and Analysis of Raman Spectra 
Contained in this appendix is a complete step by step description of the pre-
processing and analysis of Raman spectra acquired from osteo-induced DPSCs. 
A.1  Pre-processing of Spectra in Grams  
The following pre-processing steps were applied to each individual spectrum in 
Grams/32. First the average of 12 cell-free background spectra (“background 
spectrum”) were subtracted from every raw spectrum obtained from the cells (“cell 
spectrum”). The following figures are a worked example of the entire pre-processing 
using a raw cell spectrum from DPSCs following 28 days of osteo-induction. 
 
Figure 58. Representative raw cell spectrum obtained from DPSCs following 28 
days of osteo-induction with a 120 second exposure. 
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Figure 59. Average of 12 cell-free background spectra acquired with a 120 
second exposure. 
 
 
Figure 60. Cell spectrum (Figure 58) following subtraction of the background 
spectrum (Figure 59). 
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Due to variation in the microscope stage height from differences in cell layer 
thickness and from the thickness of the glue used to adhere the quartz discs to their 
flasks, the proportion of the background spectrum subtracted varied from one 
spectrum to another. This could result in “over” or “under” subtraction. Below are 
examples of over and under subtraction. 
 
Figure 61. Example of an over subtraction of a background spectrum (Figure 
59) from a cell spectrum (Figure 58). The circled trough is the result of an 
over subtraction of the contribution of the quartz to the background 
spectrum. 
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Figure 62. Example of an under subtraction of a background spectrum (Figure 
59) from a cell spectrum (Figure 58). The circled peak is the result of an 
under subtraction of the contribution of the quartz to the background 
spectrum. 
 
Circled is a peak/trough contributed by the quartz if that background has not been  
subtracted properly.  
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Following this, the baseline was flattened using four fixed points based on high/low 
points in the spectrum, marked, and the spectra smoothed using a seven point 
Savitzky-Golay filter. 
 
Figure 63. Baseline flattening of a spectrum, the four points used are marked. 
 
 
Figure 64. Smoothing of a spectrum using a 7 point Savitzky-Golay filter. 
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Finally the two axes were standardised. The x-axis was normalised to the peak at 
1000 cm-1 to correct for minor variation from the instrumentation over the course of 
the experiment and the lowest point of the spectrum reduced to a y-axis value of 0. 
  
Figure 65. X-axis adjusted so the marked peak equalled 1000 cm-1 
 
 
Figure 66. Y-axis adjusted so the lowest point of the spectrum equalled 0. 
 
All spectra were then exported and copied into Microsoft Excel. 
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A.2 Further Processing in Matlab and Principal Component 
Analysis 
Following pre-processing in Grams all the spectra from each individual donor 
sample were collated and imported into Matlab. The following figures illustrate the 
entire data handling and analysis process for all the spectra acquired from osteo-
induced DPSCs the data from which is described in Chapter 5. Figure 67-Figure 76 
illustrate the removal of outlying spectra from the same single donor, this process 
was repeated for the spectra acquired from every other donor. 
 
Figure 67. All the spectra acquired at all time points during osteo-induction 
from one donor following pre-processing in Grams. 
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Figure 68. PCA for principal components 1 and 2 of all the spectra from one 
donor following pre-processing in Grams. 
 
Whilst there appears to be a trend in the data there are clearly outlying spectra, based 
on contributions from PC1, in every time point which need to be removed. Outliers 
were determined based on extremes in principal component one as this was 
responsible for the vast majority of the variation in each data set. Approximately 
10% of the spectra in each time point were removed. The next 6 figures outline this 
removal process for each time point from one donor, boxed are those spectra that 
were removed. 
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Figure 69. Outlier removal for day 0. The removed outliers are boxed, 
everything within the dashed lines was retained. 
 
 
Figure 70. Outlier removal for day 3. The removed outliers are boxed, 
everything within the dashed lines was retained. 
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Figure 71. Outlier removal for day 7. The removed outliers are boxed, 
everything within the dashed lines was retained. 
 
 
Figure 72. Outlier removal for day 10. The removed outliers are boxed, 
everything within the dashed lines was retained. 
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Figure 73. Outlier removal for day 14. The removed outliers are boxed, 
everything within the dashed lines was retained. 
 
 
Figure 74. Outlier removal for day 28. The removed outliers are boxed,  
everything within the dashed lines was retained. 
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Figure 75. All the spectra acquired at all the time points during osteo-induction 
from one donor following outlier removal. 
 
 
Figure 76. PCA for principal components 1 and 2 of all the spectra acquired 
from osteo-induced DPSCs from a single donor following outlier removal. 
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Following outlier removal for all three patient samples the data was combined by 
taking one spectrum from each donor per time point and averaging. 
 
Figure 77. The entire data set of spectra acquired from osteo-induced DPSCs 
plotted after averaging across the three donors. 
 
 
Figure 78. PCA for principal components 1 and 2 of the entire data set 
acquired from osteo-induced DPSCs after averaging across the three 
donors. 
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Following this, second derivative spectra were calculated and further smoothing 
performed, second derivative spectra are very noisy and therefore require extensive 
smoothing (114). Other processing methods such as baseline corrections or 
calculating the standard normal variate were also assessed to find the optimal 
processing methodology but are not presented as they were not used. 
 
Figure 79. 2nd derivative spectra calculated from the average spectra across the 
three osteo-induced DPSC donor samples. 
 
Figure 80. 2nd derivative spectra calculated from the average spectra across the 
three osteo-induced DPSC donor samples following smoothing with a 25 
point filter. 
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Figure 81. PCA for principal components 1 and 2 of the fully processed spectra 
acquired from three osteo-induced DPSC donor samples. 
 
 
Figure 82. Summary work flow for processing raw DPSC spectra. 
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Appendix B 
The Commercialisation of a “Raman Cell Analyser” 
This document was produced as part of an ancillary project under the supervision of 
Avacta Group. This is intended to mirror aspects of the “stage 0” product 
development phase. This is not intended to be a realistic business plan but is an 
aspirational outline to a product whose contents would be refined through 
interaction with the target market and by technical feasibility testing. 
 
Raman Cell Analyser 
This document outlines a product that utilises Raman spectroscopy to determine 
cellular differentiation status and/or differentiate between cellular populations. The 
initial product release is intended as an R&D tool only; with subsequent releases 
finding clinical applications should the product meet regulatory requirements. The 
envisioned product possesses several key advantages over current gold standards. 
Chief amongst these is the non-invasive and non-destructive manner of the 
technique permitting in situ analysis and subsequent re-use/implantation of samples. 
The product will be competitively priced with regards to the equipment whose 
function it is intended to replace and its running costs significantly lower. 
Experiments using the Raman Cell Analyser will require the use of specialised de 
novo consumables which will generate a continuous revenue stream. 
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B.1 Product Vision 
B.1.1 Product Outline 
The Raman Cell Analyser will possess two core capabilities, the monitoring of 
cellular differentiation status and the discrimination of different cell types. This will 
position the Raman Cell Analyser to access markets in both research and clinical 
laboratories. In order to achieve this, an optical system capable of producing spot 
sizes from 1 µm to 10’s of µm will be required allowing users to study intracellular 
organelles, individual cells or clusters of cells. The system must also be capable of 
working with either adherent or suspended cell samples. Finally the Raman Cell 
Analyser will possess a software package capable of performing all the spectral data 
processing for the removal of noise etc and possess a feature for the logging of 
‘training data’ that can be used to classify subsequent samples. 
 
B.1.2 Product Development Road Map 
The first product release will be under the manual control of the researcher, they 
would have to locate the regions they wish to analyse. The accompanying software 
will be easy to use and capable of processing and classifying spectra (based on 
previous ‘training’ data). Subsequent product releases will allow automation of the 
system and increase the length of time that samples may be analysed. This will be 
achieved by incorporation of software similar to Nikon’s CL-quant which allows 
users to specify a nucleus, for example, based on its size/morphology. Such 
automation will generate interest within clinical pathology laboratories providing 
rapid automated diagnoses. For established users improvements to the software such 
as the incorporation of user generated cellular profiles will offer a library of data 
with which to reference. Automation will also save significant amounts of time for 
the user. Finally, the incorporation of temperature, gas and humidity control systems 
would allow samples to remain within the system indefinitely permitting continuous 
analysis. This would save further time for current users and permit experiments to be 
run on long timescales with a minimum of effort. Such improvements could also 
generate interest within the pharmaceutical industry as they would allow high 
throughput screening of cells in toxicology assays. A summary of information can 
be found in Table 9. 
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Table 9. A summary of the product development road map. 
Product 
Release 
Target Market Product Features Barriers 
1 R&D labs 
(academic) 
Hardware, manual 
spectral acquisition. 
Software, automatic 
spectral processing, 
capable of spectral 
classification  
Reliable predication 
of many cell 
phenotypes, 
capacity to work 
with 3D samples 
2 Users of version 1, 
late uptake R&D 
users, clinical labs 
Hardware, morphology 
based automated spectral 
acquisition. Software, 
user generated library of 
pre-loaded cellular 
phenotype 
classifications 
Regulatory approval 
(high fidelity 
prediction of 
malignancy) 
3 Previous users, 
pharmaceutical 
labs 
Hardware, gas, 
temperature and 
humidity control of the 
microscope stage 
Detection of subtle 
changes in cell 
phenotype related to 
toxicology 
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B.2 Customer Specification 
B.2.1 Research and Development Users 
Research and development scientists currently analyse cellular differentiation status 
by invasive and/or destructive methods. There is recognition within this group that 
non-invasive methods will be required for the high throughput translation of 
regenerative medicine therapies. The Raman Cell Analyser is intended to occupy 
this niche. In order to achieve this, the Raman Cell Analyser needs to reliably 
predict the phenotype of a cell/group of cells and be able to distinguish this from any 
solution the cells are in or material they are adhered to. Therefore a broad range of 
samples must be accommodated from suspended cells, to monolayers and 3D 
constructs, this however presents the opportunity for multiple consumable types. As 
a key advantage the Raman Cell Analyser will work with live samples in a minimal 
medium. Whilst alone, the Raman Cell Analyser will not be able to provide detailed 
biochemical data, for example the expression of a key gene of interest, it will be able 
to provide real-time in situ assessments of cellular differentiation status. 
 
B.2.2 Clinical Users 
The NHS pathology service performs much of the diagnostic work for the 
organisation. A recent review of the service indicated a need for more cost effective 
and efficient technologies to reduce the time for diagnosis, streamline the service 
and reduce costs. One use of the Raman Cell Analyser will be the discrimination of 
different cell types within a mixed sample, such as the presence of malignant cells 
within a biopsy. In order to achieve this, the cells would be suspended in solution 
and analysed by passing through a quartz capillary. Whilst this test would not yield 
the exact nature of a cancer, for example the presence of a particular genetic 
mutation, it would provide a quick, general diagnosis which could then be followed 
up by a more thorough analysis. This would provide a more targeted approach both 
in the time of the pathologists and in the costs of further experiments. 
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B.3 Target Market 
Clinical laboratories such as those in the NHS would be most interested in the ability 
of the Raman Cell Analyser to discriminate between different cell types such as in 
the detection of cancer. Research laboratories such as those found in Universities 
would be most interested in the capacity for non-invasive, live, monitoring of 
cellular status. However, these applications are not mutually exclusive to their target 
markets. 
   
B.3.1 Research and Development Laboratories  
One of the functions of the Raman Cell Analyser will be the in situ monitoring of 
cellular differentiation status. A literature search for stem cell differentiation shows 
the following publication trend, a quadrupling of publications in a ten year period 
with year on year increases. The number of publications where the UK was 
indicated as the country of origin is also included. It should be noted that ~25% of 
publications do not identify a country of origin Table 10. 
Table 10. Stem cell differentiation publication between 2002-2011 
Year of publication Number of publications UK publications 
2011 22902 591 
2010 22199 605 
2009 18916 511 
2008 17103 425 
2007 14056 411 
2006 12953 336 
2005 10303 255 
2004 8971 249 
2003 7596 194 
2002 6091 158 
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There are 113 universities in the UK. Some of these such as the London School of 
Economics would clearly have no use for the Raman Cell Analyser. The number of 
potential sales of the Raman Cell Analyser to the remainder will largely depend on 
the price point. If the price is seen as too high then it would likely be funded out of a 
universities capital expenditure budget, greatly reducing potential unit sales. 
Therefore a price needs to be set that would permit funding at faculty (a university 
may have several faculties, such as medicine or biological sciences where a Raman 
Cell Analyser may find use) or even individual research group level to increase unit 
sales. It is unlikely that too many research groups within a university would share a 
Raman Cell Analyser as potentially long sampling times, the logistics of moving 
samples around a campus and competing busy schedules would make too much 
sharing prohibitive. This coupled with a competitive price could further increase unit 
sales. Research in stem cell differentiation can mean researchers handling cells in 
many conformations including in suspension, monolayers and 3D constructs. This 
presents the opportunity for the de novo design of cell culture vessels specialised for 
each application that would need to be purchased for each individual 
experiment/sample. 
 
In summary, there is increasing research output both globally and nationally 
concerning the use of stem cells and their potential in regenerative medicine 
therapies. However, one barrier in the advancement of such therapies to a clinical 
setting is the lack of suitable methods for their non-invasive and non-destructive 
characterisation. The Raman Cell Analyser seeks to bridge this gap and if priced 
competitively provide an alternative to those current methods that require extrinsic 
labelling or destruction of samples.  
 
B.3.2 Clinical Laboratories 
The main clinical laboratory target would be the pathology departments within the 
NHS that perform much of their laboratory based diagnostic testing. The NHS has 
151 primary care trusts containing 353 hospitals. The aim would be to supply one 
Raman Cell Analyser into each pathology department. One application of the Raman 
Cell Analyser will be the detection of cancerous cells in a biopsy. In the UK alone 
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270000 cases of cancer are diagnosed per annum. Cancer is seldom diagnosed by 
one method alone; the Raman Cell Analyser would not claim to be able to do this. 
Instead it would be marketed as a quick test (hours in timescale) that could detect 
the presence of cancer allowing pathologists to better allocate their time and money 
with subsequent tests such histopathological screening of tissue (up to a week in 
timescale). Each test performed by the Raman Cell Analyser would require a single 
use quartz capillary to prevent cross contamination of samples, current prices on 
quartz capillaries range from £75-100 for 25 units. 
 
B.3.3 End User Specification 
There will likely be a range from students, technicians, postdoctoral researchers and 
professionally trained biomedical scientists and pathologists. A recurrent theme 
amongst these groups will be their training in biological disciplines. Therefore their 
understanding of, and desire to use, a spectroscopic technique will likely be low. As 
such the Raman Cell Analyser will need to be simple to use. Samples must be easily 
loaded into the machine and software provided that guides the user through the 
acquisition of the spectra, processing of the data and providing a concise report at 
the end. 
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B.4 Competitive Strengths and Weaknesses 
B.4.1 Research and Development Laboratories 
Core, gold standard techniques used for stem cell characterisation include 
quantitative real time polymerase chain reaction (qRT-PCR), fluorescence activated 
cell sorting (FACS) and immunohistochemistry. A common theme amongst these 
techniques is their targeting of molecular or genetic markers essential for a given 
differentiation pathway/phenotype. Such specificity is their main strength as they 
reveal key biochemical data on cellular differentiation status. Many such markers 
are well characterised for a given differentiation lineage and their detection is 
considered essential to demonstrate. However such techniques are either invasive 
(they use exogenous labels) or destructive (they require the complete destruction of 
the sample) and therefore don’t lend themselves toward clinical applications. Ideally 
researchers would like to perform in situ analysis of a sample prior to its 
implantation in a patient for increased safety. The Raman Cell Analyser would cater 
for this need.  
 
Comparison between established techniques and the Raman Cell Analyser are 
difficult. Established techniques are highly specific, targeting known proteins or 
genes of interest and therefore yield very specific data on the status of the sample. 
However, such detail isn’t always necessary, if the question posed is, “have these 
stem cells differentiated and if so to what degree” then changes seen in their spectra 
may provide a sufficient answer. Such changes have already been observed using 
Raman spectroscopy albeit under non sterile conditions. If such findings can be 
confirmed in a de novo sterile system then cells analysed in this manner could 
subsequently be used in further applications. Therefore if the aim is simply to 
demonstrate differentiation then the Raman Cell Analyser would possess a key 
advantage over established techniques. It is, however, unlikely that the Raman Cell 
Analyser would be able to compete, if information on key cell signalling events, for 
example, were the object of a study. 
 
There are several techniques currently being investigated that also seek to cater for 
the non-invasive characterisation of stem cells. These include but are not limited to 
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two photon excited fluorescence microscopy, nuclear magnetic resonance (NMR) 
spectroscopy and impedance spectroscopy. Two photon excited fluorescence 
microscopy utilises the endogenous fluorescence of common biological molecules. 
It has demonstrated good 3D depth resolution an advantage it possesses over other 
technologies. However, the only significant fluorescence detected by this method 
thus far is from NADH and FAD which means the technique is currently only 
sensitive to changes in redox status. NMR spectroscopy is capable of detecting 
many small molecules such as metabolites and can be used for both absolute and 
relative quantification. However, detection of larger molecules such as proteins is 
not possible. Further, analysis of live cells requires immersion in aqueous solutions. 
In NMR techniques must be used to supress the effect of such solutions which can 
lead to problems detecting resonances near the solution. Impedance spectroscopy 
differentiates between cell populations based on their electrical resistance. As a 
technology for the non-invasive characterisation of cells impedance spectroscopy is 
in its infancy compared with other techniques. Impedance spectroscopy involves the 
culturing of cells on platinum electrodes. Platinum is a known mutagen and its 
potential effect on cell cultures is yet to be delineated. 
 
B.4.2 Clinical Laboratories 
Cancer diagnosis generally requires a multi-faceted approach from imaging 
techniques such magnetic resonance imaging (MRI) to histopathology techniques 
such as tissue histology and screening of molecular markers through techniques such 
as enzyme linked immunosorbent assays (ELISA). The pathological methods for 
cancer diagnosis are highly specific and used to detect molecular markers indicative 
of a malignant phenotype. However, this specificity makes the reagent costs of such 
techniques expensive and they are time consuming to perform. The Raman Cell 
Analyser would not aim to replace any of these techniques but would be another tool 
available to be used in synergistic manner to speed up the diagnosis and reduce the 
cost of cancer detection. For example, a cell suspension from a tissue biopsy could 
be rapidly analysed by the Raman Cell Analyser to detect the presence of malignant 
cells. This information could then better inform on those patients who require more 
detailed follow up using more time consuming and costly techniques such as MRI. 
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B.5 Business Model 
B.5.1 Pricing, Usage and Sales Projections 
The first release of the Raman Cell Analyser into research and development 
laboratories should be priced no greater than £30000. A price at this level would be 
in a range that individual research groups could purchase. This would be 
competitive with the latest qRT-PCR machines and significantly lower than the 
price of a good confocal microscope. 
 
Monitoring of cellular differentiation status can take up to several weeks and a good 
study will test several patient samples to account for individual variability. Many 
researchers demonstrate differentiation by changes occurring over several time 
points and this would be replicated when using the Raman Cell Analyser so 
equipment usage would be high. Accounting for optimisation, the provision of 
training data and true experimental samples a good study will require 10-20 
individual consumables for the culturing of samples. 
 
A conservative estimate of potential customers within UK university research and 
development labs indicates there may be approximately 300 just at faculty level. If 
10% of this market can be reached that would generate sales of £900,000. At current 
publication levels there are 600 publications per year that could involve the use of a 
Raman Cell Analyser if 10% of these were reached this would generate consumable 
sales of 600-1200 a year generating revenue of £60,000-£120,000. 
 
Providing the Raman Cell Analyser can meet the regulatory requirements for its use 
in cancer diagnosis the aim would be to sell a unit to each NHS pathology 
laboratory. This could generate unit sales of £105,900,000, assuming sales to each 
NHS hospital, though it is unlikely that each unit would be sold at list price for such 
a bulk order. It is difficult to ascertain the number of the 270000 cancer diagnoses 
per year where the Raman Cell Analyser would be applicable however, the upper 
consumables sales this could generate are approximately £1,080,000 per annum 
based on a price of £100 for 25 quartz capillaries. 
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B.5.2 Competitor Cost Analysis 
For research and development laboratories: 
The following listed are the equipment costs associated with the core techniques 
required for publication for tissue engineering applications. There can be further 
costs but these would be associated with techniques specialised for a particular 
application. 
Basic qRT-PCR machine ~£5000 up to ~£20000 for the best with analysis software 
etc. Consumables, RNA purification ~ £200 (50 preps), reverse transcription ~ £80 
(50 preps), PCR probes ~£120 per gene (200 preps), PCR reaction mix ~£200 (200 
preps) 
Basic fluorescence microscope, ~£5000 up to £50k+ for a confocal microscope. 
Consumables, primary antibodies ~£250 per marker, secondary antibodies ~£125 
per fluorophore. 
Phase contrast microscope £1000-2000 basic up to ~£10000, additional imaging 
camera and software, tissue processor £10000-150000 and microtome £5000-10000, 
histology primary antibodies ~£250 per marker, primary antibody conjugates such as 
horseradish peroxide ~£170 (25 preps). 
 
For clinical labs: 
A review of NHS pathology criticised the service for the lack of financial data 
available so a cost analysis is difficult. However, the cost of a single experiment 
using the Raman Cell Analyser could be as little as £3, to cover the cost of a single 
use quartz capillary and an appropriate solution to suspend the sample in. In contrast 
a single ELISA test for cancer biomarkers costs ~£5 and a histology test ~£15. 
However, the Raman Cell Analyser would not be marketed as a replacement for 
these tests but as a quick and cheap guide as to whether to perform them. 
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B.6 Risk analysis 
Each of the following sections highlights the risks and potential barriers to market 
and release of the three products outlined in the product development timeline. 
 
B.6.1 Product Version One 
The first release of the Raman Cell Analyser is solely intended as a research and 
development tool intended to reliably monitor the progress of stem cell 
differentiation without destroying or damaging the sample. Listed are the main 
issues that could hinder product development at this stage. 
1. Acquiring a strong and well resolved signal in a closed system 
a. Design of sample holders that maximise this signal. 
2. Detecting differentiation before it is possible by eye: 
a. Are there differences in spectra early in the differentiation process? 
b. If the differences are small, will there be sufficient resolution in the 
system to detect them? 
3. Development of sufficiently sensitive software to analyse spectra 
4. Demonstrating depth penetration in 3D samples. 
5. Demonstrating an ability to isolate the signal of a cell from that of a scaffold 
that will likely possess a stronger Raman signal. 
6. Convincing the research community to change engrained habits. 
 
B.6.2 Product Version Two 
The second release of the Raman Cell Analyser will still function as a research and 
development tool. However, improved features that permit automation of the system 
will allow users to generate greater amounts of data with less ‘hands on’ time. Such 
features will also allow the Raman Cell Analyser to reach additional markets in 
clinical pathology where it will be able to differentiate between different cell types 
in mixed samples. Listed are the main challenges for this product release. 
1. Convincing existing users to purchase again, this may be overcome by 
designing version 1 in such a way that it may be retrofitted or by only adding 
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improved software to version 2 such that existing users need only purchase 
the additional software.  
2. Developing or licensing software that can accurately identify cells or their 
features in many different settings. 
3. Regulatory approval for clinical setting, would need to demonstrate very 
high detection for malignancy even in samples where there is very little. This 
is will likely involve clinical trials and therefore be costly. 
4. Driving the participation in the uploading of user generated profiles, which 
would greatly increase the products value and usability but will likely be 
resisted by the research community wishing to protect their work. 
 
B.6.3 Product Version Three 
The third release of the Raman Cell Analyser will build on the previous releases by 
providing a fully controllable environment for cell samples including temperature, 
humidity and gas concentrations. This will allow one machine to accommodate 
many samples and analysis may automatically switch between them. Such high 
throughput screening may open further markets in toxicity screening of new 
pharmaceuticals for example. Listed are the main challenges for this product release. 
1. Such additional hardware will likely require a redesign of the product. 
2. The additional features will add value for existing users but the cost of the 
new design must not become prohibitive. 
3. Previous versions will fit on a bench top, this version should be similarly 
small so as not to require too much lab space. 
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B.7 Summary 
 The Raman Cell Analyser will have two core capabilities, monitoring of 
cellular status and distinguishing between different cell types. 
 The technique will be entirely non-invasive and non-destructive. 
 Phased product releases will accommodate greater system automation. 
 Two core target markets, initially stem cell and regenerative medicine 
researchers within higher education research institutions. Later product 
releases targeted at clinical pathology diagnostics chiefly within the NHS. 
 The Raman Cell Analyser could replace existing techniques for the routine 
assessment of cellular differentiation but will be incapable of more specific 
biological analysis. 
 There is broad pricing potential as existing techniques are expensive so the 
Raman Cell Analyser could be priced competitively to meet the needs of the 
customer. 
 Proof of concept for the Raman Cell Analyser’s core capabilities are already 
reported in the scientific literature. However, technical challenges remain 
that must be addressed during product development. 
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Appendix C 
Research Publications 
Research Papers 
Raman Spectroscopy using an Aseptic Method can Detect Changes Associated 
with Osteogenic Differentiation in Dental Pulp Stromal Cells. Adam 
Mitchell, Lorna Ashton, Xuebin B. Yang,  Royston Goodacre, Alistair Smith, 
Jennifer Kirkham, PLOS one (under revision) 
Abstract 
There is an unmet need for the non-invasive characterisation of stem cells to 
facilitate the translation of cell-based therapies. Raman spectroscopy has proven 
utility in stem cell characterisation but as yet no method has been reported capable 
of taking repeated aseptic measurements of living cells. The aim of this study was to 
determine if Raman spectroscopy could be used to characterise human dental pulp 
stromal cell (DPSC) differentiation down the osteogenic lineage by taking repeated 
measurements from the same cell cultures over time. DPSCs were isolated from 
extracted premolar teeth from 3 consenting donors. Following in vitro expansion, 
DPSCs were maintained for 28 days in osteo-inductive medium. Raman spectra 
were acquired from the cells at days 0, 3, 7, 10, 14 and 28.  Principal component 
analysis (PCA) was carried out to assess if there was any temporal spectral variation. 
At day 28, differentiation was confirmed using alizarin red staining and qRT-PCR 
for alkaline phosphatase and osteocalcin. Alizarin red staining was positive in all 
samples at day 28 and significant increases in alkaline phosphatase (p<0.001) and 
osteocalcin (p<0.05) gene expression were also observed. PCA of the Raman data 
demonstrated trends in PC1 from days 0-10, influenced by protein associated 
features and PC2 from days 10-28, influenced by DNA/RNA associated features. 
Raman spectroscopy can non-invasively detect changes in osteogenic cell cultures 
that are commensurate with cell differentiation. The data suggest that prediction and 
monitoring of DPSC differentiation using aseptic technique prior to their use in 
further applications might therefore be possible.  
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Introduction 
The field of tissue engineering and regenerative medicine has advanced rapidly 
since its inception by Langer and Vacanti in 1993 (1), with clinical trials for the 
treatment of numerous conditions underway (80). Stem cells are an important 
component of the tissue engineering toolkit, from pluripotent embryonic stem cells 
and induced pluripotent stem cells to multipotent somatic stem cells including 
mesenchymal stem cells (MSCs) and haematopoietic stem cells (HSCs). The use of 
MSCs avoids the ethical concerns associated with embryonic stem cell research and 
whilst MSCs cannot differentiate along as many cell lineages they still possess 
demonstrable capacity for differentiation into osteoblasts, chondrocytes, adipocytes 
(55), tenocytes (235), hepatocytes (236) and neural cells (237). Such directed 
differentiation of MSCs and validation of their resulting phenotype requires 
significant expansion of stem cell cultures and testing with invasive and/or 
destructive methods that preclude their subsequent use in clinical application. Non-
invasive methods that can reliably monitor stem cell differentiation could reduce the 
need for in vitro expansion and save researchers a great deal of time and resources 
when conducting their experiments. Raman spectroscopy is one such potential 
methodology for in situ analysis. 
 
Raman spectroscopy has the capacity to be both non-invasive and non-destructive 
and utilises a monochromatic light source to determine sample chemistry. Upon 
interaction with the sample a small fraction of the light, approximately 1 in 106 to 
108 photons (108), is shifted in wavelength with respect to the incident laser. Many 
chemical bonds in the sample cause unique Raman shifts such that the resultant 
spectrum can be considered to be a ‘molecular fingerprint’ that is unique to the 
sample under analysis. Several recent publications have described the use of Raman 
spectroscopy to determine cell viability (99, 128, 129), to identify general markers 
of cell differentiation (104, 128), to track differentiation to an osteoblastic 
phenotype (132) and to elucidate changes in extracellular matrix calcification and/or 
mineralisation concomitant with osteoblastic differentiation (101, 133, 134). These 
studies have identified a signature profile for the differentiation of stem cells down 
the osteogenic lineage based on the emergence and relative ratios of peaks in their 
Raman spectra illustrated in Figure 83. Whilst these data have highlighted the 
potential usefulness of Raman spectroscopy in stem cell phenotyping, to date 
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multiple longitudinal measurements of the same cell population have been precluded 
due to the need to maintain sterility of the cell cultures. Raman scattering efficiency 
is very poor and the distance between the sample and the microscope objective 
needs to be as small as possible. In order to maximise the potential of Raman 
spectroscopy as a tool for non-invasive stem cell characterisation, studies need to be 
conducted under aseptic conditions while maintaining the strength of the Raman 
signal. This would then ultimately permit early/predictive identification of 
differentiation such that stem cells may be used in further downstream applications. 
 
 
Figure 83. Proposed timeline of events outlining the osteogenic differentiation 
process of stem cells using Raman spectroscopy, based on data from (9, 
11-15) 
 
In this study, our aim was to develop a novel methodology that permits both the long 
term aseptic culture of human dental pulp stromal cells (DPSCs) and the repeated 
acquisition of Raman spectra in the same cell cultures. DPSCs are one of several 
sources that are more broadly classed as MSCs and were first isolated by Gronthos 
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et al 2000 (53). They have since been shown to differentiate down multiple lineages 
including osteogenic, dentinogenic, adipogenic, chondrogenic, myogenic and 
neurogenic and express many of the cell surface markers used to characterise bone 
marrow derived MSCs (225, 238-241). However, it should be noted that the 
propensity for differentiation along a specific lineage can vary amongst MSCs 
derived from different sources (241, 242). DPSCs were chosen specifically for this 
study as they have a proven predisposition toward the osteogenic/dentinogenic 
lineage (192), presenting a reliable and well documented sample for evaluating our 
new method. We envisage that Raman spectroscopy would be used as part of a 
minimally invasive approach to tissue engineering as such we used unsorted stromal 
cells from the dental pulp as opposed to a fluorescence activated cell-sorted (FACS) 
enriched stem cell population. We induced DPSC osteogenic differentiation and 
acquired Raman spectra at regular time intervals throughout the osteogenic pathway 
to determine both technical feasibility and identify whether changes in the Raman 
spectra might be indicative/predictive of the differentiation process.  
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Materials and Methods 
Characterisation of Dental Pulp Stromal Cell (DPSC) Osteogenic Differentiation 
using Raman Spectroscopy 
DPSC Isolation and Culture 
Human molars were obtained from one male and two female donors, aged 9, 22 and 
35y, by informed written consent (in the case of minors, consent was obtained 
through the parent/guardian) through the Leeds School of Dentistry Research Tissue 
Bank as authorised by the Dental Research Ethics Committee (DREC 
07/H1306/93+5). DPSCs were isolated by the collagenase/dispase digestion method 
previously described by Gronthos et al (129)  and maintained in basal medium, α-
MEM containing 10% foetal calf serum (FCS) (Biosera, Ringmer, UK), 1% 10000 
units/10 mg/mL penicillin /streptomycin solution (Sigma-Aldrich, Gillingham, UK) 
and 1% 200 mM L-glutamine (Sigma-Aldrich). Cultures were incubated at 37°C, 
5% CO2 and routinely passaged. DPSCs at passage 3 were used in all subsequent 
experiments. 
 
Quartz Customised Flask Preparation 
Customised cell culture flasks with quartz windows (Figure 84), suitable for Raman 
spectroscopy, were prepared by drilling 1 cm diameter holes in 25cm2 cell culture 
flasks. Flasks were washed several times with sterile pure water to remove debris 
and finally sterilised with 70% ethanol. Heat sterilised quartz discs (Global Optics, 
Bournemouth, UK), 14 mm diameter x 0.15 mm thickness, were glued to the outside 
of the flasks using a UV cured methacrylate glue (Loctite, Hempstead, UK) and 
cured for 5 min under UV light. To ensure complete sterilisation, flasks were placed 
under a UV lamp for a further 90 min and periodically rotated to ensure penetration 
to all surfaces. 
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Figure 84. Schematic of a quartz window customised flask prepared for Raman 
spectroscopy. The microscope used to acquire Raman spectra uses an 
upright turret, therefore flasks had to be inverted toward the microscope 
objective. This necessitated the filling of the flask with HBSS to prevent 
the cells from desiccating during analysis. 
 
DPSC Sample Preparation and Raman Spectroscopy 
Sterile poly-L-lysine (0.1 mg/mL, molecular weight, 70,000-150,000 (Sigma-
Aldrich)) was used to coat the quartz surface of the customised flasks to enhance 
cell adhesion, as poly-L-lysine coatings have little/no effect on Raman spectra (140). 
The solution was then aspirated and the flask dried in an incubator at 37°C 
overnight. DPSCs suspended in basal medium were pipetted directly on to the quartz 
surface at 1 × 105 cells/cm2 (n=3) and incubated overnight at 37°C to adhere. The 
following day flasks were topped up with osteoinductive medium, (basal medium 
supplemented with 0.25 mM ascorbic acid, 10 mM β-glycerophosphate and 100 nM 
dexamethasone (all Sigma-Aldrich)). This was designated day 0. Each of the donor 
samples was cultured and analysed in triplicate. An equal number of samples were 
maintained in osteogenic conditions but did not undergo Raman analysis. These 
were used as controls for the sampling process. At no point during the cell culture 
period was there any evidence of bacterial or fungal contamination. 
 
Prior to analysis the cell culture medium was aspirated and flasks filled with Hanks 
balanced salt solution (HBSS) with glucose added to a final level of 0.45%. Flasks 
were placed on the stage of a Leica DMLM microscope attached to a Renishaw RM 
series Raman spectrometer and inverted toward the objective. A 40×/0.8NA water 
immersion objective was immersed in a small drop of HBSS placed on the quartz 
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surface. DPSCs were first brought into focus under transmitted white light then 
over-focused by 5 µm and switched to 785 nm light for spectrum acquisition. 
Spectra were acquired at days 0, 3, 7, 10, 14 and 28. At each time point 15 spectra 
were acquired over the wavenumber range 600-1800 cm-1 with an exposure time of 
120 s and the power on the sample from the 785 nm laser was 66 mW. With 9 
samples (three donors in triplicate) this produced a total of 135 spectra at each time 
point. All spectra were acquired from the DPSC monolayer even at later time points, 
despite the emergence of mineralised nodules, for consistency. Cell free sections of 
quartz were used to acquire the background spectrum. Following analysis the HBSS 
was aspirated and replaced with osteoinductive medium and the flasks returned to 
the incubator. 
 
Data Analysis 
Pre-processing of spectra was performed in Grams/32 (Thermo Scientific, Waltham, 
USA) with further processing and validation by principal component analysis (PCA) 
performed in Matlab version R2013b. In Grams each individual spectrum was 
background subtracted using cell free areas of HBSS filled quartz customised flasks, 
y-axis normalised to the peak at 1003 cm-1 to correct for any minor unavoidable 
instrumental drift due to sampling over a long period of time, and smoothed using a 
7 point Savitzky-Golay filter. All spectra were then exported to Microsoft Excel for 
further processing in Matlab. PCA was performed on all spectra from each 
individual donor and used to remove outlying spectra from each time point. The data 
were then averaged using one spectrum from each donor per time point. Finally 
second derivative spectra were calculated and further smoothing performed. PCA 
was then carried out to visualise the fully processed data. Such pre-processing was 
required to overcome intrinsic experimental constraints such as the longer working 
distance and the need to acquire spectra through an interface presented by working 
aseptically with quartz windowed flasks.  
 
Osteogenic and Cell Stress Marker Gene Expression of DPSCs ± Analysis by 
Raman Spectroscopy Determined by qRT-PCR 
To determine the stage of osteogenic differentiation and any effects of Raman 
spectroscopy on the osteoinductive process, qRT-PCR was used to determine 
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marker gene expression, RNA isolation and reverse transcription was performed on 
DPSCs following osteoinductive culture ± Raman spectroscopy analysis. Briefly, 
DPSCs were lysed by incubation with Trizol® (Invitrogen, Paisley, UK) for 20 min 
at room temperature. RNA was extracted from cell lysates using an RNeasy mini kit 
with additional DNase digestion (Qiagen, Crawley, UK) following the 
manufacturers recommendations. RNA concentrations were quantified using a 
NanoDrop spectrophotometer (Thermo Scientific). A High Capacity RNA-to-cDNA 
Kit (Applied Biosystems, Carlsbad, USA) was used to prepare 200 ng of cDNA in 
20 µL reaction volumes as per the manufacturer’s instructions. Reactions were run 
on a MJ Research PTC-100 Thermo Cycler, at 37°C for 1 h and 95°C for 5 min. 
qRT-PCR was performed using TaqMan gene expression assays (Applied 
Biosystems) for alkaline phosphatase (ALP) and osteocalcin (OC): assay numbers 
Hs01029144-m1 and Hs00609452-g1 respectively, to determine osteogenic marker 
expression and for heat shock transcription factor 1 (HSF1), hypoxia inducible 
factor 1 (HIF1A) and lactate dehydrogenase (LDH): assay numbers Hs00232134-
m1, Hs00153153-m1 and Hs00929956-m1 respectively, to investigate cell stress 
marker expression. Reactions were carried out in 96 well plates on a Roche 
LightCycler® 480 system. Optimal cDNA concentration was determined to be 5 
ng/reaction by plotting standard curves with known cDNA concentrations. Data 
were normalised to YWHAZ assay number Hs00237047-m1, and analysed using the 
comparative cycle threshold method (ΔCT). YWHAZ was selected as it has been 
shown to be a far more reliable housekeeping gene compared with some of the more 
traditional housekeeping genes such as GAPDH and ACTB (157). Three patient 
samples, one in duplicate, were analysed using both DPSCs that had undergone 
analysis by Raman spectroscopy and DPSCs cultured in parallel under the same 
conditions but without subjection to Raman spectroscopy after 28 days of 
osteoinductive culture. Samples were analysed in triplicate for a total n=12 for each 
group. Samples from day 0 were used to provide a baseline. Graphs of the mean 
ΔCT ± SE were plotted in Microsoft Excel and statistical significance was 
determined by one-way ANOVA using GraphPad Instat 3 software. 
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Extracellular Matrix Calcification of DPSC cultures ± Analysis by Raman 
Spectroscopy using Alizarin Red Staining 
Alizarin red staining was performed on day 28 DPSC cultures that had been 
analysed by Raman spectroscopy and those that had not (n=2). In both cases, DPSCs 
had been cultured in osteoinductive medium as described above. Cell monolayers 
were washed twice with PBS and fixed in 10% neutral buffered formalin for 1 h at 
room temperature. Cell monolayers were incubated with 1% Alizarin red solution 
(Sigma-Aldrich) (pH 4.2), for 20 min at room temperature. The Alizarin red solution 
was then removed and excess stain washed away with repeated washes with de-
ionised water. Cultures were then imaged using an Olympus BX50 microscope with 
accompanying Nikon DS-Fi1 camera. 
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Results 
Osteogenic Differentiation of DPSCs Characterised by Raman Spectroscopy 
Raman spectroscopy has previously been used to demonstrate late stage osteogenic 
differentiation of stem cells by analysing putative mineralised nodules (101, 134). In 
this study DPSCs were analysed by Raman spectroscopy with a focus on earlier time 
points, prior to the emergence of mineralised nodules, to ascertain if the spectra 
were indicative/predictive of the osteogenic differentiation process.  Figure 34 
depicts the average spectra for each time point (day 0 to day 28) following 
subtraction of the signal from the (quartz) background. Many peaks typical of 
biological samples were clearly evident such as phenylalanine at 1003cm-1, CH3, 
CH2 found in collagen at 1453cm
-1 and amide I at 1660cm-1. 
 
 
Figure 85. Average background subtracted spectra of osteo-induced DPSCs at 
days 0, 3, 7, 10, 14 and 28, n=135 spectra per time point from three 
separate donors. 
 
Principal component analysis (PCA) was performed on spectra obtained from 
DPSCs from three donor samples, analysed in triplicate, which had been averaged, 
n=135 spectra at each time point. PCA is a method of reducing the dimensionality of 
multivariate data into groups of potentially correlated variables called principal 
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components (PCs). PC1 represents the group of variables responsible for the greatest 
amount of variation in the data and PC2 the group of variables responsible for the 
second greatest variation in the data and so on. In the case of Raman spectra such as 
those presented here the variables are the wavenumbers which in turn correspond to 
particular molecular species within the cells. Figure 86A is a 2D scatter plot of PC1 
and PC2 scores accounting for 54.2% and 12.4% of the variation in the data set 
respectively, this indicates that the wavenumbers contained within PC1 and 
concomitantly the molecular species they are associated with accounted for 54.2% 
of the variation in the data set and so on. The PCA scores plot demonstrated a 
clustering of spectra at each time point, illustrating that the spectral collection was 
reproducible. As expected, there was overlapping of spectra between adjacent time 
points as there was a phenotypic shift that was continuous in nature during cellular 
differentiation. Despite the overlapping of time points a clear trend was observed 
from day 0 to day 10 along PC1 while a trend from day 7 to day 28 was observed 
along PC2. Loadings plots can be drawn for each PC to illustrate those spectral 
features that are responsible for the variance in that PC. Peaks on the same side of a 
loading plot will be behaving similarly, whilst peaks on opposite sides of a loading 
plot will be behaving differently with respect to their scores within a given PC. 
Figure 86B+C illustrate the loading plots for PC1 and PC2.The loading plot for PC1 
showed positive peaks for wavenumbers corresponding to amide bonds (1260 cm-1 
and 1660 cm-1), CH3, CH2 from collagen (1345 cm
-1 and 1453 cm-1), phenylalanine 
(1003 cm-1) and lipids (1126 cm-1) whilst wavenumbers corresponding to ribose 
(975 cm-1 and 1020 cm-1), the nucleic acids guanine and adenine (1420 cm-1) and 
DNA (1490 cm-1) had negative peaks. Similarly the loading plot for PC2 had 
positive peaks at 1003 cm-1, 1453 cm-1 and 1660 cm1 with negative peaks at 975 cm-
1, 1020 cm-1 and 1490 cm-1. Putative peak assignments were based on Movasaghi et 
al (97). As the above individual PCs both use the same areas it may be hard to 
differentiate which are the important vibrations with respect to time, therefore PC1 
was plotted against PC2 (Figure 86D). In this instance the position of a given 
wavenumber on the plot when transposed on the original scores plot indicates where 
that wavenumber varies most greatly. This loadings plot showed that two protein 
associated peaks at 1453 cm-1 and 1660 cm-1 transpose along the trend in PC1 from 
days 0 to 10, whilst two DNA/RNA associated peaks 975 cm-1 and 1020 cm-1 
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transpose along the trend in PC2 from days 10 to 28 as did the phenylalanine peak at 
1003 cm-1.  
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Figure 86. A) Principal component analysis of the osteogenic differentiation of 
DPSCs at days 0, 3, 7, 10, 14 and 28. 2D scatter plot for principal 
components 1 and 2. Each position displayed is the average of three 
spectra, one from each donor, for every time point. There is a clear trend 
in PC1 between days 0 and 10 and a further trend in PC2 between days 0 
and 10 and days 10 and 28, marked with arrows. B + C) PCA loadings 
plot for PC1 and PC2 respectively, from the PCA of DPSCs that had been 
osteo-induced for 0, 3, 7, 10, 14 and 28 days. Significant positive and 
negative peaks are marked. D) PCA loadings plot for PC1 versus PC2, the 
outer green circle indicates 95% confidence. In the legend are groups of 
wavenumbers from peaks that vary significantly. 
 
Finally, to confirm osteogenic differentiation of DPSCs at day 28 several Raman 
spectra were acquired from putative mineralised nodules, (Figure 87). The well 
characterised mineral associated region, 955 cm-1-964 cm-1, described in several 
previous studies (101, 133, 134), was clearly evident. 
 
 
Figure 87. Average background subtracted spectra of osteo-induced DPSCs at 
day 28 acquired from putative mineralised nodules, n=5. The well 
characterised mineral associated region at ~955cm-1-964cm-1 is clearly 
evident, marked *. 
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Osteogenic Differentiation of DPSCs ± Analysis by Raman Spectroscopy using 
qRT-PCR and Alizarin Red Staining 
qRT-PCR and Alizarin red staining were used to confirm osteogenic differentiation 
of DPSCs after 28 days in osteoinductive medium. Samples that had undergone 
Raman measurements, and those grown in parallel without being subject to Raman, 
were analysed to determine if the data acquisition process and the Raman 
spectroscopy itself had any effect on DPSC osteogenic differentiation. qRT-PCR 
showed significant increases in ALP and OC expression between days 0 and 28 of 
osteo-inductive culture irrespective of whether or not the DPSCs had undergone 
Raman analysis (p<0.001 and p<0.05 respectively) (Figure 88A). There was no 
significant difference in the expression of either gene between DPSCs which had 
been analysed by Raman spectroscopy and those that had not. 
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Figure 88. A) A comparison of DPSC osteogenic gene expression at day 0, and 
day 28 from cells that had/had not undergone Raman spectroscopy. 
Results show mean ±SE, n=3 (day 0), n=12 (day 28 + Raman), n=12 (day 
28 – Raman). *** p<0.001, * p<0.05. Significant increases in the 
expression of both genes was found between days 0 and 28 and there was 
no difference in the expression between DPSCs that had and had not 
undergone Raman spectroscopy. Alizarin red staining of DPSCs after 28 
days of osteo-induction that B) had undergone Raman measurements and 
C) had not undergone Raman measurements. Scale bars = 100 µm. 
Positive staining of bone nodules was observed regardless of whether the 
DPSCs had undergone Raman spectroscopy or not. 
 
Alizarin red staining was used to demonstrate extracellular matrix calcification in 
DPSC cultures after 28 days of osteo-induction  for samples that had been analysed 
by Raman spectroscopy (Figure 88B) and those that had not (Figure 88C). Positive 
- 169 - 
Alizarin red staining was observed in all samples, with no discernible differences 
between the Raman and non-Raman groups, however this was not quantified. 
   
Comparison of DPSCs Cell Stress Marker Gene Expression ± Analysis by Raman 
Spectroscopy using qRT-PCR 
The data acquisition process during Raman spectroscopy used in this study was 
entirely aseptic and non-invasive permitting the same cell cultures to be analysed 
repeatedly throughout the differentiation process. However, this method had the 
potential to induce a cell stress response, due to, for example, limited gas diffusion, 
exposure to ambient temperature and atmospheric gas concentrations, as well as the 
laser on the sample. In order to test for any cell stress response, the expression of 
three marker genes, heat shock transcription factor 1 (HSF), hypoxia inducible 
factor 1 (HIF) and lactate dehydrogenase (LDH) was determined by qRT-PCR for 
DPSCs at day 0 and day 28 ± Raman spectroscopy (Figure 89). No significant 
differences in the expression of all three genes were observed between the groups 
(p>0.05) showing that the Raman and the new culturing approach had not affected 
the cells. 
 
Figure 89. A comparison of DPSC cell stress marker expression at day 0, and 
day 28 from cells that had/had not undergone Raman spectroscopy. 
Results show mean ±SE, n=3 (day 0), 12 (day 28 + Raman), 12 (day 28 – 
Raman). No significant changes in gene expression were observed. 
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Discussion 
This study had two aims, to develop a method for the aseptic acquisition of Raman 
spectra from the same cell cultures over a period of time that did not perturb the 
cells during Raman analysis and to validate this approach by characterising the 
osteogenic differentiation of DPSCs, prior to the outcome becoming apparent by the 
emergence of mineralised nodules. At this end point there is no need for a non-
invasive method to determine cellular differentiation status as such nodules are 
clearly discernible under an ordinary microscope without staining. Therefore we 
focused on acquiring spectra in the first 14 days of osteo-induction with a view to 
identifying spectral features that may indicate/predict cell differentiation.  
 
The first aim of this study, to acquire Raman spectra repeatedly over time from the 
same cell cultures under aseptic conditions, was achieved by customising standard 
tissue culture flasks with quartz windows. This allowed DPSCs to be cultured and 
analysed in the same vessel making the method truly non-invasive. There was no 
evidence of any bacterial or fungal contamination of our cultures at any point. 
However, in future experiments towards the clinical application of our research an 
extensive demonstration that the technique used is aseptic would be conducted.  A 
lack of optimised environmental control during spectra acquisition had the potential 
to induce a cell stress response. In order to investigate any cell stress the expression 
of heat shock transcription factor 1 (HSF), hypoxia inducible factor 1 (HIF1) and 
lactate dehydrogenase (LDH) was determined by qRT-PCR. HSF is a transcription 
factor regulating the expression of several important heat shock factor proteins 
including HSP70 and HSP90 (195) and whilst it is primarily induced by 
hyperthermia it has been shown to be activated in response to increasing temperature 
following hypothermia (196). HIF1 is expressed in response to hypoxia which at 
physiological levels (2-9% O2) is beneficial and a key regulatory mechanism in 
several biological processes including embryogenesis and stem cell function, 
however overexpression at pathological levels (<1% O2) is associated with several 
conditions including ischemia and cancer (197-199). LDH expression is known to be 
stimulated by HIF1 expression and is associated with cancer through increased 
anaerobic glycolysis by a process termed the Warburg effect (200, 201). No 
significant differences in the expression of all three markers genes were found in 
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DPSCs regardless of the Raman sampling process and relative to the start of the 
experiment. Whilst this is not an exhaustive interrogation of the effects of 
performing Raman spectroscopy on DPSCs in ambient conditions for approximately 
3 h at a time, it does indicate that any effects were negligible. Previous studies have 
also demonstrated that Raman spectroscopy and in particular exposure of cells to 
near infra-red lasers with a power on the sample of up to 115 mW does not induce 
cell damage (102). Finally, we determined that our method had no effect, 
detrimental or otherwise, on the osteogenic differentiation process as evidenced by 
no differences in the expression of osteogenic marker genes or in Alizarin red 
staining between DPSCs that had or had not undergone analysis by Raman 
spectroscopy. 
 
The second aim of the study, to validate our aseptic method for cell phenotyping, 
was achieved using repeated Raman measurements to characterise the osteogenic 
differentiation of DPSCs. PCA was performed on spectra acquired throughout the 
osteoinductive differentiation process. The PCA scores plot of PC1 versus PC2 
demonstrated two phases in the process hinged at approximately day 10. The 
loadings for PC1 and PC2 indicated that the pattern of those spectral features 
indicative of proteins and lipids was similar while features indicative of DNA and 
RNA had the opposite pattern but were also similar to one another. When the 
loadings for PC1 and PC2 were plotted against each other, protein associated peaks 
were shown to vary the most in PC1 and therefore from days 0 to 10 while 
DNA/RNA associated peaks varied the most in PC2 and therefore from days 10 to 
28. It is clear from the averaged spectra at each time point that the protein associated 
peaks at 1453 cm-1 and 1660 cm-1 were increasing in intensity. Taken together this 
suggests that in the early stages of DPSC osteogenic differentiation increasing 
protein content is the main marker. This is in agreement with the findings of many 
others (101, 104, 134) and is the first instance where this has been demonstrated 
using the same cell cultures. However, a firm conclusion is more difficult to draw in 
the case of the DNA/RNA associated peaks contributing to the trend in PC2 due to 
their relatively low signal intensity in the original spectra and the lower contribution 
of PC2 (12.4%) to the variation within the data set.  Schulze et al 2010 (104) found 
that one of the major indicators of differentiation in embryonic stem cells was the 
ratio of spectral peaks related to proteins and DNA/RNA, concluding that the 
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intensity of protein associated peaks increased in intensity whilst DNA/RNA peaks 
decreased in intensity with differentiation. Whilst it is clear from our data that the 
intensity of protein associated peaks increases with time the trend is less clear with 
regards to DNA/RNA. Our method however, was clearly able to detect late stage 
osteogenic differentiation, when directed toward mineralised nodules as evidenced 
by the prominent mineral associated region at 955-964cm-1. 
 
In order to enhance the translation of stem cell based therapies into the clinic, 
methods that permit the non-invasive characterisation of stem cell cultures prior to 
their end point are required. Our method, involving the use of standard cell culture 
flasks customised with quartz windows to permit analysis by Raman spectroscopy is 
simple, easily reproducible and capable of detecting events  that are commensurate 
with the osteogenic differentiation process of DPSCs. This approach is easily scaled 
and capable of producing large numbers of Raman-characterised clinically relevant 
cells. As a research tool this method can greatly reduce the time and cost associated 
with producing and validating osteo-induced stem cells for use in further research 
such as the production of cell seeded tissue engineered constructs. 
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Oral Presentations 
Raman Spectroscopy in the Non-invasive Phenotyping of Human Dental Pulp 
Stem Cells (hDPSCs) – Identification of a Suitable Substrate for Cell 
Culture. Adam Mitchell, Xuebin B. Yang, Alistair Smith, Jennifer Kirkham, 
Leeds School of Dentistry postgraduate research day, July 2012 
 
Non-destructive phenotyping of stem cells is increasingly important in both research 
and clinical settings. Current methods render samples unusable for further 
applications. Using Raman spectroscopy, which has previously been employed to 
discriminate between naïve and differentiated stem cells, would permit subsequent 
sample re-use. However, on-going monitoring of stem cell differentiation in a single 
sample is lacking. To achieve this, a Raman appropriate substrate material must be 
identified as tissue culture plastic is unsuitable.  
hDPSCs were isolated from healthy teeth donated with full consent. Following 
expansion hDPSCs were seeded on magnesium fluoride (MgF2), quartz, or tissue 
culture plastic, cultured to confluence and osteo-induced. Differentiation was 
assessed at 7 and 28 days using qRT-PCR for osteogenic gene markers, and alizarin 
red staining. 
After 28 days there were no significant differences in gene expression between 
hDPSCs cultured on quartz and tissue culture plastic, those cultured on MgF2 
exhibited significantly lower levels of COL1A expression, and the late osteogenic 
marker osteocalcin. Alizarin red staining of hDPSCs grown on quartz and tissue 
culture plastic was comparable but weaker on MgF2. 
hDPSCs osteo-induced on quartz substrates possess a comparable phenotype to 
those cultured on tissue culture plastic in contrast to those grown on MgF2. The 
presence of Mg++ in culture medium has been demonstrated to inhibit calcification 
and this may explain the weaker induction of hDPSCs grown on MgF2 if Mg
++ from 
the substrate is leeching into the medium. We conclude that quartz will be a useful 
substrate for non-invasive stem cell phenotyping using Raman spectroscopy. 
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Raman spectroscopy can be used to non-invasively and aseptically characterise 
stem cell differentiation. Adam Mitchell, Lorna Ashton, Xuebin B. Yang,  
Royston Goodacre, Alistair Smith, Jennifer Kirkham, Leeds School of 
Dentistry postgraduate research day, July 2014 (1st place – oral presentation) 
 
There is an unmet need for the non-invasive characterisation of stem cells to 
facilitate the translation of cell-based therapies. Raman spectroscopy has proven 
utility in stem cell characterisation but as yet no method has been reported capable 
of taking repeated aseptic measurements of living cells, such that the cells remain 
suitable for clinical use. The aim of this study was to develop such a method and 
validate it through the characterisation of stem cell osteogenic and adipogenic 
differentiation. Human dental pulp stromal cells (DPSCs) and adipose derived stem 
cells (ADSCs) were osteo and adipo-induced respectively in custom made cell 
culture flasks with quartz windows appropriate for Raman spectroscopy. Raman 
spectra were acquired at regular time intervals during the culture periods and 
principal component analysis (PCA) used to analyse the data. qRT-PCR measured 
the expression of osteogenic, adipogenic  and cell stress markers. PCA of spectra 
obtained from osteo-induced DPSCs indicated that protein-associated features varied 
significantly early in the differentiation process (days 0-10) whilst DNA/RNA-
associated features varied significantly later on (days 10-28). qRT-PCR showed that 
osteogenic marker gene expression was significantly increased after 28 days. Cell 
stress marker expression was unaffected the Raman process. PCA of spectra 
obtained from adipo-induced ADSCs indicated that lipid-associated features varied 
significantly throughout adipogenesis (days 0-14) whilst protein and DNA/RNA-
associated features varied significantly later on (days 7-14). Adipogenic marker 
gene expression was significantly increased after 14 days. The Raman spectra 
acquired in this study and the important spectral features revealed through PCA are 
broadly in agreement with the findings of previous studies using fixed (non-living) 
cells and/or non-sterile methods that preclude repeated measurements over time. In 
contrast, this study has demonstrated that repeated Raman measurements of living 
cells can be obtained under aseptic conditions, providing a potential method for non-
invasive stem cell characterisation for subsequent clinical use. 
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Raman spectroscopy can be used to non-invasively and aseptically characterise 
stem cell differentiation. Adam Mitchell, Lorna Ashton, Xuebin B. Yang,  
Royston Goodacre, Alistair Smith, Jennifer Kirkham, Joint Doctoral 
Training Centre in Tissue Engineering and Regenerative Medicine 
conference, July 2014 
 
There is an unmet need for the non-invasive characterisation of stem cells to 
facilitate the translation of cell-based therapies. Raman spectroscopy has proven 
utility in stem cell characterisation but as yet no method has been reported capable 
of taking repeated aseptic measurements of living cells, such that the cells remain 
suitable for clinical use. The aim of this study was to develop such a method and 
validate it through the characterisation of stem cell osteogenic and adipogenic 
differentiation. Human dental pulp stromal cells (DPSCs) and adipose derived stem 
cells (ADSCs) were osteo and adipo-induced respectively in custom made cell 
culture flasks with quartz windows appropriate for Raman spectroscopy. Raman 
spectra were acquired at regular time intervals during the culture periods and 
principal component analysis (PCA) used to analyse the data. qRT-PCR measured 
the expression of osteogenic, adipogenic  and cell stress markers. PCA of spectra 
obtained from osteo-induced DPSCs indicated that protein-associated features varied 
significantly early in the differentiation process (days 0-10) whilst DNA/RNA-
associated features varied significantly later on (days 10-28). qRT-PCR showed that 
osteogenic marker gene expression was significantly increased after 28 days. Cell 
stress marker expression was unaffected the Raman process. PCA of spectra 
obtained from adipo-induced ADSCs indicated that lipid-associated features varied 
significantly throughout adipogenesis (days 0-14) whilst protein and DNA/RNA-
associated features varied significantly later on (days 7-14). Adipogenic marker 
gene expression was significantly increased after 14 days. The Raman spectra 
acquired in this study and the important spectral features revealed through PCA are 
broadly in agreement with the findings of previous studies using fixed (non-living) 
cells and/or non-sterile methods that preclude repeated measurements over time. In 
contrast, this study has demonstrated that repeated Raman measurements of living 
cells can be obtained under aseptic conditions, providing a potential method for non-
invasive stem cell characterisation for subsequent clinical use. 
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Poster Presentations 
Raman Spectroscopy in the Non-invasive Phenotyping of Human Dental Pulp 
Stem Cells (hDPSCs) – Identification of a Suitable Substrate for Cell 
Culture. Adam Mitchell, Xuebin B. Yang, Alistair Smith, Jennifer Kirkham, 
Joint Doctoral Training Centre in Tissue Engineering and Regenerative 
Medicine conference, July 2012 
 
Introduction: 
Non-destructive phenotypic characterisation of stem cells is becoming increasingly 
important in both research and clinical settings. Current methods such as 
immunohistology, qRT-PCR and western blotting render samples unusable for 
further applications. One of several methods that would permit the subsequent re-use 
of samples is Raman spectroscopy. Raman spectroscopy has already been used to 
discriminate between cancerous and non-cancerous cells (1), and naïve and 
differentiated stem cells (2). However, an on-going assessment of stem cell 
differentiation of a single sample is yet to be demonstrated. In order to achieve this, 
a suitable substrate material that does not interfere with the differentiation process 
must be identified as tissue culture plastic is unsuitable for Raman spectroscopy 
applications 
Materials and Methods: 
hDPSCs were isolated from healthy teeth donated with appropriate ethical consent. 
Following population expansion hDPSCs were seeded on to magnesium fluoride 
(MgF2), quartz, or tissue culture plastic, cultured to confluence and osteo-induced. 
Differentiation was assessed at 7 and 28 days using alizarin red staining, and qRT-
PCR for osteogenic gene markers. 
Results: 
After 28 days there were no significant differences in gene expression between 
hDPSCs grown on quartz and tissue culture plastic. However, those cultured on 
MgF2 exhibited significantly lower levels of expression of type 1 collagen, and the 
late osteogenic marker osteocalcin (fig 1). Alizarin red staining of hDPSCs grown 
on quartz and tissue culture plastic after 28 days was comparable, but weaker for 
those cultured on MgF2. 
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Discussion: 
hDPSCs osteo-induced on quartz substrates possess a comparable phenotype to 
those cultured on tissue culture plastic, whilst those grown on MgF2 do not. The 
presence of Mg++ in culture media has been demonstrated to inhibit calcification in a 
dose dependant manner (3). This may explain the weaker induction of hDPSCs 
grown on MgF2 if Mg
++ from the substrate is leeching into the media. 
Conclusion: 
Raman spectroscopy of hDPSCs cultured on quartz substrates will provide a 
mechanism for non-invasive phenotyping of stem cell differentiation along the 
osteogenic pathway. 
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Development of a method for the non-invasive and non-destructive 
characterisation of human dental pulp stem cells. Adam Mitchell, Xuebin B. 
Yang, Alistair Smith, Jennifer Kirkham, Leeds School of Dentistry 
postgraduate research day, July 2013 
 
There is need for characterisation of stem cell differentiation using non-invasive and 
non-destructive methods for both research applications and prior to their use in cell-
based regenerative therapies. Raman spectroscopy, which uses near infra-red light to 
determine sample chemistry, has been used to characterise stem cells but its 
application has been limited due to an inability to maintain sterility. The aim of this 
study was to design a system to permit repeated application of Raman spectroscopy 
to living stem cells in long term culture. This required 1) identification of a Raman 
appropriate substrate, 2) development of a system to maintain culture sterility and 3) 
selection of an optical configuration to maximise the Raman signal. Quartz and 
MgF2 were investigated as potential cell culture substrates. Dental pulp stem cells 
(DPSCs) were osteo-induced and their stage of differentiation assessed by qRT-PCR 
and alizarin red staining. Quartz cuvettes and cell culture flasks, customised to 
accommodate quartz coverslips were tested for culture sterility. A variety of 
microscope lenses were tested for optimal Raman signal acquisition and average 
spectra produced from 50 individual loci for each cell culture. Results demonstrated 
that DPSCs cultured on quartz but not MgF2 had similar osteogenic differentiation to 
those cultured on tissue culture plastic. DPSCs cultured in quartz cuvettes and in 
customised culture flasks were successfully maintained in sterile conditions for up to 
28 days. Customised culture flasks were selected as the thickness of the cuvette 
quartz precluded successful acquisition of Raman spectra. A 40x 0.8NA water 
immersion lens demonstrated reproducible spectra and the best signal intensity to 
noise ratio. Sterility can be maintained and Raman spectra successfully acquired 
using cell culture flasks customised with quartz windows and a water immersion 
lens. This offers a non-invasive system by which Raman spectroscopy may be used 
to characterise the differentiation status of stem cells. 
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Development of a method for the non-invasive and non-destructive 
characterisation of human dental pulp stem cells. Adam Mitchell, Xuebin B. 
Yang, Alistair Smith, Jennifer Kirkham, Joint Doctoral Training Centre in 
Tissue Engineering and Regenerative Medicine conference, July 2013 
 
There is need for characterisation of stem cell differentiation using non-invasive and 
non-destructive methods for both research applications and prior to their use in cell-
based regenerative therapies. Raman spectroscopy, which uses near infra-red light to 
determine sample chemistry, has been used to characterise stem cells but its 
application has been limited due to an inability to maintain sterility. The aim of this 
study was to design a system to permit repeated application of Raman spectroscopy 
to living stem cells in long term culture. This required 1) identification of a Raman 
appropriate substrate, 2) development of a system to maintain culture sterility and 3) 
selection of an optical configuration to maximise the Raman signal. Quartz and 
MgF2 were investigated as potential cell culture substrates. Dental pulp stem cells 
(DPSCs) were osteo-induced and their stage of differentiation assessed by qRT-PCR 
and alizarin red staining. Quartz cuvettes and cell culture flasks, customised to 
accommodate quartz coverslips were tested for culture sterility. A variety of 
microscope lenses were tested for optimal Raman signal acquisition and average 
spectra produced from 50 individual loci for each cell culture. Results demonstrated 
that DPSCs cultured on quartz but not MgF2 had similar osteogenic differentiation to 
those cultured on tissue culture plastic. DPSCs cultured in quartz cuvettes and in 
customised culture flasks were successfully maintained in sterile conditions for up to 
28 days. Customised culture flasks were selected as the thickness of the cuvette 
quartz precluded successful acquisition of Raman spectra. A 40x 0.8NA water 
immersion lens demonstrated reproducible spectra and the best signal intensity to 
noise ratio. Sterility can be maintained and Raman spectra successfully acquired 
using cell culture flasks customised with quartz windows and a water immersion 
lens. This offers a non-invasive system by which Raman spectroscopy may be used 
to characterise the differentiation status of stem cells. 
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Development of a method for the non-invasive and non-destructive 
characterisation of human dental pulp stem cells. Adam Mitchell, Xuebin B. 
Yang, Alistair Smith, Jennifer Kirkham, Regener8 conference, Leeds, 
October 2013 
 
There is need for characterisation of stem cell differentiation using non-invasive and 
non-destructive methods for both research applications and prior to their use in cell-
based regenerative therapies. Raman spectroscopy, which uses near infra-red light to 
determine sample chemistry, has been used to characterise stem cells but its 
application has been limited due to an inability to maintain sterility. The aim of this 
study was to design a system to permit repeated application of Raman spectroscopy 
to living stem cells in long term culture. This required 1) identification of a Raman 
appropriate substrate, 2) development of a system to maintain culture sterility and 3) 
selection of an optical configuration to maximise the Raman signal. Quartz and 
MgF2 were investigated as potential cell culture substrates. Dental pulp stem cells 
(DPSCs) were osteo-induced and their stage of differentiation assessed by qRT-PCR 
and alizarin red staining. Quartz cuvettes and cell culture flasks, customised to 
accommodate quartz coverslips were tested for culture sterility. A variety of 
microscope lenses were tested for optimal Raman signal acquisition and average 
spectra produced from 50 individual loci for each cell culture. Results demonstrated 
that DPSCs cultured on quartz but not MgF2 had similar osteogenic differentiation to 
those cultured on tissue culture plastic. DPSCs cultured in quartz cuvettes and in 
customised culture flasks were successfully maintained in sterile conditions for up to 
28 days. Customised culture flasks were selected as the thickness of the cuvette 
quartz precluded successful acquisition of Raman spectra. A 40x 0.8NA water 
immersion lens demonstrated reproducible spectra and the best signal intensity to 
noise ratio. Sterility can be maintained and Raman spectra successfully acquired 
using cell culture flasks customised with quartz windows and a water immersion 
lens. This offers a non-invasive system by which Raman spectroscopy may be used 
to characterise the differentiation status of stem cells. 
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Introduction 
Stem cell based therapies are becoming increasingly prominent with many now in 
clinical trials (1). Non-invasive and non-destructive characterisation of stem cells 
prior to their use in downstream applications is important both for safety reasons and 
in reducing material, time and monetary costs. Raman spectroscopy has been used 
previously in live cell analysis (2). However, a methodology for repeated live cell 
measurements under sterile conditions has yet to be demonstrated. The aim of this 
study was to develop such a method utilising osteoinduced human dental pulp 
stromal cells (hDPSC). 
  
Materials and Methods 
hDPSCs were isolated and maintained for 28 days in osteo-inductive medium in cell 
culture flasks customised with quartz windows suitable for Raman analysis. Raman 
spectra were acquired from the cells at days 0, 3, 7, 10, 14 and 28 n=135 per time 
point. Principle Component Analysis (PCA) assessed spectral variation with time. 
At day 28, osteogenic differentiation was assessed using alizarin red staining and 
qRT-PCR for ALP and OC. qRT-PCR was also used to assess the expression of the 
cell stress markers HIF-1, HSF-1 and LDH at day 0 and at day 28 on hDPSCs that 
had undergone Raman spectroscopy and those that had not. Statistical significance 
was determined by one-way ANOVA. 
 
Results 
PCA demonstrated trends in PC1 and PC2, Figure 1. Loadings for PC1 showed a 
positive effect in peaks indicative of proteins (1003cm-1, 1260cm-1, 1345cm-1, 
1453cm-1 and 1660cm-1) and a negative effect of peaks indicative of DNA and RNA 
(975cm-1, 1020cm-1, 1420cm-1 and 1490cm-1). PC2 was positive for peaks at 
1003cm-1, 1453cm-1 and 1660cm-1 and negative for peaks at 975cm-1, 1020cm-1 and 
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1490cm-1. Alizarin red staining was positive in all samples at day 28 and significant 
increases in ALP (p<0.001) and OC (p<0.05) gene expression were observed. No 
significant variation in the expression of the three cell stress markers was detected ± 
Raman spectroscopy. 
 
Figure 1. PCA of osteo-induced DPSCs 
 
Discussion and Conclusions 
Raman spectroscopy can detect changes in hDPSCs under osteo-inductive culture 
that are commensurate with cell differentiation, particularly in the first two weeks, 
prior to any phenotypic changes observed using other invasive methodologies. The 
novel methodology used was able to maintain sterility for the course of the 
experiment, permitted repeated measurements of the same cultures and did not 
induce a cell stress response. The data suggest that prediction and monitoring of 
hDPSCs differentiation prior to their use in further applications might therefore be 
possible. 
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in Dental Pulp Stromal Cells. Adam Mitchell, Lorna Ashton, Xuebin B. 
Yang,  Royston Goodacre, Alistair Smith, Jennifer Kirkham, International 
Association of Dental Research world congress, Cape Town, South Africa, 
June 2014 
Objectives: 
Traditional methods for characterising stem cell differentiation are often destructive 
and/or invasive. To facilitate scale up and clinical translation of cell-based therapies, 
non-invasive methods are therefore required. Raman spectroscopy has previously 
been used in cell analysis but there are no methodologies available capable of 
making repeated Raman measurements on the same living cells in long term culture 
while maintaining sterility. The aim of this study was to determine if Raman 
spectroscopy could be used to assess human dental pulp stromal cell (hDPSC) 
differentiation down the osteogenic lineage by taking repeated measurements from 
the same cell cultures. 
Methods: 
hDPSCs were isolated from extracted premolar teeth from 3 consenting donors. 
Following in vitro expansion, hDPSCs were maintained for 28 days in osteo-
inductive medium. Raman spectra were acquired from the cells at days 0 (n=108), 3 
(n=102), 7 (n=114), 10 (n=105), 14 (n=105) and 28 (n=72).  Principle Component 
Analysis (PCA) was carried out to assess spectral variation with time using MatLab. 
At day 28, differentiation was assessed using alizarin red staining and qRT-PCR for 
alkaline phosphatase and osteocalcin. 
Results: 
PCA demonstrated a trend in PC1, responsible for ~90% of the variation in the data 
set, which increased between days 0 and 10, plateauing afterwards. Loadings for 
PC1 showed an increase in spectral peaks indicative of proteins (1000cm-1, 1320cm-
1 and 1650cm-1). Peaks indicative of lipids (1450cm-1 and 1300cm-1) and DNA, 
(1080cm-1) decreased. Alizarin red staining was positive in all samples at day 28 and 
significant increases in alkaline phosphatase (p<0.001) and osteocalcin (p<0.05) 
gene expression were observed. 
Conclusion: 
Raman spectroscopy can non-invasively detect changes in osteogenic cell cultures 
that are commensurate with cell differentiation, particularly in the first two weeks. 
The data suggest that prediction and monitoring of hDPSCs differentiation prior to 
their use in further applications might therefore be possible.  
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